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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
SYMPOSIUM ON PANCREATITIS
One of the effects of sponsorship of the 
Canadian Journal of Surgery by the Royal 
College of Physicians and Surgeons of Can­
ada was the Journal’s acceptance of a great­
er role in the continuing education of sur­
geons. It was to become more reader- 
oriented. One way in which the Journal 
hopes to fulfil this responsibility is to publish 
presentations from annual or regional meet­
ings of the Royal College on subjects that 
are of interest to broad groups of Canadian 
surgeons. Obviously the efficacy of this ap­
proach will depend on the quality of the 
programs at the various meetings. If pro­
gram committees organize sessions on topics 
that are appropriate to the activities of large 
numbers of Canadian surgeons, then much 
valuable material will be available. But if 
the thrust of presentations is restricted to 
one segment of readers, the Journal and 
the College will not fulfil their educational 
responsibilities to Canadian surgeons.
This issue of the Journal (page 191) con­
tains four papers based on a symposium on 
pancreatitis that was one of the prestruc­
tured sessions at the 44th annual meeting 
of the College in Winnipeg, January 1975. 
Though to some, such presentations may 
appear to provide a minimum of informa­
tion that is new or original, by their very 
nature these papers contain critical, consi­
dered views and observations by experi­
enced physicians. Such informed understand­
ing on the part of proficient contemporaries 
can only benefit surgeons who are willing to 
challenge the validity of their personal clinic­
al practices and scientific concepts. It is 
to be hoped that publication of these papers 
will help each of us prevent deterioration in 
the quality of medical care that results from 
intellectual complacency and obsolescence.
J. E. D evitt, MD, FRCS(Edin), FRCS[C]
Director,
Continuing medical education,
University of Ottawa,
Ottawa, Ont. *
DEVELOPMENT OF NATIONAL GUIDELINES FOR TREATMENT: 
A UROLOGIST’S VIEWPOINT
No practical method for assessing primary 
medical care has yet been developed. Both 
organized medicine and the medical agencies 
responsible for the financial support of med­
ical care are groping for methods of assessing 
the quality of care. As statistics are gathered 
concerning care as related to procedures, 
there has been a demand from some gov­
ernment agencies to establish guidelines for 
the treatment of various conditions. Argu­
ments in favour of national guidelines re­
volve around such issues as cost control, 
quality control and uniformity of care.
The working party in urology concluded 
in their recent report to the requirements 
committee of the Committee on Physician 
Manpower that the number of urologists 
required to do a specific volume of work 
would be increased if national guidelines 
for the treatment of urologic conditions 
were established. Guidelines that were 
developed by the American Urological 
Association were obviously meant to cover 
every possible contingency. Should these be 
adopted, every patient attending a urology 
clinic would require the full investigation 
outlined in these guidelines. This would be
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necessary in order to protect the urologist 
against possible medicolegal action and 
future charges of operating without a com­
plete workup. These two inevitable results 
would not control costs but rather increase 
them.
The working party also concluded that it 
would be impossible to establish national 
guidelines acceptable in all parts of the 
country because of varying socioeconomic, 
racial, cultural and regional differences.
In view of their own practical experi­
ences, members of the working party be­
lieved that the establishment of national 
guidelines would not aid the effectiveness of 
the disciplinary process. The adversary 
method at the provincial level may lead to 
acquittal on a legal technicality, even when 
discipline for inferior work seems necessary, 
and the physician who is disciplined may re­
verse the decision by the clever manipulation
of political pressure. It seemed to members 
of the working party that each hospital, 
through its tissue and audit committees (with 
the provincial licensing body as a referee) 
should be able to establish more efficiently 
the best kind of quality control of its sur­
gical staff.
Finally, potential changes in the malprac­
tice situation in Canada could lead to a 
situation where surgeons would feel com­
pelled to carry out every preoperative assess­
ment test listed in the national guidelines in 
order to protect themselves from possible 
future medicolegal action; they would be 
forced to practise defensive medicine.
The need for the development of national 
guidelines for treatment has not been proved.
W. E. C o l l in s , MD, FRCS[C]
Professor of surgery (urology),
University of Ottawa,
Ottawa, Ont.
SELF-ASSESSMENT
SESAP II QUESTION
433. Which of the following indicates an especially poor prognosis for a patient with acute 
hemorrhagic pancreatitis?
(A) Serum amylase level greater than 1000 Somogyi units
(B) Serum calcium concentration less than 7 m g/100 ml
(C) Hematocrit of 46 per cent
(D) Increased serum bilirubin concentration
(E) None of the above
For this question select the one answer that is BEST from those noted above.
For the critique of Item 433 see page 210 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: 
Surgical Education and Self-assessment Program No. 2.)
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DO GALLSTONES CAUSE PANCREATITIS?
PAUL R.
M o st  cases of pancreatitis are caused either 
by biliary tract disease or alcoholism. Gall­
stones can produce pancreatitis by several 
mechanisms:
1. A common etiologic agent.— Over­
weight patients are more likely to develop 
gallstones and pancreatitis than patients of 
normal weight. Experimentally, it is easy to 
induce bile pancreatitis in well-fed dogs but 
it is nearly impossible to do so in nutritional­
ly depleted animals.1 Obesity must be con­
sidered an important factor. It is not the 
only factor since most obese patients remain 
obese after biliary tract surgery for pan­
creatitis due to gallstones, but recurrent 
pancreatitis develops in only 5% of them.2
2. Obstruction of the pancreatic duct.— 
In animal experiments, ligation of the pan­
creatic duct followed by a strong stimulation 
of pancreatic secretions consistently results 
in acute edematous pancreatitis. Pancreatic 
necrosis is produced only if the venous or 
lymphatic drainage is impaired3 or if there 
is interference with the arterial supply.4 
Only 25% of patients with “gallstone pan­
creatitis” have stones in the common bile 
duct, and in less than 5% a stone is found 
blocking both the common bile duct and 
the pancreatic duct.5 The common explana­
tion is that a stone obstructs the ampulla of 
Vater but then passes spontaneously into the
Reprint requests to: Dr. P. R. Poncelet, Depart­
ment of surgery, Centre Hospitalier Universitaire, 
Laval University, Quebec, PQ HOS 1N0.
PONCELET
duodenum. Another explanation is that 
edema or spasm blocks pancreatic out­
flow.6 Our policy is to operate as soon as 
possible on patients with acute pancreatitis 
when there is a strong clinical suspicion 
that gallstones are responsible. A cholan- 
giogram with manometric measurement of 
common-bile-duct pressure is performed in 
each patient. In all patients with gallstone 
pancreatitis operated upon within 24 hours 
of the onset of symptoms a stone was found 
in the common bile duct, edema was present 
radiologically, or manometry demonstrated 
increased resistance of the sphincter of Oddi. 
Whether this spasm and edema are the 
cause or the consequence of pancreatitis is 
debatable. Most patients with gallstones 
harbour enteric bacteria in their biliary tract, 
and infected bile can produce intense spasm 
of the sphincter of Oddi, probably related 
to the presence of deconjugated bile salts.6
3. The common channel theory.— The 
common bile duct and the pancreatic duct 
open into the ampulla of Vater or the 
duodenum so that reflux is possible in either 
direction in 95% of patients.7 After 12 
hours of obstruction, the pressure gradient 
is such that bile can reflux into the pan­
creas.8 Since bile containing bacteria or free 
bile salts can produce extensive pancreatic 
necrosis, reflux of bile into the pancreas is 
possible. A mixture of pancreatic juice and 
bile is toxic, probably because of its high 
lysolecithin content.9
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4. Bacteria and toxins.— Pancreatic ne­
crosis can be produced by the injection of 
Staphylococcus aureus toxins10 or patho­
genic strains of Escherichia coli into the 
pancreatic duct.11 A Shwartzman pheno­
menon or an Arthus reaction can also pro­
duce pancreatic necrosis when triggered by 
E. coli endotoxins or meningococcal 
toxins.12' 13 These can easily reach the 
pancreas through a common channel or 
through lymphatic pathways.
Co n c l u s io n
Although the exact mechanism of gall­
stone pancreatitis is unknown, the presence 
of bacteria and toxins in the biliary tract 
of these patients is an indication for early 
operation to limit the development of pan­
creatitis.
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INVESTIGATION OF THE “PANCREAS PATIENT”
MANSOUR JABBARI
T h e  diagnosis of chronic disease of the pan­
creas can be difficult. The measurement of 
serum amylase and lipase concentrations, 
though helpful in the diagnosis of acute 
pancreatitis, is of little help in the diagnosis 
of chronic disease or carcinoma of the pan­
creas. While chronic disease of the pancreas 
may impair both the endocrine and exocrine 
functions of pancreas, steatorrhea is a late 
manifestation, which occurs only when pan­
creatic enzyme output is decreased by 90%.
C o n v e n t io n a l  D iag no stic
T e c h n iq u e s
Impaired pancreatic function can be 
tested by stimulating the pancreas with se­
cretin and then collecting the pancreatic
Reprint requests to: Dr. M. Jabbari, Department 
of medicine, Queen Mary Veterans’ Hospital, 4565 
Queen Mary Rd., Montreal, PQ H3W 1W5.
juice from the duodenum. Abnormal meas­
urements of volume, bicarbonate and en­
zymes indicate significant impairment of 
exocrine pancreatic function. In mild, chro­
nic pancreatitis or in carcinoma of the pan­
creas, the values may be well within normal 
limits. Radiologic investigation may help in 
assessing pancreatic disease. The presence 
of pancreatic calcification in the plain film 
is pathognomonic of chronic pancreatitis. 
Gastrointestinal series may reveal changes 
in the duodenal loop indicating involvement 
of the head of pancreas. This can be studied 
further by hypotonic duodenography. With 
this technique the muscular activity of the 
duodenum is paralyzed by an anticholinergic 
drug given by parenteral injection, and ba­
rium is introduced into the duodenum. The 
duodenal wall becomes relaxed against the 
pancreas and changes in the mucosa can be 
observed. A diagnostic accuracy of 85% for
M a y  1976 THE CANADIAN JOURNAL OF SURGERY 193
diseases affecting the pancreaticoduodenal 
interface has been reported,1 but the differ­
ential diagnosis between carcinoma of the 
head of the pancreas and chronic pancrea­
titis is not always easy.
The use of selenomethionine in scanning 
the pancreas has been disappointing. Be­
cause of appreciable variation in the normal 
anatomy of the pancreas and the accumula­
tion of radioactive material in the liver, 
there have been both false-positive and 
false-negative results. This technique has 
been abandoned in most centres.
Although in many patients conventional 
techniques are successful in demonstrating 
pancreatic disease, a large number of pa­
tients with abdominal pain and weight loss, 
suspected of having pancreatic disease, re­
main in whom the results are inconclusive. 
A method of detecting pancreatic disease, 
particularly carcinoma of the pancreas in an 
early stage, is needed.
Specific Techniques
One of the oldest diagnostic procedures 
for pancreatic carcinoma is cytologic exam­
ination. The collection of suitable pancreatic 
juice is difficult, but with duodenoscopy 
after the injection of secretin, pancreatic 
juice can be collected directly from ampulla 
of Vater or from the main pancreatic duct 
if it enters separately into the duodenum. 
In a recent report from Japan,2 carcinoma 
of the pancreas was diagnosed by this tech­
nique in 22 out of 29 patients by cytologic 
examination alone.
Angiography has been used for the diag­
nosis of pancreatic tumour and pseudocyst. 
Because most tumours of the pancreas are 
avascular the diagnosis can only be made in 
the advanced stage when there is invasion 
of blood vessels, “tumour cuffing”, or dis­
placement of vessels by a large mass. Despite 
success rates of up to . 75%, confirmed by 
autopsy, there are frequent false-positive 
and false-negative diagnoses.3 A small car­
cinoma of the pancreas is unlikely to be de­
tected by this method. Angiography is use­
ful in the diagnosis of islet cell tumours as 
these tumours are vascular, and tumour 
vessels and tumour blushing can be demon­
strated with a success rate of 60% .4
Ultrasound in a frequency range of 1 to 
10 MHz (1 to 10 million cps) is absorbed in 
homogeneous organs such as the liver. It is 
rejected at tissue interfaces, and the return­
ing echo can be photographically recorded. 
This is a noninvasive and nonionizing proce­
dure, which can be performed repeatedly in 
the same patient without ill effect. Although 
its value in the diagnosis of pancreatic tu­
mours is limited, it is the procedure of choice 
in the diagnosis of pseudocysts, a diagnostic 
accuracy of 90% having been achieved.5
Endoscopic retrograde cholangiopancrea­
tography (ERCP) has been pioneered by 
Japanese endoscopists. Experienced endo­
scopists can perform ERCP successfully in 
90% of patients. Although occasional fatal 
cases of pancreatic sepsis have been report­
ed,6 serious complications are rare. Transient 
elevation of the serum amylase concentra­
tion is not uncommon. After local anesthe­
tic and diazepam have been administered to 
the patient, the duodenoscope is passed and 
the stomach and duodenum are evaluated. 
The duodenum is relaxed by an anticholi­
nergic drug, the ampulla of Vater is visual­
ized and a small catheter passed into it. 
Diatrizoate methylglucamine 60% (Reno- 
grafin) is injected under fluoroscopic con­
trol and appropriate radiographs are taken. 
This technique not only provides the correct 
diagnosis in most patients with pancreatic 
disease but also demonstrates the underlying 
anatomic changes. Normal pancreatic ducts 
are smooth, without areas of stenosis or 
dilatation. In acute pancreatitis the small 
branches of pancreatic ducts are opacified 
and the dye enters the pancreatic acini. In 
chronic pancreatitis there are specific and 
pathognomonic changes. The ducts are irreg­
ular in outline with areas of stenosis and 
dilatation. In all our patients with subse­
quently proven chronic pancreatitis, ERCP 
was abnormal. The diagnostic success rate 
with ERCP in patients with chronic pan­
creatitis ranges from 50 to 100%.7-9 About 
60% of pseudocysts of the pancreas connect 
with the pancreatic duct. In carcinoma of 
the pancreas there is stenosis, obstruction or 
displacement of the duct. ERCP and cyto­
logy can now be combined to give, perhaps, 
an early diagnosis of carcinoma of the pan­
creas.
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Conclusions
Serum amylase, lipase and blood glucose 
determinations are of limited value in diag­
nosing chronic pancreatitis or tumour of 
the pancreas, as is a barium series, even with 
hypotonic duodenography. Arteriography 
helps in the diagnosis of islet cell tumours 
and ultrasonography is valuable in the diag­
nosis of pseudocyst. Retrograde pancreato­
graphy is the most promising aid for diagnos­
ing chronic pancreatitis and carcinoma.
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HOW I TREAT ACUTE PANCREATITIS
MARION C. ANDERSON
In planning therapy for patients with acute 
pancreatitis, certain fundamental principles 
should be considered.
1. Acute pancreatitis is not a single dis­
ease entity. It is an inflammatory process 
that occurs in response to a number of dis­
orders in normal physiology, which are 
usually associated with chronic biliary tract 
disease, or chronic alcoholism, or both. The 
clinical severity is variable; treatment meth­
ods, morbidity and mortality figures are dif­
ficult to evaluate and compare.
2. The magnitude of the inflammatory 
process is unpredictable, especially at the 
outset of the attack. The changes range from 
mild edema, which usually is self-limiting, 
to less common acute necrotizing pancrea­
titis.
3. Presently there is no specific test that 
unequivocally will identify the patient with 
acute pancreatitis. Clinical findings, labora­
tory studies and other diagnostic tests permit 
a reasonably accurate assessment of these 
patients; however, the initial diagnosis is pre­
sumptive and the physician must be willing 
to revise his approach in keeping with the 
subsequent course of the patient.
Reprint requests to: Dr. M. C. Anderson, Depart­
ment of surgery, Medical College of Ohio, Box 
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4. The more severe forms of pancreatic 
inflammation are associated with a reduc­
tion in the effective circulating blood vol­
ume. Fluid is lost into the pancreas, the re­
troperitoneal area, the peritoneal cavity and 
the gastrointestinal tract; portal pooling may 
occur. The circulating blood volume in any 
given patient may drop to 60 to 70% of 
normal.
Medications and Methods of
Treatment
The keystone to successful treatment of 
patients with acute pancreatitis is adequate 
replacement of fluid and electrolytes. There 
is no magic formula. Replacement should 
be sufficient to maintain a urine volume of 
40 to 60 m l/hr and should include albumin 
to replace protein losses. In some instances, 
red cell mass must also be replaced. After 
replacing fluid losses in the acute phase of 
dehydration, serial hemograms and elec­
trolyte determinations help in estimating re­
placement needs. Suppression of exocrine 
secretion is important. Patients should be 
treated with nasogastric suction to remove 
gastric hydrochloric acid, to decrease se­
cretin stimulation, and to control the disten­
sion caused by swallowed air and secondary 
ileus.
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Anticholinergic drugs decrease the se­
cretion of gastric hydrochloric acid and may 
reduce the amount of spasm, including 
sphincteric spasm, in the upper gastrointes­
tinal tract. The use of these drugs in acute 
pancreatitis is controversial because they 
also increase the viscosity of secretions in 
both the pancreas and the pulmonary tree 
and they reduce bowel motility thereby con­
tributing to ileus. Anticholinergics elevate 
the pulse rate, and thus eliminate one of the 
valuable clinical signs used to monitor fluid 
and electrolyte replacement. We currently 
use carbonic anhydrase inhibitors, such as 
acetazolamide; these reduce the volume of 
exocrine pancreatic secretion by 50% al­
most immediately after their administra­
tion.1
We control pain with meperidine and see 
little evidence for more aggressive therapy. 
We rarely use nerve blocks or epidural anes­
thesia.
In theory, an enzyme inhibitor would be 
of great value. In practice we are dealing 
with a series of enzymes, including trypsin, 
chymotrypsin, lipase and phospholipase A, 
and a polyvalent enzyme inhibitor is not 
available for clinical use. It is at the moment 
impossible to conceive of a single agent 
that would inhibit all the substances impli­
cated in the inflammatory process.
Hyperglycemia develops in many patients 
during the course of acute pancreatitis but 
is rarely clinically important.
We do not use prophylactic antibiotics; 
patients who manifest signs of sepsis re­
ceive broad-spectrum antibiotics until cul­
ture reports are available.
Disseminated intravascular coagulation 
should be suspected in patients with evidence 
of multiple system involvement. We have 
administered heparin to these patients with 
favourable results.
Some advocate peritoneal lavage.2 Our 
experience to date is limited. We have not 
been impressed with the value of this form 
of therapy.
Steroids in experimental animals block 
the effects of trypsin on small vesels in the 
pancreas. Vasodilatation, stasis and in­
creased capillary permeability do not occur 
in the animal treated with steroids. It is for 
this theoretical purpose that we have used
steroids clinically in severely ill patients who 
have not responded to other forms of treat­
ment; our results suggest that steroids may 
be helpful in some cases.
A high percentage of patients respond 
favourably to the relatively empirical meas­
ures mentioned above. The remainder (less 
than 10%) do not improve or actually de­
teriorate during therapy. In these patients 
abdominal exploration should be seriously 
considered.
Acute fulminating pancreatitis in some pa­
tients is easily confused with many other 
serious abdominal conditions such as 
strangulation of an intestinal loop. In such 
cases laparotomy will either confirm the 
diagnosis of pancreatitis (with or without 
a complication, such as pancreatic abscess, 
tissue necrosis or pseudocyst), or establish 
the true cause of the patient’s symptoms.
If the patient does have pancreatitis, what 
should be done surgically? If the gallbladder 
is distended and the patient has acute pan­
creatitis, we would decompress the extra- 
hepatic biliary tract with a cholecystostomy. 
We would not attempt to carry out a com­
prehensive correction of extrahepatic biliary 
tract disease. We would not explore the 
common duct, open the duodenum or divide 
the sphincter of Oddi at the time of an acute 
attack of pancreatitis. Occasionally an acute 
pseudocyst that requires drainage will be 
encountered; treatment should be limited to 
simple external drainage. A necrotic segment 
of pancreas may be found; it requires de­
bridement and external drainage. Recently 
interest has been shown in the use of gastro­
stomy and jejunostomy to eliminate the need 
for nasogastric suction and provide a route 
for early alimentation. We have seen a series 
of these patients referred, not for pancrea­
titis, but for the complications that occurred 
because the enterostomy site failed to heal. 
Wounds in patients with acute pancreatitis 
do not heal well, therefore any kind of in­
cision into the intestinal tract during the 
acute phase of pancreatitis should be made 
only after serious consideration has been 
given to the consequences.
It is extremely important to use care in 
closing the abdominal incision. Permanent 
nonabsorbable sutures are essential. We use 
a figure-eight Smead-Jones type of closure.
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We prefer not to use firm rubber or plastic 
catheters for sump drainage because in 
some of our patients these tubes have eroded 
into the intestinal tract and produced enteric 
fistulas. We may use sump suction in the 
isolated pseudocyst or abscess requiring 
prolonged drainage. Usually we place multi­
ple, soft rubber drains throughout the up­
per abdomen to provide adequate drainage. 
Abscesses, which usually develop during the 
2nd or 3rd week after operation, should be 
treated by external drainage as soon as the 
diagnosis is made.
Complications
Complications of acute pancreatitis are 
formidable and account for most of the 
morbidity and mortality of this disease. In­
volvement of the central nervous system in 
acute pancreatitis is becoming better under­
stood. Many patients were thought to have 
delirium tremens as a consequence of alco­
hol excess, but evidence suggests that in 
some cases this may be related to demyeli- 
nization of the brain as a result of lipase and 
phospholipase-A activity.3 Cardiac ab­
normalities, including electrocardiographic
changes, are fairly common. The most criti­
cal problem is pulmonary insufficiency.4 In 
some patients pulmonary changes develop, 
with all the characteristics of shock lung. In 
others, atelectasis, pneumonitis and pleural 
effusion develop. Ventilatory support is 
often required if the patient is to survive, 
and failure to provide such support is prob­
ably the most common cause of serious mor­
bidity and mortality in patients with acute 
pancreatitis. Hepatic insufficiency, renal in­
sufficiency and ileus also occur. A number 
of patients are unable to tolerate adequate 
oral nutrition because of the extensive in­
flammatory reaction involving the stomach 
and upper gastrointestinal tract.
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PSEUDOCYSTS OF THE PANCREAS
ALAN G. THOMPSON
Pancreatic pseudocysts usually develop as 
a complication of acute pancreatitis when 
there is disruption of the pancreatic duct, or, 
in chronic inflammation of the pancreas, 
when there is stricture within the duct 
system. In either event, some portion of 
the pancreas, usually the tail, or the 
body and tail, secretes into the pseudo­
cyst rather than into the duodenum because 
of the disrupted or stenotic ductal pathway. 
With secretion into this pseudocyst space 
there is pain and distension of the surround­
ing structures. The patient may notice a 
palpable mass in the upper abdomen. It can 
be detected by x-ray or by ultrasonic B scan­
ning.
Differentiation between acute and chronic 
pseudocysts is important. The acute variety
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develops during severe acute pancreatitis; 
it is commonly present in the lesser sac but 
may be associated with any part of the pan­
creas. The impression that many acute pseu­
docysts disappear spontaneously has recent­
ly been confirmed by serial B scanning 
where one can see the gradual diminution 
in size of a collection of fluid with eventual 
disappearance within a few weeks. On the 
other hand, the acute pseudocyst may per­
sist and enlarge constituting a dangerous, 
potentially lethal complication; in such cases 
it should be drained externally. Because it 
is part of an acute inflammatory process, 
internal drainage is contraindicated, since 
hemorrhage, infection and leakage of both 
pancreatic and gastrointestinal contents into 
the peritoneal cavity may follow.
The chronic pseudocyst is much less fra­
gile. It can be drained internally into some 
portion of the gastrointestinal tract, in most 
instances with excellent results. Again, this
M ay 1976 THE CANADIAN JOURNAL OF SURGERY 197
collection of fluid can occur in relation to, 
or within, any portion of the pancreas. It 
varies in size, and the severity of symptoms 
does not usually relate to its size. A 50-ml 
collection of fluid in the head of a chronic­
ally inflamed pancreas can cause debilitating 
pain as severe as that of a large collection 
in the lesser peritoneal sac.
Until recently pseudocysts were thought 
to occur as a complication of alcoholic pan­
creatitis but not gallstone pancreatitis. In 
our experience and that of others1 this is 
not so. A review of our cases showed that 
over 50% of the pseudocysts were asso­
ciated with gallstone pancreatitis. This was 
especially true of the acute pseudocysts.
O perative E xperience  at M ontreal
G eneral H ospital
A review of our operative experience with 
pancreatic pseudocysts is shown in Table 
I. Forty-eight operative procedures were 
performed in 45 patients; 4 patients died. 
In the earlier years of the review external 
drainage was the most common procedure. 
Later this type of drainage was reserved 
almost entirely for patients with acute pseu­
docysts. We believe that treatment for the 
acute pseudocyst should be similar to that 
for pancreatic abscess.
External Drainage
In our 23 patients with acute pseudocysts 
treated by external drainage, 6 had recur­
rent pseudocyst or persistent pancreatic fis­
tula; in 3, a second operation was necessary 
(internal drainage, 2; removal of seques­
trum and external drainage, 1), 1 had a 
foreign body (silk suture) removed and 2 
were untraced. Two patients with acute 
pseudocysts died; both had secondary in­
fection and hemorrhage.
Partial Pancreatectomy
Excision of pancreatic pseudocysts has
TABLE I.—Procedures Used in Review of P an­
creatic P seudocysts at M ontreal General 
H ospital (N = 48)
No. of
Procedure operations
External drainage......................................  23
Partial pancreatectomy.................... 6
Cystgastrostomy...............................  8
Cyst jejunostomy........................................ 11
been discussed in the literature,2 but this is 
impossible with extrapancreatic pseudocysts 
in which the walls are formed by surround­
ing viscera such as the stomach, spleen, 
liver and bowel. However, when the cyst is 
within the pancreas or is associated with the 
extreme left portion of the pancreas (four 
patients), or extends into the mediastinum 
(two patients), partial pancreatectomy and 
excision of as much of the cyst as possible 
is indicated. All six patients in this group 
had chronic pancreatitis, usually alcoholic, 
and each had varying degrees of steatorrhea 
after operation. There were no deaths in 
this group and no recurrences, but two pa­
tients had persistent symptoms.
Cystgastrostomy
Our experience with cystgastrostomy is 
limited (eight patients). It is probably the 
procedure of choice for the chronic pseudo­
cyst in the lesser sac posterior to the 
stomach. Unfortunately, in the early years 
of our experience with this type of drainage, 
two patients had severe hemorrhage post- 
operatively; one patient with pyloric obstruc­
tion due to inflammatory change died, and 
the other required two further operations.
Cystjejunostomy
Of our 11 patients who had a cystjejuno­
stomy, 1, a renal transplant patient, died but 
in the other 10 the results were uniformly 
satisfactory. The standard procedure is a 
Roux-en-Y cystjejunostomy through the 
transverse mesocolon.
C o m m e n t
It is worth while differentiating between 
acute and chronic pancreatic pseudocysts 
both for treatment and prognosis. The diag­
nosis of these pseudocysts has been simpli­
fied by ultrasonic B scanning. Acute pseu­
docysts should be treated by external drain­
age and the chronic pseudocyst by drainage 
into some portion of the gastrointestinal 
tract or by excision of an appropriate seg­
ment of pancreas.
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DISCUSSION
Question: Dr. Poncelet, is infection of the 
biliary tract important in the etiology of 
gallstone pancreatitis?
Dr. Poncelet: Yes, it is important. I op­
erate on many of these patients as soon as 
possible and in almost every instance one 
can culture from the bile, bacteria such as 
Staphylococcus aureus, or bacteria that can 
deconjugate bile salts such as Clostridium 
perfringens, Streptococcus fecalis or Bac- 
teroides spp.
Question : Dr. Anderson, do you have any 
comments on infection in pancreatitis?
Dr. A nderson: We give antibiotics to pa­
tients with biliary tract disease but not usual­
ly to those with recurrent bouts of low-grade 
pancreatitis associated with chronic alco­
holism. This is because of the presence of 
bacteria in the gallbladder and because of 
the possibility of ascending cholangitis dur­
ing attacks of biliary-induced pancreatitis. 
One interesting concept is the possibility of 
bacterial contamination from an obstructed 
gallbladder passing retrograde from the gall­
bladder wall into the extrahepatic biliary 
lymphatics and into the pancreas. We in­
jected staphylococcal toxin into the lym­
phatics of the gallbladder wall in dogs and 
in a few instances produced necrotizing 
pancreatitis. It is difficult to ascertain 
whether this applies to humans or not. 
Question: Dr. Anderson and Dr. Poncelet, 
how often do you find common-duct stones 
in patients operated on for acute gallstone 
pancreatitis?
Dr. A nderson: Until 2 or 3 years ago the 
reported figure was in the neighbourhood of 
10%. In a South American centre the 
stools from patients with acute pancreatitis 
were collected immediately after an attack 
and in those with biliary tract disease a sub­
stantial number had stones in their stool. 
This finding was interpreted as indirect evi­
dence that common-duct stones might be 
the culprit in many cases of acute gallstone 
pancreatitis. T suspect that probably 60 to 
70% of stones are missed because they 
have already passed.
Dr. Poncelet: Since I operate on many 
of these patients as soon as possible, there is 
always a stone, ampullary edema, or spasm,
but manometry must be used to differentiate 
obstruction from spasm.
Question: When do you operate on pan­
creatic pseudocysts in the acute phase?
Dr. A nderson: If the patient has an acute 
pseudocyst and his general condition is im­
proving, that is, he has no fever and is able 
to tolerate some kind of oral intake, I would 
not operate because the only procedure in 
this acute phase is external drainage. The 
wall of the cyst will not hold sutures and 
bleeds profusely if an attempt is made to 
drain the cyst internally. A number of these 
cysts will disappear in time. The real risk 
with acute pseudocysts in their early course 
is that they may suddenly become septic, and 
when this happens emergency operation is 
indicated because the mortality associated 
with the infected acute pseudocyst or pan­
creatic abscess is high.
Question: I would like to ask Dr. Jabbari 
about the technical difficulties of transduo- 
denal intubation of either the common bile 
duct or the pancreatic duct.
Dr. Jabbari: The procedure requires prac­
tice. At first 1 thought the technique would 
be impossible, but, with increasing ex­
perience, recognition of the duodenal open­
ing of the duct system or systems became 
easier. At present I am able to do retro­
grade pancreatography in 80% of patients 
in whom this is attempted. Intubation of 
the biliary tract is more difficult and in these 
patients I have only 50 to 60% success. 
Question: In patients diagnosed by retro­
grade pancreatography as having carcinoma 
of the body of the pancreas or of the tail, 
has the carcinoma proved operable in any 
patients?
Dr. Jabbari: I believe there has been suc­
cess in cases of early diagnosis of pancreatic 
carcinoma and in a few instances the lesion 
has proved operable. However, I cannot 
give you a figure because the technique of 
endoscopic pancreatography is still in its 
infancy and sufficient data is not yet avail­
able. In my own experience it is unfortunate­
ly true that by the time the patient’s disease 
is symptomatic the lesion is usually inoper­
able.
Dr. A nderson: We have done 75 to 100
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pancreatograms at the time of operation, 
almost all in patients with pancreatitis. Ap­
proximately 80% of the patients had alco­
holic pancreatitis and in these patients I 
have been impressed by the frequency with 
which the pancreatic duct enters at the sum­
mit of the ampulla of Vater and not further 
up inside the biliary duct system. I wonder, 
Dr. Jabbari, if you could tell us what you 
find to be the common pattern of biliary 
and pancreatic ducts because I think that in 
a large number of patients, especially alco­
holics, a long, drawn-out, common, terminal 
ampulla of Vater is not found.
Dr. Jabbari: The shape of the ampulla 
varies widely from patient to patient. I 
could not find any consistent pattern in 
alcoholics with pancreatitis.
Dr. A nderson: But is the junction of the 
main pancreatic duct with the common bile 
duct well inside the ampulla?
Dr. Jabbari: In many instances it is. 
Question: Should the surgeon operate on 
the patient with symptomatic, chronic, re­
current pancreatitis who is not an alcoholic 
and does not have demonstrable gallstone 
disease and if so, when? What would be 
your operative procedure?
Dr. Poncelet: I believe that operation is 
indicated in a patient who has recurrent 
episodes of severe pancreatic pain. At oper­
ation I would first do a cholangiogram and 
a pancreatogram. If this shows stenosis at 
the tip of the duct of Wirsung, then sphinc­
teroplasty is indicated. More often there are 
multiple dilatations and strictures of the 
main duct system and under such circum­
stances 95% excision of the pancreas is in­
dicated.
Dr. Anderson: My approach would be 
similar to that of Dr. Poncelet. I would first 
explore the common bile duct, then open 
the duodenum and widely open the ampulla 
of Vater. Following this a pancreatogram, 
either retrograde or antegrade, should be 
performed. Only then can one decide on the 
treatment. If there is a dilated duct extend­
ing to the tail of the pancreas with no evi­
dence of stricture, sphincterotomy is probab­
ly sufficient. Some patients respond well to 
simple transduodenal sphincteroplasty. If the 
pancreatogram shows stricture in the duct 
system then probably a Puestow procedure
is indicated. Ordinarily I would not resect 
the pancreas; however, in a small group of 
patients the pancreas is diffusely indurated 
and the pancreatogram shows a normal duct 
system. Obviously ductal decompression is 
not the answer and in these patients prob­
ably a 95 % pancreatectomy is indicated. 
Question: H ow about the results of sur­
gery in this type of patient?
D r. A nderson: If the patient is an alco­
holic who continues to drink then the re­
sults of any operative procedure are poor. 
Question: Is Trasylol (aprotinin) in its new 
form any better than it was a few years ago? 
D r. Thompson: Trasylol is a kallikrein and 
bradykinin inactivator. Based on animal 
experiments, it was thought that this agent 
would be useful in the management of acute 
pancreatitis. After 5 years’ experience with 
Trasylol we realized that when a disease is 
studied intensively, the general supportive 
treatment improves and we concluded that 
although our results in the Trasylol-treated 
group of patients were better than in patients 
not treated with Trasylol, it was probably 
the result of the overall increased intensity 
of treatment, rather than to any one factor. 
Dr. Anderson has mentioned the severity 
of respiratory complications in patients with 
acute pancreatitis and there is reason to be­
lieve that such complications may relate to 
the elaboration of vasoactive kinins; if so, 
then Trasylol, as a kinin inactivator, could 
possibly have a beneficial effect on this 
aspect of the disease process.
Question: Dr. Jabbari, many of our pa­
tients who have had surgery for chronic pan­
creatitis develop steatorrhea. Is this difficult 
to control?
D r. Jabbari: No, exocrine insufficiency in 
patients with chronic pancreatitis generally 
responds to pancreatic extract. The stool-fat 
content cannot usually be returned to nor­
mal but it can be reduced to a reasonable 
degree. If there is considerable acid in the 
stomach then the pancreatic extract should 
be given with bicarbonate since acid de­
stroys the extract.
Question: Our patients with severe pan­
creatitis all have chest complications, which 
you have mentioned. What do you do in 
addition to putting such a patient on a 
respirator? Specifically, do you think steroids 
make any difference?
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Dr. A nderson: Intensive ventilatory sup­
port for this group of patients is obviously 
essential. John Howard is convinced that 
we should worry more about the blood gases 
than we do about the concentration of 
serum amylase in the critically ill patients. 
With respect to steroids, I have not had a 
great deal of experience in evaluating the 
effect of these drugs. One interesting pos­
sibility is that some of the pancreatic en­
zymes such as lipase and phospholipase A 
are implicated in the shock-lung syndrome 
and if their action is predominately vascular 
the question does arise as to whether steroids 
would be beneficial.
Question: Dr. Poncelet, at operation in 
the early stages of acute pancreatitis, do you 
resect part or all of the pancreas?
D r. Poncelet: In selected patients, necrotic 
pancreas can be removed with a low mor­
bidity. I have operated on 12 patients in 
the acute stage of pancreatic necrosis, with 
only 1 death. If pancreatic necrosis is sus­
pected, operation should be performed be­
tween the 5th and 8th day of the illness, but 
not later because of increased organization 
and vascularity, which makes excisional 
surgery difficult and dangerous. In three of 
our patients necrosis was limited to the body 
and tail of the pancreas and in these pa­
tients it was technically easy to remove the 
pancreas and the spleen. In two other pa­
tients a sequestrectomy was performed.
Dr. A nderson : There is a risk of misinter­
preting this principle. In some patients I 
have found a swollen, highly vascular, acute­
ly inflamed gland and in these I do not 
believe that I could have removed the gland 
and still have had a live patient. On the 
other hand, where there is a completely 
necrotic, devascularized, devitalized struc­
ture that is the source of toxic material being 
absorbed into the blood stream, then it is 
better to remove this at operation.
Question: What does Dr. Anderson con­
sider the indication for operation in the pa­
tient with acute pancreatitis?
Dr. Anderson: If the patient is improving 
on conservative treatment, there is no need 
for operation. However, if the patient’s con­
dition is deteriorating in the face of what is 
considered adequate supportive treatment, 
operation is indicated. In gallstone pancrea­
titis the first procedure is a cholecystostomy 
if the biliary tract is distended. If it is not, 
then I doubt if this procedure will have any 
beneficial effect. In our experience, most 
patients with a diagnosis of acute pancrea­
titis respond to proper medical management 
and if they are improving operation is not 
indicated. But there are disease entities other 
than acute pancreatitis that lead to an 
elevated serum amylase concentration; one 
of these is necrotic bowel. This leads to the 
warning that where the diagnosis is in 
doubt and the patient’s course is not as good 
as it should be, operation should be con­
sidered. I am not convinced that oper­
ating on patients with pancreatitis is particu­
larly threatening to them, and the results of a 
large series over the past 10 years suggest 
that with good surgery, good anesthesia, and 
good care, operation has little morbidity and 
mortality. If, at operation, the abdomen 
contains necrotic pancreas, this should be 
removed; if there is a large collection of 
fluid such as an acute pseudocyst or abscess, 
this must be drained.
Dr. Thompson: A final remark on an area 
of supportive treatment that has not been 
mentioned. Intravenous hyperalimentation 
has proved to be an important adjunct to 
the treatment of acute pancreatitis. It should 
be started soon after admission to hospital. 
I would also reiterate Dr. Anderson’s re­
marks concerning the indications for opera­
tion. These are (a) when the patient’s condi­
tion is deteriorating in spite of adequate sup­
portive therapy; (b) when there is suspicion 
of an abscess, and (c) when the diagnosis is 
uncertain. The only patients we lose at 
present are those with uncontrolled sepsis.
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DISTENSION ARTHROGRAPHY OF THE SHOULDER JOINT*
M. W. J. OLDER, MB, BS, BDS, FRCS(Edin), J. L. McINTYRE, MB, ChB, FRCP[C] 
and G. J. LLOYD, MB, ChB, FRCS, FRCS[C]
Pain and stiffness resulting from degenerative 
disease of the rotator cuff of the glenohumeral 
joint is not always self-limiting. In a few patients, 
the symptoms persist despite medication and 
physiotherapy. Distension arthrography, a meth­
od of hydrostatic manipulation, has been used in 
six such patients; five recovered full range of 
abduction and rotation and the sixth was im­
proved. It is concluded that distension arthro­
graphy should be part of the treatment of in­
tractable pain and stiffness of the shoulder joint.
La douleur et la rigidite resultant d'une arthrose 
du manchon rotateur de I'articulation gleno-hu- 
merale n'evoluent pas toujours vers la guerison 
spontanee. Chez quelques patients, les sympto- 
mes persistent en depit de la medication et de 
la physiotherapie. L'arthrographie avec disten­
sion, une technique de manipulation hydrosta- 
tique, a ete utilisee chez six de ces patients; 
cinq ont retrouve une amplitude complete d'ab- 
duction et de rotation et le sixieme s'est ame- 
liore. II est conclu que l’arthrographie avec 
distension devrait jouer un role dans le traite- 
ment de la douleur tenace et de la rigidite de 
I'articulation scapulo-humerale.
The painful, stiff shoulder has been of con­
cern to orthopedic surgeons since treatment 
by manipulation was introduced by Duplay 
in 1872.1 In most patients the disorder is 
self-limiting, but some are resistant to phy­
siotherapy and medication. Such patients are 
not treated or are treated either by manipu­
lation or an operative procedure. Manipula­
tion is safe in the early stages of the stiff, 
painful shoulder syndrome but in the later 
stages, when intra-articular adhesions have 
developed, troublesome complications occur. 
Over the past 3 years we have treated a 
group of patients with intra-articular lesions 
by distension arthrography (a method of 
hydrostatic manipulation). This paper is a 
report of our experience.
*From the division of orthopedic surgery, depart­
ment of surgery, Toronto Western Hospital, Univer­
sity of Toronto and department of diagnostic 
radiology, York Finch General Hospital, Toronto, 
Ont.
Reprint requests to: Dr. G. J. Lloyd, Ste. 101, 25 
Leonard Ave., Toronto, ON M5T 2R2.
T e c h n iq u e
Before the procedure, patients receive an 
analgesic and, in particularly apprehensive 
patients, a sedative. The patient lies supine 
with the shoulder girdles turned obliquely 
to the table, so that the affected joint faces 
down. With local anesthesia, a double-needle 
technique (originally designed for discogra­
phy) is used to gain access to the joint and 
to introduce the contrast medium. Under 
fluoroscopic control the anteroinferior part 
of the glenohumeral joint is identified and 
a 5-cm 18-gauge needle is inserted through 
the skin towards the joint. Through the first 
needle, a 10-cm 22-gauge needle with tro- 
char is inserted into the joint space and the 
needle is connected by an extension tube to 
a 50-ml syringe containing sodium iothala- 
mate 68% (Conray 400, Mallinckrodt Phar­
maceuticals). (Sodium iothalamate is used 
in preference to the diatrizoate derivatives 
because chemically it is less irritant.)
Contrast material (1 ml) is injected to 
confirm that the needle is in the joint space; 
then, by manually injecting contrast me­
dium, the physician gradually distends the 
joint until the capsule ruptures. In most in­
stances the contrast material suddenly leaves 
the joint space and moves medially. When 
this occurs no further fluid is injected. Dur­
ing distension of the joint, the patient may 
experience discomfort, and some have felt 
as if something “gave way” just before rup­
ture of the capsule. A radiopaque contrast 
medium enables one to see the distension 
and rupture of the capsule.
Distension arthrography is performed in 
hospital and is followed by a program of 
assisted exercises. Appropriate doses of 
analgesics are provided to increase the pa­
tient’s participation in the exercise program.
C l in ic a l  F e a t u r e s  a n d  R e s u l t s
We report the results of distension 
arthrography in six patients. All had stiff 
painful shoulders resistant to medication, 
local steroid injection and a program of 
exercises. The procedure was performed by 
one of the authors (JL Mcl) and the patients
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TABLE I.—Clinical Data and Results of Arthrography
Range of motionf
Patient Age, 
no. (yr)
sex
Diagnosis
Time
before
arthrogram
Vol.
contrast*
(ml)
Prearthrogram Postarthrogram
Early Late
1 46. M Degenerative 2 yr 55 Abd 30° 60° ) Full)
disease of IR 0 0 ) Immediate Full) 2J yr
rotator cuff ER 0 0 ) Full)
2 41, F Degenerative 6 mo 25 Abd 40° 60° ) Full)
disease of IR 0 0 ) 6 wk Full) 21 yr
rotator cuff ER 0 15° ) Full)
3 61, F Degenerative 5 yr 40 Abd 20° 50° ) Full)
disease of IR 0 0 ) 3 wk Full) 2) yr
rotator cuff ER 0 20° ) Full)
4 62, M Degenerative 6 mo 55 Abd 40° 60° ) Full)
disease of IR 0 0 ) Immediate Full) 1 yr
rotator cuff ER 0 0 ) Full)
5 45, M Secondary to 9 mo 55 Abd 40° 60° ) Full)
multiple IR 0 0 ) Immediate Full) 2 yr
injuries ER 0 0 ) Full)
6 17, M Primary 3 mo 35 Abd 40 — 80° 0 - -9 0 °  ) Full)
trauma IR 0 0 ) Immediate 0) 10 mo
ER 0 0 ) 0)
*Volume of contrast material injected before rupture occurred. 
fAbd =  abduction; IR = internal rotation; ER = external rotation.
were reviewed by another (MWJO) who, at 
the time of review, had no knowledge of the 
prearthrographic findings. In this way there 
was no bias in assessing the results. The 
clinical details and results are summarized 
in Table I. All patients, with the exception 
of patient 6, noted that recovery was gradual 
— the distension arthrography “freed” or 
“loosened” the joint and helped them to co­
operate more enthusiastically with the exer­
cise program and in this way helped to in­
crease the range of movement.
Patient 1 was uncomfortable during the 
procedure (Fig. 1) and complained of per­
sistent pain afterwards. Improvement was 
gradual but 2 months after the distension 
arthrography the shoulder was painless, ab­
duction was 70° with 10° internal and ex­
ternal rotation. At 2Vi-year follow-up his 
only complaint was minor weakness.
Patient 2 had no discomfort or pain on 
arthrography (Fig. 2) and at 9 months the 
range of shoulder movement and rotation 
were normal.
In patient 3 arthrography revealed an 
extremely narrow joint suggesting a restric­
tive capsulitis. This patient had no imme­
diate relief but the symptoms gradually re­
solved.
The observations in patient 5 were inter­
esting because on distension arthrography 
only 15 ml of contrast medium was ac­
cepted before the pressure increased, then 
another 5 ml was injected with ease; at this 
point we noted that the synovial pouch along 
the biceps tendon had filled (Fig. 3). The 
joint space accepted another 35 ml of con­
trast medium before the capsule ruptured.
Patient 6, who had been hit across the 
shoulder by a hockey stick, had a complete 
tear of the supraspinatus tendon. The torn 
ends of the tendon could be sutured together 
only with the arm in 40° of abduction. De­
spite intensive physiotherapy the range of 
abduction of the arm was only 40 to 80° 
and there was no rotation. Distension arthro­
graphy was therefore performed. The proce­
dure was painful. Rupture was down the 
biceps tendon (Fig. 4). The joint was small­
er than normal with narrowing in the area 
of the superior insertion of the rotator cuff. 
There was an immediate increase in the 
range of abduction and the pain resolved 
after 4 weeks, but at 10-month follow-up 
there was still no rotation.
D iscussion
The painful, stiff shoulder syndrome is
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Fig- I.—Patient 1. Radiopaque contrast medium defines joint space whose infra-articular recess 
shows irregular or spiculated outline and which does not expand. N o contrast medium has entered 
subacromial bursa. Joint capsule has ruptured medially with release o f contrast into soft tissues.
Fig-. 2.—Patient 2. Infra-articular recess is obliterated and does not expand. Entire joint capsule is 
reduced in volume. Lining of joint capsule is spiculated and there is medial rupture o f capsule.
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Fig. 3 .—Patient 5. Joint lining is smooth, recesses are well filled and contrast extends down long 
tendon sheath of long head of biceps. (Small amount of contrast just medial to infra-articular recess is 
artefactual, being deposited on attempted entry to joint.)
Fig. 4.—Patient 6. Joint capsule shows normal 
joint lining and infra-articular recesses.
characterized by a well-known cycle of 
events: increasingly severe pain in the shoul­
der, often radiating down the arm as far as 
the insertion of the deltoid, occurs most fre­
quently in the fourth, fifth and sixth decades, 
sometimes being precipitated by a com­
paratively minor injury; the pain persists 
and glenohumeral movement decreases; lat­
er the pain becomes less severe but the 
stiffness persists; gradually the pain resolves 
and the range of motion is slowly regained. 
Some authorities consider the condition to 
be self-limiting. Codman stated that the 
prognosis is excellent and given time, recov­
ery is complete.2 Simmonds,3 however, re­
ported that the shoulder returned to normal 
in only one third of his patients, and 
others now agree that, however much time 
elapses, some patients are left with perma­
nent, painful restriction of shoulder motion.4 
These are the types of patients we have 
treated.
We believe the main cause of the painful, 
stiff shoulder lies in the fixator tendons of 
the capsule. Simmonds3 drew attention to 
the supraspinatus component of the rotator 
cuff. He submitted that the basic lesion
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was cell death, which causes an inflammatory 
response. His suggestions have recently 
been confirmed experimentally.5 The in­
flammation may progress to contraction of 
the joint capsule, including obliteration of 
the axillary recess.4
Initially treatment is rest and relief of 
pain, with physiotherapy in the form of 
active exercises being recommended as the 
severity of the pain decreases.
The role of manipulation has been con­
troversial since it was described by Duplay 
in 1872.1 In the early phase, though the­
oretically it may cause further damage in 
the form of scarring, there are no serious 
complications. In the later stages, when 
there is persistent pain and stiffness, mani­
pulation under general anesthesia is often 
associated with severe pain and, unless ex­
treme care is exercised, mechanical com­
plications such as fracture and subluxation 
of the joint may occur.
A few writers4- '*• 7 have recommended 
hydrostatic pressure to rupture the capsule. 
DePalma6 has suggested that, before mani­
pulation, one should distend the joint with 
saline under pressure until free flow is estab­
lished. Reeves7 has reported favourable re­
sults in two patients treated with serial dis­
tension. Recently a method of infiltration 
brisement has been described by Simon:4 
under general anesthesia the joint is dis­
tended with a fluid mixture of lidocaine and 
triamcinolone until rupture occurs. The 
shoulder is put through a range of motion 
with a short lever arm. Simon has claimed 
excellent results.
Arthrography of the shoulder as a thera­
peutic procedure was reported by Andren 
and Lundberg in 1965,8 who treated 64 
“rigid” shoulders in patients with rotator 
cuff ruptures, fractures and frozen shoul­
ders. As one might expect, the results were 
mixed and the follow-up was only 2 months. 
We reviewed British and French literature 
and found that therapeutic distension ar­
thrography is rarely used in the manage­
ment of persistent, painful stiffness of the 
shoulder.
It is difficult to assess the efficacy of any 
therapeutic procedure because patients are
unable to pinpoint the exact time at which 
complete, free, painless motion is obtained. 
However, we believe there is a group of 
patients in whom no further spontaneous 
improvement can be expected. Such patients 
can be treated by distension arthrography 
and hydrostatic manipulation, followed by 
a closely supervised, active, assisted, phy­
siotherapy program, and the prospects of 
relieving their pain and restoring the range 
of movement are good.
Co nclusions
In patients with painful stiff shoulders, 
who do not respond to conventional therapy, 
hydrostatic distension of the joint capsule 
can relieve the pain. This is best done by 
arthrography immediately followed by an 
intensive, active exercise program. Disten­
sion arthrography is easy to perform and 
although patients may have some pain dur­
ing the procedure, it does not upset them 
and there are no complications.
These views are supported by the results 
of distension arthrography in six such pa­
tients: five patients regained a full range 
of movement and the sixth was considerably 
improved.
It is recommended that distension arthro­
graphy be considered by surgeons and ra­
diologists as a mode of treatment for painful 
stiffness of the shoulder.
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/ 0  preserves platelets thereby reducing the risk of intravascular coagulation1
•  preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern of deteriorating pul­
monary function, commonly described as shock lung. This pulmonary insufficiency 
progresses despite restoration of haemodynamic balance and apparent stabilization of 
the acute episode.
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A  number of clinical and laboratory para­
meters can serve to estimate the prognosis 
for a patient with acute hemorrhagic pan­
creatitis.
It is not possible to predict either the 
certainty of the diagnosis or the severity of 
the process from the blood level of amylase 
activity alone. Serial hematocrit determina­
tions are helpful as a guide to assess the 
degree o f plasma volume depletion but do 
not accurately predict the prognosis if ap­
propriate treatment is instituted. Elevation 
of the serum bilirubin is more apt to be 
influenced by concomitant disease of the 
biliary tract than by the degree of pancreatic 
destruction.
Generally, a serum calcium level of less 
than 7 mg/100 ml in a patient with acute 
pancreatitis is indicative of a severe disease 
process and provides the most reliable index 
of a poor prognosis.
Other adverse findings which contribute 
to a poor prognosis include advanced age, 
elevated blood glucose levels above 200 
mg/100 ml, and increased lactic dehydro­
genase (LDH ) or serum glutamic oxaloacetic 
transaminase (SGOT) levels in the blood.
B
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MARLEX MESH FOR REPAIR OF ABDOMINAL WALL DEFECTS*
P. M. WALKER, MD and B. LANGER, MD, FRCS[C]
The best synthetic material available for repair 
of abdominal wall defects associated with an 
insufficiency of tissue is Marlex mesh. Among 
14 patients with large hernias and 3 who under­
went tumour resection only 2 manifested recur­
rence of the defect. In three of these patients 
infection developed, but its control made it un­
necessary to remove the Marlex. In another 
three with gross infection of the abdominal wall, 
Marlex was used successfully to provide abdo­
minal wall closure.
Le meilleur materiau synthetique pour la plastie 
des anomalies de la paroi abdominale dues a 
une insuffisance de tissu, est la fibre Marlex. 
Chez 14 patients presentant une hernie impor- 
tante et chez 3 sujets ayant subit la resection 
d'une tumeur, seulement 2 ont eu une recurrence 
de I'anomalie. Une infection est surveue chez 
trois de ces patients, mais elle put etre jugulee 
sans qu'il soit necessaire de retirer la fibre 
Marlex. Chez trois autres presentant une infec­
tion severe de la paroi abdominale, la fibre Mar­
lex a ete utilisee avec succes pour refermer la 
paroi.
A lthough the ideal method for repairing 
an abdominal wall defect is by accurate re­
storation of normal anatomic continuity, 
this is not always possible and an alterna­
tive method must be found. For example, 
abnormally large incisional hernias may oc­
cur after postoperative infections or in obese 
people; when these hernias develop in the 
epigastrium it may be particularly difficult 
to close the defect due to the rigidity of 
the adjacent costal margins. Parallel abdo­
minal incisions may devascularize a large 
segment of the supporting fascia causing it 
to slough. When resectable tumour involves 
the abdominal wall, or when a large segment 
is lost as a result of trauma, there may not 
be enough tissue to close the defect.
In such situations, fascia lata grafts were 
used for many years because they were 
thought to remain viable and retain normal 
strength.1 However, these grafts gradually 
became attenuated and the repairs frequent-
* From the department of surgery, University of 
Toronto, and the division of general surgery, 
Toronto General Hospital, Toronto, Ont.
Reprint requests to: Dr. B. Langer, Room 124, 
University wing, Toronto General Hospital, 101 
College St., Toronto, ON M5G 1L7.
ly broke down. Also, a second incision was 
required to procure the grafts and the size 
available was limited. A variety of homo­
grafts and xenografts was tried, but the re­
sults were unsatisfactory.2 Next, a variety of 
synthetic grafts was used, but each had its 
disadvantages. Tantalum and stainless-steel 
mesh fragmented; nylon and Dacron proved 
unstable in the presence of infection.3 Mar­
lex mesh (knitted polypropylene monofila­
ment) has proved to be the best material. It 
is strong, it can be cut to the proper size 
and shape without unravelling, and it can 
be sterilized by autoclaving. Usher, Cogan 
and Lowry,4 in studies on dogs and humans, 
showed that use of Marlex is followed by 
formation of a porous sheath, 3 to 5 mm 
thick, and infiltration of the mesh through 
activity of fibroblasts. It can be placed over 
the omentum or in direct contact with the 
bowel without erosion or injury to underly­
ing organs. In canine studies, Usher5 in­
fected Marlex replacements of the abdominal 
wall and found that, with drainage and anti­
biotics, the defect would heal by secondary 
intention without disturbing the Marlex. 
Marlex mesh resists infection because its 
uniform molecular structure prevents en­
trapment of bacteria, permitting the host to 
combat infection in the normal way. This 
ability to resist infection is the major ad­
vantage of Marlex in clinical situations.
In this paper we describe our experience 
using Marlex mesh to repair large hernias or 
defects in 20 patients, seen at the Toronto 
General Hospital from 1967 through 1975.
D etails o f  Patients
Of the 20 patients, 14 (11 men and 3 
women; age range, 40 to 70 yr) had large 
hernias that were repaired electively—two 
of these were recurrent hernias and one was 
associated with a chronic draining sinus.
In two patients a large chondrosarcoma 
involved the abdominal wall, and in one, 
carcinoma of the sigmoid colon recurred in 
the abdominal wall. When these tumours 
were widely excised, the resulting defect was 
too large to be covered by conventional 
means, so Marlex mesh was used.
In three patients (two men and one worn-
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Abdominal Wall
Site of Anterior 
Sheath Split
Marlex
Fig. 1.—Repair of defect on one side of linea 
alba using posterior rectus sheath and Marlex 
mesh.
an; age range, 18 to 62 yr) with large ab­
dominal wall defects complicated by gross 
bacterial contamination and systemic infec­
tions, Marlex mesh was used to replace the 
missing abdominal wall.
T ech niq ue
In each case, an appropriate-sized piece 
of Marlex mesh was cut and then sewn in 
place with a monofilament Marlex suture. 
In 6 of the 14 hernias repaired electively, 
the defect was localized to one side only 
of the linea alba. In these cases, the 
anterior rectus sheath of the contralateral 
side was split lengthwise, opened out, 
and then sewn to the remnant of the 
posterior sheath on the affected side (Fig. 
1). The Marlex patch was then sewn 
to the edge of the anterior sheath on both 
sides to close the defect. In seven other 
cases, the hernial sac was dissected out, and 
a single or double layer of Marlex sewn to 
the musculofascial edges under moderate 
tension with through-and-through stitches 
(Fig. 2). In one instance, in which a com­
bined midline suprapubic and recurrent 
femoral hernia was repaired, Marlex was 
used extraperitoneally.
When tumour resection resulted in an 
irregularly shaped defect, Marlex was cut 
to the correct size and sewn to the remain­
ing tissue, including directly to the peri­
osteum. Rotational skin flaps were used to 
cover the Marlex. When infection was al-
Single Layer Marlex
Fig. 2.—Repair of midline defect using single or 
double layer of Marlex mesh.
ready present and no skin cover was avail­
able, the Marlex mesh was covered only 
with a moist dressing.
R esults
Herniorrhaphy in the 14 patients with 
uninfected defects was followed by recur­
rence in two instances; in each case the pa­
tient had cirrhosis and the defect was in the 
lateral attachment of the Marlex. The fol­
low-up ranged from 3 months to 9 years 
(mean, 25 mo). Repair in the three patients 
who underwent tumour resection (follow-up, 
8 mo to 6 yr) was not followed by recur­
rence.
Of these 17 patients, 3 had postoperative 
wound infections (Escherichia coli in 2, 
Staphylococcus aureus in 1). In each, treat­
ment with local drainage and systemic anti­
biotics eradicated the infection without dis­
turbing the Marlex.
Two patients required reoperation 
through Marlex repairs—in one, a cholecys­
tectomy, and in the other, a colostomy and 
subsequent colectomy for carcinoma. In 
each case, the incision in the Marlex mesh 
was closed with Marlex sutures; postopera- 
tively, there was neither infection in the 
wound, nor recurrence of the defect. A 
biopsy of the abdominal wall was taken and, 
when viewed through polarized light (Fig. 
3), showed the Marlex mesh infiltrated with 
fibrous tissue. As a result of our favourable 
experience we decided to use Marlex in the 
three patients with grossly infected wound 
defects.
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Fig. 3.—Anterior abdominal wall showing Mar- 
lex mesh infiltrated with fibrous tissue (viewed 
through partially polarized light) (hematoxylin 
and eosin, reduced by 40% from x 40).
Case D etails
Case 1.—Enterovaginal fistula and pelvic 
abscess developed in a 62-year-old woman after 
vaginal hysterectomy. Two further operations 
through parallel incisions resulted in a loss of 
the full thickness of the abdominal wall, in­
fection and persisting ileal fistula. After a long 
period of treatment with antibiotics and intra­
venous alimentation, the patient underwent 
another operation. The fistula was closed and 
the scar tissue excised leaving a full-thickness 
abdominal wall defect. Marlex mesh was used 
to replace missing abdominal wall and a large 
skin flap was rotated to supply missing skin. 
Antibiotics controlled the postoperative infec­
tion and septicemia. The patient recovered, 
and the repair was secure 14 months after 
operation.
Case 2.—An 18-year-old boy sustained head 
and extensive abdominal wall and intra-ab­
dominal injuries in a motor vehicle accident. 
At operation, the jejunum was resected and 
the colon was brought out to form a double- 
barrelled colostomy. The abdominal wound 
was contaminated with Clostridium perfrin- 
gens. Treatment included intubation, ventila­
tory support and administration of antibiotics. 
On the 5th postoperative day the wound 
eviscerated. At operation the necrotic muscle 
and fascia were removed and a sheet of Marlex 
mesh ( 7 x 6  cm) was sewn to the remaining
transversalis fascia to cover the defect. A 
moist dressing was used to cover the mesh. 
After 5 days the wound was clean, and healthy 
bowel could be seen adjacent to the Marlex. 
After the Marlex mesh had been in place for 
20 days gastrointestinal bleeding developed 
and, despite reoperation, he died. At the time 
of his death the condition of the abdominal 
wall was satisfactory.
Case 3.—A 38-year-old man had a right 
hemicolectomy for a solitary diverticulum of 
the cecum. Postoperatively, a respiratory in­
fection developed and the wound became in­
fected with Clostridium sp., Streptococcus feca- 
lis, and Bacteroides sp. At operation, a large 
abscess surrounded the anastomosis; a Miku­
licz exteriorization was done. After the opera­
tion, pus continued to drain from the wound 
with signs of septicemia and altered coagula­
tion. At reoperation, all the necrotic fascia 
and skin was excised leaving a full-thickness 
defect with bowel exposed. The defect was 
closed with two layers of Marlex with a dou­
ble-barrelled stoma. No skin closure was at­
tempted. Moist dressings were then applied 
over the Marlex; the purulent drainage gradu­
ally decreased. After 24 days, the granulating 
areas were covered with split-thickness skin 
grafts and remaining exposed Marlex was re­
moved. Closure of the stoma and definitive ab­
dominal wall repair have since been carried 
out.
C o m m en t
Our experience with the use of Marlex 
mesh indicates that it is the best available 
synthetic material for repair of abdominal 
wall defects. It is not a substitute for dissec­
tion and anatomical restoration and should 
be reserved for those cases where such re­
pair is not possible. Also, it may be useful 
in securing temporary cover in grossly in­
fected abdominal wounds where primary 
closure is undesirable.
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GLIMPSES OF SURGICAL HISTORY: 
I FOR ENDOTRACHEAL INTUBATION
D. A. E. SHEPHARD
A 16th century anatomist, a 17th century 
natural philosopher and a 19th century 
teacher of singing—these three men, none of 
them either surgeons or anesthetists, laid the 
foundations of endotracheal INTUBATION. 
Surgery and anesthesia is safer, and respira­
tory care more effective, because of them.
Andreas Vesalius, professor of anatomy 
at Padua, performed a celebrated experiment 
in resuscitation that is illustrated in his fam­
ous Fabrica. He passed a tube into the tra­
chea of an animal, probably a boar or pig, 
with the animal’s chest wall open, and 
showed that by blowing air into the endotra­
cheal tube he could maintain artificial venti­
lation. Robert Hooke, curator of experi­
ments to London’s Royal Society and best 
remembered for his researches in micro­
scopy, followed up Vesalius’ experiments and 
paved the way for others to intubate the 
trachea in cases of asphyxia and of cardio­
respiratory arrest consequent on anesthesia.
Great advances came in the 19th century. 
Manuel Garcia, Spanish-born professor of 
singing at the Paris Conservatoire, deepened 
his understanding of singing by studying the 
vocal cords with the aid of a dental mirror. 
Until Garcia’s day the larynx was terra in­
cognita; after Garcia’s studies indirect 
laryngoscopy provided information about 
the larynx in the living and set the stage for 
the rational procedure of intubation.
Onto this stage strode John Snow, who 
administered chloroform vapour through a 
tube in a laryngotomy wound; Friedrich 
Trendelenburg, who recognized the need to 
protect the respiratory tract during opera­
tions in this area and performed intubation 
through a tracheotomy; William MacEwen, 
who decided to introduce tubes through the 
mouth instead of performing a laryngotomy 
or tracheotomy; and Joseph O’Dwyer, who 
used endotracheal intubation in the manage­
ment of a nonsurgical condition, diphtheria. 
By the end of the 19th century intubation 
had become an established technique; but 
like so many developments in the history of 
surgery, it was the outcome of work of many 
men, laymen and surgeons alike.
Calmic Limited
Montreal. Toronto
a i
For prophylactic 
security-during 
indwelling _ 
catheterization...
Neosporin
Irrigating
Solution
(Sterile)
neomycin sulphate 
polymyxin B sulphate
helps prevent bacteriuria and Gram-negative 
rod bacteremia associated with indwelling 
catheters
wide antibacterial activity against susceptible 
Gram-negative and Gram-positive organisms 
including most strains of Proteus and 
Pseudomonas
low index of allergenicity — low incidence of 
irritation — low absorption from mucosa 
recommended in diluted solution for 
continuous bladder irrigation in short-term 
therapy (upto 10 days). NOT FOR INJECTION.
Additional product information is available on request.
i mmmm
M ay 1976 T H E  C A N A D IA N  JO U R N A L  O F SU R G E R Y 217
KNEE ARTHRODESIS: LONG-TERM RESULTS*
T. N. SILLER, MD, FRCS[C], FACS and A. HADJ1PAVLOU, MD, FRCSLC]
A review of 41 patients in whom knee fusion was 
performed mainly for degenerative arthritis and 
sepsis disclosed that only 15% of patients were 
without complications. Complications were nu­
merous and appeared both early and late —  
persistent knee and back pain were the most 
common. Many patients were unable to return 
to work or to participate in social activities. The 
optimal position for fusion is 15 to 20° of flexion, 
which results in a smoother gait and less diffi­
culty for the patient in driving a car. Because of 
the continued refinement in total knee joint re­
placement, the indications for knee arthrodesis 
should be confined to the treatment of chronic 
infection and failed total joint replacement.
Une revue de 41 patients ayant subit une fusion 
du genou, faite surtout dans des cas d'arthrite 
degenerative avec etat septique, a revele que 
seulement 15% ne presentait pas de complica­
tion. Les complications ont ete nombreuses et 
sont apparues aussi bien de fagon precoce que 
tardivement, une douleur persistante du genou 
et du dos etant la plus frequente. Plusieurs pa­
tients ont ete incapables de retourner au travail 
ou de s’adonner a des activites sociales. La 
position optimum pour la fusion est un angle de 
flexion de 15 a 20°, ce qui permet une demarche 
plus souple et cause moins de difficulty au pa­
tient lorsqu'il conduit son automobile. Avec les 
ameliorations continuelles apportees a la tech­
nique de remplacement total de I'articulation du 
genou, les indications de I'arthrodese du genou 
devraient etre limites au traitement des infec­
tions chroniques et aux echecs du remplacement 
total de I'articulation.
T here are several techniques for arthrode­
sis of the knee. Continuous compression was 
first used by Key1 in 1932. It was later aban­
doned- but its use was revived and popular­
ized by Charnley3 in 1948. It has continued 
to be the most popular method.4 Charnley 
since has modified it, using additional ante­
rior pins and clamps to prevent angulation 
and rotation, and a more recent method” 
also uses this principle. Studies suggest 
that the time required for fusion is not as 
short as was originally thought.4- 6
The development of new surgical tech­
niques for degeneration and other disorders
*From the division of orthopedic surgery, Queen 
Mary Veterans’ Hospital, M ontreal, Que.
Reprint requests to: D r. T. N. Siller, Ste. 605, 
5025 Sherbrooke St. W, Montreal, PQ IM A 1S9.
TABLE I.—Duration of Symptoms to T ime of 
Fusion
Indication
No. of 
patients
Duration
(yr)
Post-traum atic arthritis 30 2-43
Closed injury 21 2-43
Fracture 5 9-18
G unshot wound 4 10-32
Septic arthritis 7 1-28
Jo in t instability 
(Charcot joint)
2 20-40
Prim ary osteoarthrosis 2 3-4
of the knee makes it appropriate to review 
the results of fusions as now performed. 
Because of the decreasing incidence of tu­
berculosis, indications for arthrodesis are 
less frequent than they were and they con­
tinue to become less frequent, but the proce­
dure is still indicated in some instances. This 
study is a review of the treatment and re­
sults of knee arthrodesis in 41 men who were 
treated between 1940 and 1970.
D etails of P atients
The principal indications for operation in 
these 41 patients were persistent severe pain 
due to post-traumatic arthritis (30 patients), 
followed by septic arthritis (7 patients), joint 
inability (Charcot joints) (2 patients) and 
usieoannrosis o r ____ ;wn etiology (2 pa­
tients) (Table I). It is interesting that in all
21 patients who had arthrotomy with re­
moval of menisci, severe degenerative 
changes developed.
The duration of symptoms up to the time 
of fusion is elaborated in Table I.
The average age of the patients at the 
time of fusion was 44 years (range, 18 to 
68 yr).
T echnical  D etails
Of our 41 patients, the healing period in
22 after the first fusion ranged from 3 to 
10 months (mean, 4.7 mo) (Table II). In 12 
patients details of the healing time were not 
provided.
In seven patients, fusion was unsuccessful. 
In five, the second procedure was success­
ful (mean healing time, 7 mo), but two re­
quired a third fusion (mean healing time, 5 
mo).
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TABLE II.—Duration of H ealing
No. of patients
Duration {mo) (« =  22)
3  ................................... 6
4  ..............................................  6
5  ..............................................  4
6  ......................................  2
7 .................................................  3
10.................................................  1
In those undergoing second and third fu­
sions, four types of arthrodesis were used: 
four patients received a sliding tibial graft; 
one had a Brittain’s arthrodesis; one re­
ceived a cancellous bone graft; and one 
underwent a second Charnley fusion.
The treatment of neuropathic joints con­
stitutes a challenge to the orthopedic sur­
geon, but can be successful,7’ 8 and this was 
borne out by the satisfactory results of fu­
sion in our two patients with Charcot joints.
C o m plica tio n s
Complications are outlined in Table III. 
Six (15%) of the 41 patients had no com­
plications, 22 (54%) had one or two com­
plications, and 13 (31%) had three or more. 
The number of both local and general com­
plications appeared to increase with time. 
Persistent knee pain (15 cases, 36%) was 
the most common local long-term complica-
TABLE III.—-Complications
Complication No.
Early
Local
Osteomyelitis.....................................  3
Pressure sore......................................  1
Neuroma............................................. 2
Foot-drop...........................................  5
General
Thrombophlebitis.............................. 3
Pulmonary embolism........................ 1
Painful donor graft site.................... 1
Crutch-walking ulnar neuritis........  1
Late
Local
Persistent knee pain.........................  15
Fracture:
supracondylar................................  2
through fusion site........................  1
high tibial....................................... 1
multiple..........................................  2
General
Back pain...........................................  18
Hip arthritis......................................  6
Psychiatric problems........................  7
Amputation:
above knee.....................................  3
Syme’s ............................................  1
Renal stones......................................  1
tion, and back pain (18 cases, 44%) was 
the most common general long-term com­
plication. There were five instances of foot- 
drop, with recovery in four. No serious pin- 
track infection was encountered. Table III 
suggests that a leg with a fused knee joint 
has increased susceptibility to subsequent 
injury.9
E x t en t  of D isability
Many patients encountered difficulty in 
returning to work. Those doing heavy work 
seldom returned to their former occupations. 
Even patients doing light work were re­
stricted, especially when the right knee was 
fused, because they could not drive. Al­
though it is possible to obtain a manually 
operated automobile, it is rarely practical 
and not one of our patients took advantage 
of this option. Unless the patient had a pro­
fession, employment incapabilities became 
obvious.
Social activities such as theatre, cinema, 
and athletic contests were greatly curtailed. 
The difficulties of obtaining an aisle seat and 
of public transportation made attendance at 
such events extremely difficult. Even simple 
tasks such as dressing were complicated — 
one patient noted that he had to use a long 
meat hook to help him pull his trousers on. 
As others have found, stairs, rugs and 
ladders created hazards in the home.
D iscussion
The persistent knee pain after arthrode­
sis of the joint was attributed to neuromas, 
scar tissue, and in some cases, psychosoma­
tic problems. In some patients with neuroma, 
further procedures were performed, but 
without benefit. With respect to the psycho­
somatic pain, it was impossible to tell whether 
the pain was a learned behaviour pattern re­
sulting from the primary disease or whether 
the patient was malingering.10
Radiographs of the lumbosacral spine of 
patients with low-back pain did not show 
the marked changes we expected. We do not 
know whether shortening of the arthrodesed 
side caused the pain or whether the adopted 
pathologic gait contributed to it by sub­
jecting the patient to constant lumbosacral 
strain.
Patients with an arthrodesed knee adopted 
two types of pathologic gait: when the knee
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was fused in extension, even with some 
shortening (1.5 to 2 cm), the patient adopted 
either the ‘‘gait en fauchant” or a “gait with 
excessive pelvic rise”. In those with gait en 
fauchant, the patient walks by abducting 
the limb at the hip joint and swinging the 
affected leg out sideways, thus fashioning a 
scythe-like curve, while the sound leg re­
mains almost normal, without excessive pel­
vic rise; shoulder motion is in the normal 
direction in relation to the pelvic tilt. On 
the other hand, when the homolateral pelvis 
rises upwards excessively (gait with excessive 
pelvic rise) the patient bounces up and 
down more than in the normal situation. 
This excessive bounce probably increases 
consumption of energy and predisposes the 
patient to lumbosacral strain.
There is no consensus as to the best 
position for knee fusion (Table IV3’ 6' 
», l i .  1 2 ) Green, Parkes and Stinchfield6 
found equally good results with extension or 
slight flexion. Mazzetti,13 in studies of ener­
gy consumption in various degrees of flexion, 
suggested that 15 to 20° of flexion was op­
timum for fusion. Some degree of flexion 
gives an improved gait, makes sitting easier, 
and is cosmetically more acceptable. We 
noted that patients who had the knee fused 
in flexion also had a smoother gait. The 15° 
flexion corresponds to about 2 cm of short­
ening, which means that the patient can 
clear the floor without excessive pelvic tilt 
and can also drive a car with less difficulty. 
Flexion places the leg in a more favourable 
position to increase propulsive thrust at the 
expense of vertical thrust (Fig. 1).
Conclusion
Knee arthrodesis completely alters the 
patient’s life style. In many cases employ­
ment is lost and social activities are cur­
tailed. Indications for fusion must be in­
dividualized and should be reserved mainly
TABLE IV.—Recommended Positions for Knee 
Fusion
Position
Author (°  flexion)
Charnley3...........................................  0 -— 5
Chapchal11...............................................  20 — 25
Green, Parkes and Stinchfield6. . . .  0 — 30
Moore and Smillie9 ........................... 0 — 30
Nelson and Evarts4
Male............................................  5 — 10
Female........................................  20
Stewart and Bland12..............................  10 —-20
Fig. 1.—Forces in gait: with flexion, horizontal 
component increases, vertical component de­
creases, transforming more of vertical thrust (ab) 
into a horizontally propulsive thrust (ac). Aac >  
Bac.
for the treatment of chronic infection, failed 
total joint replacement, and as an emergency 
when no other facilities are available. Fu­
sion of the joint in 15 to 20° of flexion 
improves the gait. The continued refinement 
of total joint replacement will decrease need 
for arthrodesis.
References
1. Key JA: Positive pressure in arthrodesis for
tuberculosis of knee joint. South M ed J 
25: 909, 1932
2. Idem : Arthrodesis of knee with large central
autogenous bone peg. South M ed J 30: 
574, 1937
3. Charnley, JC: Positive pressure in arthrode­
sis of knee joint. /  Bone Joint Surg [Br] 30: 
478, 1948
4. N elson CL, Evarts CM: Arthroplasty and
arthrodesis of knee joint. Orthop Clin 
North A m  2: 245, 1971
5. Cloutier JM, Fortin R: Arthrodese du ge-
nou avec un long clou de KUntscher. 
Union M ed Can 101: 1842, 1972
6. G reen DP, Parkes JC, Stinchfield FE:
Arthrodesis of knee, follow-up study. J 
Bone Joint Surg [Am] 49: 1065, 1967
7. Winter FE: Arthrodesis of knee for neuro­
pathic disease. Calif Med 97: 33, 1962
8. Wiseman IW: Neurogenic arthrodesis and
problems of arthrodesis of neurogenic knee. 
Clin Orthop 8: 218, 1952
9. Moore FH, Smillie IS: Arthrodesis of knee
joint. Clin Orthop 13: 215, 1959
10. Clawson DK, Bonica JJ, F ordyce WB: Man­
agement of chronic orthopaedic pain prob­
lems, in Instructional Course Lectures, v 
21, American Academy of Orthopaedic 
Surgeons, St Louis, Mosby, 1972, p 8
11. Chapchal G: Intramedullary pinning for arth­
rodesis of knee joint. J Bone Joint Surg 
[Am] 30 : 728, 1948
12. Stewart MJ, Bland WG: Compression in
arthrodesis; comparative study of methods 
of fusion of knee in ninety-three cases. 
J Bone Joint Surg [Am] 40: 585, 1958
13. Mazzetti RF: Effect of immobilization of
knee on energy expenditure during walk­
ing. Proceedings of Western Orthopaedic 
Association. J Bone Joint Surg [Am] 42: 
533, 1960
Gram-negative septicemia?
Host defences 
weakened. 
Antibiotic '
-i*
*
i
M
Start with Garamycin — When the condition of 
your patient with suspected gram-negative 
septicemia precludes susceptibility testing. 
Garamycin Injectable offers a high probability of 
effectiveness against pseudomonas aeruginosa- 
E-coli, • Proteus species • Klebsiella— 
Enterobacter-Serratia species. 1 3
Start with l =  
Garamycin:
Garamycin Injectable may be life saving in 
septicemia... may give a dramatic response in 
conditions such as wounds and burns 
complicated by sepsis. 1 4 13
Stay with Garamycin — When indicated by the 
results of sensitivity tests.
Garamycin Injectable has demonstrated that it 
maintains a high degree of sensitivity.14-16 
Bacterial resistance has not been a problem to date.
Stay with 
Garamycin.
(gentamicin sulphate U.S.P.)
Garamycin Injectable has shown a relatively low 
incidence of adverse reactions when used as 
recommended.13’15’17-________________________
Simplified I.M./I.V. Dosage Guidelines1
222 THE CANADIAN JOURNAL OF SURGERY Vol. 19
Garamycin 
Injectable IM/IV
(gentamicin sulphate U.S.P.)
GARAMYCIN Injectable (40 mg (base)/ml)
GARAMYCIN Pediatric Iniectable ( 10 mg (base)/ml)
INDICATIONS:
GARAMYCIN is indicated in the treatment of senous infections caused by proven susceptible 
organisms. In suspected or documented gram-negative septicemia, particularly when shock or 
hypotension are present. GARAMYCIN should be considered for initial antimicrobial therapy 
In staphylococcal infections, GARAMYCIN should be considered when conventional antimi­
crobial therapy is inappropriate or when susceptibility testing and clinical ludgment 
indicate its use
ADMINISTRATION AND DOSAGE
INTRAM JSCULAR/INTRAVENOUStf ADMINISTRATION
A Urinary Tract Infections
The usual dosage in lower unnary tract infections is 0,8— 1,2 m g/kg /day in two or three equally 
divided doses for seven to ten days For increased antibacterial activity it may be advantageous 
to alkalinize the urine. Infections of the upper urinary tract, such as pyelonephritis, should be 
treated according to one of the schedules for systemic infections 
B Systemic Infections-Norm al Renal Function
The treatment of systemic infections in patients with normal renal function requires a dosage of 
3 m g/kg /day in three equally divided doses. A course of seven to ten days of treatment will 
usually clear an infection due to  a susceptible organism In patients with life-threatening 
infections, dosages up to 5 m g/kg /day should be administered in three or four equally 
divided doses This dosage should be reduced to 3 m g/kg /day as soon as clinically indicated 
C Patients with Impaired Renal Function
In patients with diminished renal function or those undergoing intermittant hemodialysis, the 
dosage has to be adjusted depending on the degree of renal impairment 
For detailed information consult the product monograph or the Schering Representative 
t t INTRAVENOUS ADMINISTRATION
The usual effective dosage of GARAMYCIN Injectable administered intravenously is 
3 m g/kg /day in three equally divided doses
For intravenous administration, a single dose (1 m g/kg) of GARAMYCIN Injectable is diluted
in 100-200 ml of sterile normal saline or 5% dextrose The solution is infused over a period of
one to two hours and repeated two to three times a day The usual duration of treatment is
seven to ten days
PRECAUTIONS
Ototoxicity
Gentamicin, like other aminoglycosides, has produced ototoxicity in experimental animals and 
man It is manifested by damage to vestibular function and may be delayed in onset. Damage 
has occurred in patients who were uremic, had renal dysfunction, had prior therapy with 
ototoxic drugs or recaved higher doses or longer therapy than those recommended The 
concomitant use of ethacrymc acid and furosemide should be avoided The physician should 
strongly consider discontinuing the drug if the patient complains of tinnitus, dizziness or loss 
of hearing. Serum GARAMYCIN levels in excess of 12 ^ g /m l should be avoided 
Nephrotoxicity:
Nephrotoxicity manifested by an elevated BUN or serum creatinine level or a decrease in the 
creatinine clearance has been reported with GARAMYCIN In most cases these changes have 
been reversible
Neuromuscular Blocking Action
Neuromuscular blockage and respiratory paralysis have been reported in animals The possi­
bility of this occurnng in man should be kept in mind particularly in those patients receiving 
neuromuscular blocking agents 
ADVERSE REACTIONS
Among other adverse reactions reported infrequently and possibly related to GARAMYCIN are 
elevated SGOT. increased serum bilirubin, granulocytopenia and urticaria Reactions reported 
rarely and possibly related to GARAMYCIN include drug fever, hypotension, hypertension 
itching, hepatomegaly and splenomegaly 
OVERDOSAGE
Peritoneal or hemodialysis will aid in the removal of GARAMYCIN from the blood
SUPPLIED:
Each ml of aqueous parenteral solution at pH 4 5 contains: 40 mg or 10 mg (pediatric) of 
gentamicin base Preservatives, me>hylparaben U.S.P.. propylparaben U S.P , sodium bisulfite 
U.S.P.. disodium edetate U.S.P Available in 2 ml multiple-dose vials and 1 5 ml Unidose* 
ampoules containing 60 mg gentamicin base/1 5 ml Solutions are heal stable and do not 
require refrigeration
REFERENCES
I Cox. C E Gentamicin M Clin 
North America 511395, 1970 
"  ;h, P.D new antimicrobics for th
n gentamicin
4 Brayton. R. G , and Louria, D B Gentamicin 
m gram-negative urinary and pulmonary 
infections. Arch. Int Med 114.205, 1964 
5, Louria, D. R. Young. L Armstrong, D , and 
Smith, J. K.: Gentamicin in the treatment of 
pulmonary infections, J Infect, Dis 119183, 
1969.
6 Cox, G. E Gentamicin, a new aminoglycoside 
antibiotic Clinical and laboratory studies in 
unnary tract infection, J. Infect Dis
f f 9486, 1969
7 Cox, C. E . and Harrison. L. H Gram-negative 
bacteremia and comparison of gentamicin and 
polymyxin B -  kanamycm therapy Presented at 
the Annual Meeting of the American Urological 
Association, Philadelphia. Pennsylvania,
May 10-14, 1970
8 Groll. E.: Clinical experience with gentamicin, 
data from 12 German clinics, in Gentamicin 
First International Symposium. Paris. January 
1967, Lucerne, Essex Chemie AG. 1967, p 121
9 Jackson. G G Laboratory and clinical 
investigation of gentamicin, ibid., p 62
10 Medeiros, A E Discussion. J. Infect Dis 
119 533. 1969
11 Polk. H Discussion. J Infect Dis 
119529, 1969
12. McCracken. G. H , Jr., and Jones.
L. G.: Gentamicin in the neonatal period. Am. J 
Dis Child 120.524, 1970
13 Nunnery, A W , and Riley, H. D.. Jr 
Gentamicin Clinical and laboratory studies in 
infants and children. J Infect. Dis. 119169. 1969
14 Jackson. G G Highlights of a Symposium 
on Gentamicin, a filmed panel discussion 
summarizing a symposium on gentamicin, 
University of California School ol Medicine.
Los Angeles. January 26, 1971
15. Cox. C. E . ibid
16 Weinstein, M J Drube. C G : Moss, E L .
J r . and Waltz, J A Microbiology studies related 
to bacterial resistance to gentamicin, J Infect 
Dis 121 811. 1971
17 Arieri. G M Falco. F. G : Smith, H. M.. and 
Holson, L B Clinical research experience with 
gentamicin Incidence of adverse reactions 
Supplement to the Medical Journal of Australia, 
June 13. 1970
Product monograph available on request from .
Schering Corporation Limited, Pointe Claire, Quebec H9R 1B4 ‘Reg.T.M.
D IR ECTIVES A U X  C O NTRIBU ANTS
Toute communication initiale doit etre adres- 
see au Coredacteurs, CP 8650, Ottawa, On. 
K1G 0G8 sous la mention: “Le journal cana- 
dien de chirurgie”.
Manuscrits. Les texts originaux des articles 
et des autres communications y compris un 
nombre limite de rapports sur des cas spe- 
ciaux doivent etre rediges en double exem- 
plaire, en franqais ou anglais, et accompagnes 
d’une lettre demandant leur publication dans 
le Journal. Veuillez les dactylographier sur une 
seule face d’une feuille normal avec double 
interligne et grandes marges.
Illustrations. Les illustrations telles que des 
photographies d’appareils cliniques, des ra- 
diographies, des photomicrographies, des gra- 
phiques et des digrammes doivent etre four- 
nies sous la forme d’epreuves sur papier glace 
sans montage, les bordures intactes, d’un format 
ne depassant pas 12 x 17 cm. Chaque illustra­
tion doit etre munie d’une legende dactylo- 
graphiee sur une page separee du texte de 
1 article. S’il s’agit d’une photomicrographie, 
expliquez le contraste et l’echelle de l’agran- 
dissement. Les lettres qui servent a identifier 
les elements d’une illustration doivent etre d’u­
ne dimension suffisante afin de demeurer visi­
bles lorsque les necessites de (’impression im- 
posent une reduction de l’image fournie. II 
ne faut pas qu’on puisse identifier un patient 
grace a une illustration a moins qu’il n’y ait 
expressement consenti par ecrit; faute de per­
mission les traits de sa physionomie doivent 
etre obliteres. Les illustrations en couleur ne 
seront publiees qu’aux frais de leur auteur. 
.Si 1 illustration provient d’une autre source que 
celle de l’auteur, il convient d’obtenir tant de 
l’auteur que de l’editeur de l’ouvrage dont elle 
est tiree, l’autorisation de s’en servir aux fins 
de la publication.
Tables. II faut en les etablissant se conformer 
au format rectangulaire du Journal et les 
rediger sur des feuilles separees du texte, une 
table par feuille.
References. Celles-ci doivent etre citees dans 
le texte au moyen d’un chiffre et groupees 
dans 1 ordre a la fin de votre article en vous 
conformant a la maniere de faire adoptee par 
ce Journal. Les references a des periodiques 
doivent etre conformes a celles qu’adopte 
YIndex Medicus.
Un resume qui ne doit pas depasser 125 mots 
doit accompagner chaque article sur une page 
separee.
Une epreuve en placard sera adressee a l’au- 
teur de l’article avant sa parution; on ne peut 
autoriser que de Iegeres retouches. Ce n’est 
qu’au moment de restituer ces epreuves d’au- 
teur au Journal qu’il y aura lieu de passer 
commande de reimpression.
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VALUE OF INTRAOPERATIVE ARTERIOGRAPHY IN ARTERIAL 
EMBOLECTOMY SURGERY*
F. N. McKENZIE, MB, ChB, MD, FRCS(Edin), W. J. WALL, MD, FRCS[C] 
and R. O. HEIM BECKER, MD, FRCS[C], FACS
Clinical assessment of the adequacy of arterial 
embolectomy and reconstruction is often un­
satisfactory and inadequate. Objective informa­
tion on the state of the distal circulation can be 
readily obtained at the time of surgery by arterio­
graphy. Illustrative cases demonstrating the 
usefulness of control arteriography obtained 
during the surgical procedure are presented.
[.'evaluation clinique de I'efficacite de l’embolec- 
tomie arterielle demeure insuffisante. Une in­
formation objective sur I'etat de la circulation 
distale peut etre rapidement obtenue au moment 
de I'intervention chirurgicale au moyen de I'arte- 
riographie. Quelques exemples sont ici presen- 
tes demontrant I'utilite d'un controle arteriogra- 
phique durant I’embolectomie.
T he symptoms and signs of limb embolism 
are generally sufficiently characteristic to 
permit diagnosis and to establish the approx­
imate level of arterial obstruction; preoper­
ative arteriography is rarely required. At 
operation, doubt remains in a number of 
cases as to the adequacy of the distal circu­
lation. Problems can occur because, even 
with satisfactory clearance of the distal tree, 
in the presence of atherosclerotic peripheral 
vascular disease, palpable pulses may not 
return and the amount of back bleeding 
from an arteriotomy is an uncertain guide.
We have found intraoperative arterio­
graphy a simple and reliable guide to the 
adequacy of clearance of the distal tree. In 
addition, it provides information on the like­
lihood of achieving satisfactory clearance.
M ethods
The whole of the affected limb is pre­
pared and draped and the common femoral 
artery in the groin (or the brachial artery 
above the elbow in the upper limb) is ex­
posed under local anesthesia. After control 
of appropriate vessels, heparin is given intra­
venously and clamps are applied to the 
exposed arterial segment. With a Fogarty
*From the department of cardiovascular and 
thoracic surgery, University Hospital, London, Ont. 
Reprint requests to: Dr. R. O. Heimbecker, De­
partment of cardiovascular and thoracic surgery, 
University Hospital, 339 Windermere Rd., Lon­
don, ON N6G 2K3.
arterial embolectomy catheter, the proximal 
arterial tree is first cleared until a pulsatile 
arterial inflow has been achieved.
Clearance of the peripheral arterial seg­
ment is achieved in a similar fashion; the 
balloon catheter is passed distally as far as 
possible. Repeated passage of the catheter 
is usually required to clear the artery of 
thrombotic material. If a pulsatile and force­
ful arterial inflow is achieved, no attempt is 
made to outline the proximal arterial seg­
ment with radiopaque dye. Arteriography of 
the peripheral segment is invariably per­
formed regardless of the amount of retro­
grade bleeding through the arteriotomy. 
Arteriography is performed by rapid injec­
tion of dye (15 to 20 ml of Hypaque 35%) 
through a 14 FG plastic cannula introduced 
via the arteriotomy. The film is taken using 
portable apparatus with the plate centred 
immediately below the knee or elbow joints. 
Patients are warned that they might feel a 
sensation of warmth in the limb. The con­
trast medium is immediately flushed out of 
the arterial tree using heparin-saline solu­
tion. The arteriotomy is closed while the 
films are developed.
C ase R eports
C ase 1
A 27-year-old man who had sustained a 
myocardial infarction 2 years previously, pre­
sented with a 2-hour history of severe pain of 
sudden onset in his left leg. The electrocardio­
gram showed sinus rhythm and an old anterior 
myocardial infarction. Pulses could not be felt 
below the common femoral artery on the af­
fected left side, and the left foot was cool and 
numb. There was no other evidence of cardio­
vascular disease.
A small embolus lodged at the common 
femoral bifurcation was removed; this resulted 
in a restoration of pedal pulses. Arteriography 
(Fig. 1) showed the popliteal bifurcation to be 
free of disease but the anterior tibial artery 
was occluded approximately 7.5 cm below its 
origin. Since both posterior tibial and dorsalis 
pedis pulses were present no attempt was made 
to achieve complete clearance. Recovery was 
uneventful.
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Fig. 1. Case 1. Operative arteriogram showing Fig. 2.—Case 2. Progressive narrowing of vas- 
occlusion of anterior tibial artery in mid-calf. cular tree without intraluminal disease.
Comment.—The occlusion of the anterior 
tibial artery in the presence of an otherwise 
normal peripheral arterial tree and normal 
foot pulses was presumed to be due to an 
earlier, minor and unsuspected embolic epi­
sode.
Case 2
A 46-year-old woman sustained a subarach­
noid hemorrhage, which was treated by fluid 
restriction, diuretics, antihypertensives and 
aminocaproic acid (Amicar). She was seen in 
consultation 8 days after admission. There were 
no pulses below the right femoral artery; the 
right foot was cold and the right calf moder­
ately swollen. It was believed that embolism 
may have arisen from the site of repeated 
femoral arterial punctures or from thrombus 
material formed in the femoral artery second­
ary to hypotension and hypovolemia. At opera­
tion the right femoral artery showed a good 
pulse and contained no thrombus. Repeated 
distal passage of an embolectomy catheter 
produced no thrombotic material. An oper­
ative arteriogram showed gradual tapering of
the distal arterial tree (Fig. 2) consistent with 
external vascular compression; fasciotomy was 
immediately performed.
Comment.—The diagnostic clue in this un­
usual case stemmed directly from the arterio­
gram. This information was available at a 
time when it was feasible to undertake imme­
diate appropriate action.
Case 3
This 65-year-old woman with mitral stenosis 
and chronic atrial fibrillation was admitted 
with a painful, cold, left leg. No pulses could 
be palpated on the left side. All peripheral 
pulses were present on the right. At operation, 
a mixture of old and fresh thrombus was 
flushed out of the left external iliac artery and 
propagated thrombus removed from the distal 
segment, but pedal pulses did not return. Op­
erative arteriography (Fig. 3) confirmed paten­
cy of the popliteal trifurcation. The postopera­
tive course was uneventful.
Comment.—Despite the absence of pedal 
pulses, the operation was terminated in the 
knowledge that adequate vascular clearance 
had been obtained.
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Fig. 3.—Case 3. Satisfactory clearance of po­
pliteal bifurcation and adequate run-off.
i f
Fig. 4. — Case 4. Subclavian artery occlusion at 
level of first rib.
Case 4
A 72-year-old man presented with a 10-hour 
history of increasing numbness and weakness 
in his left arm and hand. The left subclavian 
artery pulse could be felt in the neck but the 
left arm pulses were otherwise absent. The 
axillary artery was exposed; old and fresh 
thrombi were removed proximally and distally. 
Inflow improved but was nonpulsatile in na­
ture. Operative arteriography showed occlu­
sion of the subclavian artery (Fig. 4). This 
vessel was exposed and thrombectomy per­
formed with restoration of all distal pulses.
Comment.— A retrograde arteriogram via 
the arteriotomy gave precise information about 
the level of vascular obstruction and permitted 
immediate corrective surgery.
D iscussion
The introduction of the Fogarty balloon 
catheter greatly facilitated the operation of 
arterial embolectomy. It permitted a stand­
ardized procedure without the need of pre­
operative information on the precise level of 
vascular occlusion. Nevertheless, the over­
all results of arterial embolectomy remain 
disappointing. In several series the mortality 
rates ranged from 20 to 40%. Death usual­
ly was the result of complications from as­
sociated cardiovascular disease.1'3 Fogarty4 
reported a reoperation rate of 10% for in­
complete clearance of the popliteal trifurca­
tion — an underestimate because some pa­
tients who died would otherwise have re­
quired re-exploration. Since vascular re-ex­
ploration itself carries a high mortality3 any 
measure that can be taken to assess the ade­
quacy of the primary procedure should be 
encouraged. Both Doppler flowmetry and 
radionuclide scanning have been proposed 
as methods of assessing the distal arterial 
tree; however, neither of these methods will 
provide definitive information at the time 
when it would be most useful.
Reluctance to use intraoperative radio- 
graphic control stems in part from the view 
that the techniques are complex and time- 
consuming. This reluctance diminishes as 
expertise develops with frequent use. This, 
together with the lack of other satisfactory 
methods of objective assessment at the time 
of surgery, underlies our advocacy of intra­
operative arteriography as a routine proce­
dure. While many papers on arterial em­
bolectomy indicate that the operation should 
not be terminated before peripheral pulses 
or signs of blood flow to the extremity have 
been restored, it is important to recognize 
the occasions when this cannot be done ow­
ing to the extent of pre-existing peripheral 
vascular disease. The return of palpable 
distal pulses may be delayed or they may 
never return despite adequate clearance, as 
exemplified by one of our cases. Converse­
ly, pulses may be palpable in the presence
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of incomplete clearance. The amount of 
back bleeding from an arteriotomy is not a 
satisfactory measure of distal patency.
In each of the cases described, arteriogra­
phy contributed valuable information without 
significantly prolonging operative time. Ar­
teriography itself has not been associated 
with any morbidity. The additional risk to 
the patient of injecting a small volume of 
dilute contrast material under direct vision 
into the peripheral circulation and taking 
a single radiograph is extremely small; this 
risk is certainly smaller than the morbidity 
associated with a percutaneous arteriogram. 
No special equipment is required. A  simple 
cassette film-holder on which the patient 
lies can be readily constructed by a hospital 
workshop. This is constructed in such a way 
that radiography of any part of the body, 
apart from the upper limbs, can be done 
without disturbing the sterile drapes.
The concept of intraoperative radiographic 
control in vascular surgery is not new.6’ 7 
We wish to re-emphasize the advantages of 
objective assessment by arteriography in the 
operating room. The value of this procedure 
is insufficiently recognized. It is a simple 
and reliable indicator of the state of the 
distal circulation and we believe that oper­
ative arteriography should be considered an 
integral part of arterial embolectomy sur­
gery.
We are grateful to Dr. N. F. Gergely for permis­
sion to study patients admitted under his care. 
We appreciate the support of the Ontario Heart 
Foundation, the Bickell Foundation, the Nelson 
Hyland Foundation and the Medical Research 
Council o f Canada.
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SPONTANEOUS ESOPHAGEAL 
RUPTURE
(BOERHAAVE’S SYNDROME)
Boerhaave, a Dutch physician, first described 
spontaneous rupture of the esophagus in 1724. 
The patient, Baron van Wassenaer, died 18 hours 
after seif-induced vomiting. In those days it was 
a sign of affluence to induce vomiting with ipecac­
like preparations, and then eat another large meal. 
A t autopsy Boerhaave found olive oil and roast 
duck in the left pleural cavity, and a transverse, 
rather than linear, tear in the distal esophagus. 
The first successful surgical therapy was published 
by Frink in 1941. Barrett, in 1947, accomplished 
the first successful surgical repair.
Survival rate with surgical intervention for spon­
taneous esophageal rupture is 70%. Early diag­
nosis and appropriate surgical treatment are 
important. Complications include sepsis, hypovo­
lemia and shock. Curd and Hormon (Ann Surg 
183: 401, 1976) report their experience with two 
cases treated successfully and review the literature.
The first case was that of a 49-year-old Cauca­
sian man with a long history of alcohol abuse. 
He was admitted to the emergency department 
after two episodes of vomiting approximately 1 
hour earlier. The second episode was followed by 
severe epigastric pain radiating to the midback, 
associated with profuse perspiration. Breath sounds 
were clear bilaterally, but he had marked epi­
gastric tenderness and rigidity with rebound. Peri­
stalsis was absent and crepitus was palpable in 
the neck. The chest radiograph showed pneumo­
mediastinum without pneumothorax or pleural 
effusion, and the barium swallow showed extra­
vasation of contrast material from the distal eso­
phagus to the left posterolateral mediastinum. A t 
thoracotomy a 2-cm linear perforation of the 
lateral distal esophagus was found 1.5 cm above 
the hiatus. Postoperative complications included 
delirium tremens and aspiration pneumonia requir­
ing tracheostomy and assisted ventilation. The 
patient was discharged within a month of admis­
sion.
The second patient, a 76-year-old Caucasian 
man, was seen 1 hour after an episode of vomit- 
(Continued on page 234)
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FATAL CEREBRAL EMBOLUS — A COMPLICATION OF 
LEFT VENTRICULAR VENTING*
DAVID A. MURPHY, MD, FRCS[C] and VERNON W. KRAUSE, MD, FRCP[C]
A 3-year-old child died following a routine tetra­
logy of Fallot repair. Death was caused by a 
cerebral embolus. Injury to the left ventricle 
during left ventricular venting resulted in an 
apical myocardial infarct. The embolic source 
was a mural thrombus covering the area of in­
farction. A technique is described whereby left 
ventricular venting can be avoided during open- 
heart surgery in small patients.
Un deces est survenu chez un enfant a la suite 
de la refection chirurgicale de routine d'une 
tetralogie de Fallot. La mort a ete causee par 
une embolie cerebrate. Durant la ventilation 
ventriculaire gauche, une lesion du ventricule 
gauche a entraine un infarctus de I’apex du 
myocarde. L'origine de I'embolie a ete un throm­
bus dans la paroi recouvrant la region de I'in- 
farctus. On decrit une technique permettant 
d’eviter la ventilation ventriculaire gauche du- 
rant les interventions a coeur ouvert chez les 
sujets jeunes.
During the repair of congenital heart le­
sions, it has been standard practice to vent 
the left ventricle, both to remove blood ac­
cumulating during the operative procedure 
and to remove air at the end of the 
procedure. Access to the left ventricle for 
venting commonly has been through a small 
stab wound in the left ventricular apex. Al­
though venting via the right superior pul­
monary vein, the left atrium behind the 
aorta, or the left auricular appendage is 
possible, these sites are less satisfactory in 
small patients for removing accumulated air 
from the ventricular cavity.
We report a serious complication of 
apical left ventricular venting in a young 
child and describe a technique for removing 
air without the use of ventricular vents.
Case R eport
A 3-year-old girl was first admitted to the 
Izaak Walton Killam Hospital for Children at 
the age of 1 month when she was found to 
have a 3.5:1 left-to-right shunt through a
*From the departments of surgery and pathology, 
Izaak Walton Killam Hospital for Children, Dal- 
housie University, Halifax, NS.
Reprint requests to Dr. David A. Murphy, Divi­
sion of cardiovascular surgery, Izaak Walton Kil­
lam Hospital for Children, 5850 University Ave., 
Halifax. NS B3J 3G6.
ventricular septal defect. There were systemic 
pressures in the right ventricle and a gradient 
of 40 mm Hg across the pulmonary outflow 
tract. No infundibular obstruction was seen 
on angiography.
At the age of 7 months (weight, 5.6 kg), 
catheterization was repeated because of inter­
mittent cyanosis. Evidence of right ventricular 
infundibular outflow obstruction was found. 
The right-sided pressures (mm Hg) were: right 
atrium (mean), 4; right ventricle (RV), 100/0; 
RV infundibulum, 53/9; and main pulmonary 
artery, 20-30/10-15. In view of her cyanotic 
spells, a right Blalock shunt was advised.
While the right subclavian artery was being 
mobilized, a small amount of blood was lost. 
Bleeding was controlled. A rapid supraventri­
cular tachycardia of 270 beats/min and fever 
of 40°C developed, and fixed dilated pupils 
were observed. The response to sodium bicar­
bonate and propranolol was favourable; how­
ever, because of this complication, the opera­
tion was terminated. Postoperatively neurologic 
function returned to normal over 24 hours. She 
was subsequently discharged without having 
had a Blalock shunt performed; she was still 
being treated with propranolol.
The patient was readmitted at the age of 3 
years (weight, 10 kg) with recurrent cyanotic 
spells. Cardiac catheterization revealed a ty­
pical tetralogy of Fallot with infundibular pul­
monic stenosis and a gradient of 60 mm Hg 
across the outflow tract.
Surgical correction was carried out using a 
Bentley oxygenator with flows of 2.2 l/m 1 at 
27°C. Aortic inflow was through a no. 14 
French plastic cannula in the aortic root. The 
aorta was cross-clamped intermittently for 45 
minutes while a standard repair was per­
formed. The left ventricle was vented with a 
no. 12 French plastic suction catheter inserted 
through a small stab wound made with a no.
11 Bard Parker blade and dilated with a closed 
mosquito forceps. The catheter was held in 
place with a purse-string stitch on a small 
rubber snare. The postoperative pressures 
(mm Hg) were: RV, 40; pulmonary artery, 20; 
and left ventricle, 100.
The endotracheal tube was removed when 
the patient arrived at the intensive care unit. 
A right pneumothorax was treated with simple 
aspiration; apart from this minor problem, her 
postoperative course was stable. The following 
morning, the right and left atrial pressure
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catheters were removed; at this time approx­
imately 100 ml of chest tube drainage was re­
placed with whole blood. Approximately 30 
minutes later generalized muscle rigidity de­
veloped followed by cardiac arrest. Cardiac 
tamponade was suspected and the patient was 
returned to the operating room; there was no 
evidence of tamponade.
Autopsy revealed a small, recent, apical 
myocardial infarct in the area of the stab 
wound. This was on the endocardial surface 
and was covered by an irregular, ragged mural 
thrombus. The right internal carotid artery 
was completely occluded by red embolic 
thrombus. Central nervous system findings in­
cluded cerebral edema with coning of the 
right cerebellar tonsil and bilateral Kernohan’s 
notching of the hippocampus.
D iscussion
This patient’s cerebral embolus was 
thought to be a fragment of the mural throm­
bus from her apical infarct. Tachycardia 
caused by blood loss at the time of atrial 
catheter removal probably helped to dis­
lodge a fragment of mural thrombus. There 
are, however, other possible origins of the 
cerebral embolus. A thrombus could have 
formed in the left atrial catheter and then 
become dislodged when the catheter was 
withdrawn from the superior pulmonary 
vein. The catheters (no. 3.5 French) are in­
serted 0.125 cm into the left atrium. The 
catheter was functioning well until it was 
removed and no clot was seen either at the 
catheter tip or the entry point into the left 
atrium. The Dacron velors patch used in 
the repair of the ventricular septal defect 
was entirely free of thrombus. The aorto- 
tomy site was oversewn with 6-0 Prolene 
everting horizontal mattress sutures and no 
thrombus was seen on this repair.
Apical venting was conceived as a means 
of draining the bronchial arterial return 
flow from the left ventricle during the re­
pair of intracardiac defects and as a means 
of preventing left ventricular distension dur­
ing fibrillation. Venting also allows a path­
way of escape for any accumulated air in 
the left ventricle at the conclusion of the 
repair when the left ventricle is tilted up.
A left ventricular vent inserted in an 
adult heart probably results in a minimal 
left ventricular injury, particularly if small 
coronary vessels are avoided at the apex.
However, in a child with a small left ven­
tricle, the catheter still has to be sufficiently 
large (no. 8 to 10 French) to drain the col­
lected blood and air. Bypass techniques for 
infants have improved; it is now possible to 
avoid left ventricular venting entirely.
The need to remove excessive bronchial 
return that tends to obliterate the operative 
field can be avoided by reducing bypass 
flows to 0.5 / / m- at 27°C for 10-minute in­
tervals or by stopping cardiopulmonary by­
pass entirely for 3- to 4-minute periods 
during placement of critical sutures. When 
the transatrial route is used to close ventri­
cular septal defects, excessive left atrial 
blood can be drained through a small stab 
wound in the exposed right atrial septum. 
Alternatively, in infants, bronchial flow can 
be eliminated entirely by using profound hy­
pothermia and circulatory arrest.
Air from the left ventricle is removed 
through a small, transverse aortotomy, prox­
imal to the aortic inflow line. The egress of 
blood is controlled with a single transverse 
mattress stitch of 5-0 Prolene on a no. 8 
French rubber snare (Fig. 1).
For correction of an intracardiac defect 
using conventional cardiopulmonary bypass 
with moderate hypothermia, the aorta is 
cross-clamped and the vent aortotomy is 
made proximal to the clamp. Through this 
aortotomy a no. 18 Teflon needle is inserted 
and, by gravity flow, iced (4°C) Ringer’s 
lactate solution is infused into the aortic 
root until the heart fibrillates and relaxes. If
Fig. 1.—Control of bleeding and egress of air. 
Small transverse aortotomy (2 to 3 mm) is made 
at most prominent anterior convexity of aorta 
(Ao) proximal to aortic inflow line, and aorta is 
cross-clamped. Egress is controlled by single hori­
zontal stitch on snare. (PA =  pulmonary artery; 
RCA =  right coronary artery.)
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cross-clamping is required for more than 1 
hour, the coronary vessels can be perfused 
with blood. This can be done in the follow­
ing way: (a) the aortotomy snare is re­
leased; (b) the right coronary artery ostium 
is compressed; (c) th aortic valve is made 
incompetent (either by external valve dis­
tortion or by inverting the aortic cusps tem­
porarily with a blunt instrument through 
the ventricular septal defect); and (d) the 
aortic clamp is released.
To evacuate air from the left ventricle at 
the conclusion of the procedure, full cardio­
pulmonary bypass flows are resumed and 
the patient is rewarmed. The aorta remains 
cross-clamped and bronchial flow fills the 
left ventricle. The aortotomy snare is fully 
released. The left auricular appendage is 
inverted into the left atrial cavity with for­
ceps, and the lungs are intermittently over­
inflated by hand. The left ventricular myo­
cardium is massaged to express any air 
trapped in the trabeculae. At this point, 
before defibrillating the heart, the aortic 
clamp is reapplied by sliding it off the 
posterior one half of the aorta and carefully 
cross-clamping the anterior one half of the 
aorta (Fig. 2). At this point, the right heart 
may become distended and it is important 
to release the snare on one of the caval 
lines to decompress the right side. This 
usually is sufficient to decompress both the 
right and left sides. If the heart becomes
Fig. 2.—Procedure on completion of repair. 
Aortotomy snare is released, orifice of right coro­
nary artery (RCA) is temporarily compressed and 
aortic cross-clamp is slid forward to occlude only 
the anterior two thirds of the aortic lumen. Resi­
dual air in left atrium is evacuated by inverting 
left auricular appendage, inflating lungs and man­
ually massaging left ventricle (LV). Once the 
heart is beating, any residual air will be ejected 
via the aortotomy.
distended, the left ventricle can be massaged, 
expressing the increased volume through the 
aortotomy incision. The aortotomy can be 
partially snared and covered with a sponge 
so that the jet stream is contained. When 
coarse fibrillation ensues and the heart is 
sufficiently warm, countershock is used to 
start sinus rhythm. Sinus rhythm may re­
turn spontaneously. Occasionally there is an 
inadequate volume of blood in the left ven­
tricle to permit complete evacuation of air. 
This can be treated by releasing one of the 
caval snares and temporarily pinch-occlud­
ing this caval line.
Once the heart is beating, the sequence 
of atrial inversion, lung inflation and left 
ventricular massage is repeated. The aortic 
clamp partially occluding the aorta is left 
on and other chores are attended to while 
the heart becomes sufficiently warm to main­
tain adequate ejection. Systemic dispersal, 
via the partially occluded aorta, of air re­
maining in the left ventricle is prevented 
and ejected through the vent aortotomy.
Once air has been completely removed, 
the aortic clamp is fully released and the 
snare stitch on the aortotomy is tied.
When hypothermia and circulatory arrest 
are used, the myocardium can be further 
cooled by this technique. Once cardiopul­
monary bypass has been restarted, it may be 
difficult to get enough blood back into the 
left heart to fill it properly and allow com­
plete evacuation of air. The aortic clamp is 
carefully reapplied as described, allowing 
a little perfusion to occur behind the tip of 
the clamp, the snared aortotomy is left wide­
ly open and the right coronary artery is 
compressed. This will usually give sufficient 
coronary sinus flow to fill the right side of 
the heart. Massage of the right side and 
manual overinflation of the lungs will usual­
ly fill the left side. Once the heart begins to 
beat, the left ventricle is filled with coronary 
sinus and caval blood.
This technique has been used routinely in 
approximately 40 bypass procedures requir­
ing complex atrial or ventricular surgery. 
There have been no neurologic sequelae. It 
is also useful in patients requiring reopera­
tion in that the left ventricle does not need 
to be freed from the pericardial bed. This 
avoids troublesome bleeding from adhesions, 
torn conorary veins or torn myocardium.
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(continued from page 226)
ing. He complained o f severe, constant left “stab­
bing” chest pain radiating to the left upper back 
and upper abdomen. On examination he was found 
to be acutely ill with tenderness in the left flank 
and absent peristalsis. Serum amylase was normal 
and the electrocardiogram showed no evidence of 
myocardial infarction. The chest radiograph 
showed a left hydropneumothorax and Gastro- 
grafin-swallow radiographs showed extravasation 
of contrast material into the left pleural space. 
An emergency left thoracotomy was done and 
almost 1 I of serosanguinous fluid was aspirated. 
A 2-cm perforation of the lateral wall o f the 
distal esophagus just above the hiatus was found. 
The patient was discharged approximately 2 weeks 
after admission.
The authors point out that the rising incidence 
of alcoholism may lead to an increasing number 
of such postemetic ruptures, but the syndrome 
has been reported after severe strains associated 
with such acts as weight lifting, severe coughing 
and childbirth. They discussed at length the 
various theories to explain esophageal rupture.
The authors state that in approximately 90%  
of cases, the tear is in the left distal esophagus. 
It is usually linear and has sharp edges. Mucosal 
tears are usually longer than the muscle tears. 
Massive hemorrhage rarely is associated with the 
postoperative course o f Boerhaave’s syndrome. 
Should this occur, other sources of bleeding should 
be sought. The equally common Mallory-Weiss 
syndrome and the rare syndrome o f intraluminal 
esophageal dissection must be considered in evalu­
ating patients. The initial triad of common symp­
toms includes forceful vomiting, mild hematemesis 
and substernal chest pain. It is important for the 
clinician to remember that in the early stages of 
Boerhaave’s syndrome, the results of physical 
examination o f the chest may be completely 
normal. It is also important to remember that an 
esophagogram with barium or water-soluble con­
trast material such as Gastrografin is positive in 
less than 75% of cases, and that a lack of extra­
vasation does not exclude a perforation. This 
syndrome has been confused with perforated ulcer, 
acute myocardial infarction, pericarditis, pul­
monary embolus, dissecting aortic aneurysm, spon­
taneous pneumothorax and pulmonary embolus,
f
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SURGICAL RATES IN THE CANADIAN PROVINCES, 1968 TO 1972*
EUGENE VAYDA, MD, FRCPfC], FACP, FAPHA, MARY MORISON, MA and 
GARY D. ANDERSON, PhD
Canadian and provincial rates for eight elective 
and seven nonelective operations were deter­
mined from 1968 through 1972. Of the elective 
procedures considered, the Canadian tonsillec­
tomy rate decreased substantially and rates for 
hysterectomy and cholecystectomy showed large 
increases. The provinces reflected national 
trends for these three operations. Except for 
colectomy, which increased 36%, rates for the 
nonelective procedures showed little change.
Correlations between the numbers of surgical 
personnel and the elective surgery rates in the 
provinces were demonstrated in 3 of the 5 
years; these are best shown at the extremes. 
Newfoundland had the fewest surgeons, a bed: 
population ratio below the national average and 
the lowest combined elective surgical rate; Al­
berta ranked high in all three categories. In the 
seven other provinces, there was less variation 
in the number of surgeons, hospital beds and 
elective surgical rates.
Provinces with extensive insurance coverage 
prior to universal medical insurance reduced 
their combined elective surgery rate, while 
provinces where fewer people were insured 
showed increases. In the absence of different 
methods of payment for surgical services and 
marginal changes in the number of hospital beds 
and the number of surgeons, more insured per­
sons produced more elective surgery.
Les indices canadiens et provinciaux pour huit 
interventions non urgentes et sept operations 
urgentes ont ete determines pour la periode al­
lant de 1968 a 1972. Parmi les interventions non 
urgentes, I'indice canadien pour les amygdalec- 
tomies a diminue sensiblement alors que les 
indices des hysterectomies et des cholecystec­
tomies ont montre d’importantes augmentations. 
Les provinces refletent les tendances nationales 
pour ces trois operations. A I’exception de I'in- 
dice pour les colectomies, qui a augmente de
*From the department of clinical epidemiology 
and biostatistics, faculty of health sciences, Mc- 
Master University, Hamilton, Ont.
Revised from a paper presented at the 103rd an­
nual meeting of the American Public Health As­
sociation, Chicago, IL, Nov. 18, 1975.
Supported in part by National Health and Wel­
fare Research and Training Centre Grant no. 
606-22-12.
Reprint requests to: Dr. E. Vayda, Department 
of clinical epidemiology and biostatistics, Mc- 
Master University Medical Centre, 1200 Main St. 
W, Hamilton, ON L8S 4J9.
36%, ceux des interventions urgentes n’ont 
montre que peu de changement.
Des correlations entre I'importance du per­
sonnel chirurgical et les indices des interven­
tions non urgentes des provinces ont ete de­
montrees au cours de 3 des 5 annees; ces 
correlations sont d'autant plus evidentes aux 
extremes. Terre-Neuve avait le plus petit nombre 
de chirurgiens, un rapport du nombre de lits 
par habitant sous la moyenne nationale et le 
plus faible indice combine d'interventions non 
urgentes; I'Alberta se classait aux premiers 
rangs pour les trois categories. Dans les sept 
autres provinces, il n'y avait que peu de varia­
tion dans le nombre de chirurgiens, de lits d'ho- 
pital et dans les indices d'interventions chirur- 
gicales non urgentes.
Les provinces qui comprenaient un grand nom­
bre de personnes assurees avant I'instauration 
de I'assurance sante universelle ont diminue 
leur indice combine d’interventions chirurgicales 
non urgentes, alors que les provinces ou peu 
de personnes etaient assurees ont montre des 
augmentations. En I’absence de modes de paie- 
ment differents pour les services de chirurgie, 
et avec des changements marginaux dans le 
nombre de lits d'hopital et dans le nombre de 
chirurgiens, une augmentation du nombre de 
personnes assurees a entraine une augmenta­
tion des interventions chirurgicales non urgen­
tes.
E lec tiv e  surgery rates in the Canadian 
provinces in 1968 varied by approximately 
100% and were correlated with numbers 
of surgical personnel.1 Inglis,2 commenting 
on this finding, suggested that 1 year was 
an inadequate period in which to establish 
baseline rates or trends and that comparisons 
of provincial rates gave no indication of 
actual surgical needs. Data regarding the 
numbers of operations are now available 
for 5 years (1968 through 1972), so that 
more accurate baseline rates can be deter­
mined and trends established. The question 
of too many or too few surgical procedures 
(actual need) remains unanswered by these 
longer-term interprovincial comparisons and 
awaits further investigation with specifically 
designed studies.
The elective procedures studied, with 
rubrics of the International Classification 
of Diseases Adapted (ICDA) (eighth edition)
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given in parentheses, included hysterectomy 
(69.1-69.4; 70.1-70.2); cholecystectomy
(43.5); all tonsillectomy and adenoidectomy 
(21.1-21.4); extraction of lens (14.1-14.5); 
prostatectomy (58.1-58.3); hemorrhoidec­
tomy (51.3); varicose-vein stripping (24.4); 
and nonrecurrent inguinal herniorrhaphy 
(38.2). The seven nonelective procedures 
comprised radical mastectomy (65.3-65.6); 
partial thyroidectomy (22.1); heart valve 
surgery (29.2-29.4); lobectomy-pneumonec­
tomy (34.2-34.4); nephrectomy (54.4-54.5); 
colectomy (47.5-47.6); and appendectomy 
(41.0-41.1).
This report identifies national and pro­
vincial trends and also considers some of 
the causes of the differences in rates. These 
include the number of surgeons, the number 
of hospital beds, economic status and the 
rural-urban mix ratio. The early effects of 
universal medical insurance in Quebec, New 
Brunswick and Nova Scotia (where 75% or 
less of the residents were covered before 
universal insurance was enacted) is de­
scribed. Finally, the uses and limitations of 
large-scale utilization data are discussed, 
and areas of future investigation suggested.
To facilitate comparison, all rates have 
been age-sex standardized with the 1968 
Canadian population as the reference stand­
ard. Data for Prince Edward Island have 
been eliminated from the provincial com­
parisons because of its small population.
National and Provincial Trends
Elective Procedures
The eight elective operations studied ac­
counted for more than one third of all prim­
ary surgical operations in each of the 5 
years, but the seven nonelective operations 
made up only about 5% of all primary 
surgery.
Changes greater than 20% in the Cana­
dian rates were noted for three elective oper­
ations; those for the other five changed less 
(Table I). Rates for hemorrhoidectomy, 
varicose-vein stripping and nonrecurrent in­
guinal hernia decreased; extraction of lens 
and prostatectomy increased about 15%. 
Cholecystectomy, which was done five times 
more frequently in Canada than in England 
and Wales in 1968,:i increased in frequency 
by 23% over the 5-year period, and hys­
terectomy, which was done twice as fre­
quently, increased 41% . It seems unlikely 
that these increases were due to changes in 
the prevalence of associated diseases. For 
example, the prevalence of gallstones prob­
ably did not increase 23% during the 5- 
year period.
Rates for tonsillectomy and adenoidec­
tomy (TA) decreased 33%. In 1968 TA 
was twice as frequent in Canada as in Eng­
land and Wales in 1967 and 1.7 times as 
frequent in Canada as in the United 
States.4' r> By 1971, Canadian TA rates, 
although lower, were still 1.5 times the 1971 
US rates, which had also decreased.6’ 7 Al­
though it appears that indications for ton­
sillectomy may have become more restricted 
in North America, the Canadian TA rate is 
still 50% greater than the US rate.
Provincial elective surgery rates varied 
more over the 5 years (Table II). The trends
TABLE I.—Age-Sex Standardized Canadian Elective Surgical Rates per 100 000 P opulation,*
1968 to 1972f
Procedure
A ll tonsil- Nonrecurrent
leclomy and Varicose- inguinal
Hyslerec- Cholecystec- adenoide- Extraction Prosta- Hemorrhoi- vein herniorrha-
Year tomy% lomy tomy of lens tectomy\ dedomy stripping phy
1968 .........  474 311 1008 87 183 101 103 225
1969 .........  549 314 883 86 183 93 99 215
1970 .............  622 333 855 88 190 91 96 215
1971 .........  684 366 821 95 197 93 97 226
1972 .............  666 382 679 100 213 89 95 221
Change, % +41  + 2 3  - 3 3  + 15  + 16  - 1 2  - 8  - 2
*Source: tapes supplied by Statistics Canada. 
(Canada 1968 as reference standard. 
tAge standardized for women only.
§Age standardized for men only.
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are summarized in Table III. For hysterec­
tomy and cholecystectomy, all provincial 
rates increased (mirroring the national 
trend). There was a statistically significant 
correlation between the rankings of in­
dividual provincial rates for these two pro­
cedures in 1968 and 1972 (r, hysterectomy 
=  0.68, P <  0.05; r» cholecystectomy =  
0.88, P <  0.05). For TA , all provincial 
rates decreased and, again, the rankings of 
provincial rates in 1968 and 1972 were 
correlated significantly (r* =  0.82, P <  
0.05). Variation between the highest and
lowest provincial rates for these three elec­
tive procedures remained about 100% for 
all 5 years.
For the other five elective procedures, 
changes in the provinces were less con­
sistent. The national rate of lens extraction 
increased 15% and seven of the nine pro­
vincial rates also increased. Rates for three 
provinces (Quebec, Nova Scotia and New 
Brunswick) increased more than 30% while 
the others changed only slightly. The Cana­
dian prostatectomy rate, which was 16% 
higher in 1972 than in 1968, increased in
TABLE II.—Eight Elective Prodecures—Provincial Rates* per 100 000 Population!
Procedure
Province
Hyslerec-
iomyX
Cholecystec­
tomy
All tonsil­
lectomy and 
adenoid- 
ectomy
Extraction 
of lens
Prosta­
tectomy'§
Hemorrhoi­
dectomy
Varicose-
vein
stripping
Nonrecurrent
inguinal
herniorrha­
phy
Newfoundland
1968 339 155 530 40 144 57 53 142
1970 545 176 384 44 165 52 48 137
1972 502 221 368 47 139 42 53 126
Nova Scotia
1968 471 231 795 60 139 65 79 177
1970 642 341 786 87 182 77 107 200
1972 870 366 644 89 185 71 89 202
New Brunswick
1968 582 282 903 45 141 83 76 180
1970 777 316 832 59 131 93 87 171
1972 757 403 687 82 179 108 112 245
Quebec
1968 484 400 854 81 146 104 72 213
1970 568 375 712 79 139 87 61 193
1972 665 452 632 104 174 91 83 216
Ontario
1968 448 261 1186 100 184 104 118 259
1970 614 297 1012 102 196 93 114 244
1972 630 347 741 112 219 89 104 237
Manitoba
1968 322 323 917 83 212 80 85 219
1970 473 358 770 86 203 81 92 217
1972 522 391 597 90 220 78 87 205
Saskatchewan
1968 482 304 1032 76 204 104 99 190
1970 686 354 911 85 227 98 83 195
1972 664 378 732 91 237 91 75 195
Alberta _ _
1968 575 363 1052 100 205 125 140 233
1970 814 398 870 90 229 103 132 219
1972 858 424 705 97 270 100 119 227
British
Columbia
1968 537 271 1104 83 252 96 153 223
1970 680 309 899 76 246 95 117 212
1972 663 321 691 82 253 88 93 206
Canadian
average
1968 474 311 1008 87 183 101 103 225
1970 622 333 855 88 190 91 96 215
1972 666 382 679 100 213 89 95 221
♦Source: tapes supplied by Statistics Canada.
(Age and sex standardized, Canada 1968 as reference standard. 
JAge standardized for women.
§Age standardized for men.
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TABLE III .—Canadian and Provincial T rends Compared for E ight Elective 
Procedures, 1968 to 1972*
Change, %
Procedure Canada Provinces
Hysterectomy +41 All increased
Cholecystectomy +23 All increased
All tonsillectomy and adenoidectomy -3 3 All decreased
Extraction of lens +  15 3 provinces increased
> 30. These included 
Quebec +31 
Nova Scotia +48 
New Brunswick +82
4 provinces increased slightly 
2 provinces decreased slightly
Prostatectomy +  16 All increased except 
Newfoundland 
Quebec +  22 
Alberta, New Brunswick, 
Nova Scotia increased 
>  30
Hemorrhoidectomy -1 2 All decreased except
New Brunswick +30 
Nova Scotia +  8
Varicose-vein stripping -  8 All decreased or remained 
unchanged except 
Nova Scotia, Quebec +13 
New Brunswick +36
Nonrecurrent inguinal herniorrhaphy -  2 Minimal changes except 
Nova Scotia +14 
New Brunswick +36
*Source: summary of Tables I and II.
eight of the nine provinces but decreased 
in Newfoundland. Increases greater than 
30% were noted in New Brunswick, Nova 
Scotia and Alberta. The three procedures 
for which rates decreased slightly in Canada 
(herniorrhaphy, varicose-vein stripping and 
hemorrhoidectomy) showed small but 
mainly downward changes in most prov­
inces; however, rates in New Brunswick in­
creased at least 30% in all three, in Nova 
Scotia they increased slightly in all three 
and in Quebec the rata for varicose-vein 
stripping increased 13%.
Nonelective Procedures
Of the seven procedures designated non­
elective, the change in Canadian rates be­
tween 1968 and 1972 was 15% or less for 
all except colectomy, where a 36% increase 
was recorded (Table IV). Increases in colec­
tomy rates of this magnitude were recorded 
in all provinces, partially as a result of the 
increased incidence of colon cancer as ev­
idenced by a 5% increase in its crude death 
rate.8, 9
Rates for nonelective operations except 
appendectomy were smaller than those for 
elective surgery. Thus, the 36% increase
in the colectomy rate (from 22 to 30 proce­
dures per 100 000) resulted in about 1600 
additional operations per year in Canada, 
whereas the 41% increase in hysterectomy 
produced about 38 000 more operations 
annually. Since small changes in actual num­
bers of nonelective operations could produce 
large changes in rates, variations of only 
15% or less indicate that the amount of 
nonelective surgery did not change over the 
5-year period. Apparently indications for 
nonelective surgery are more sharply de­
fined and more precisely followed than for 
elective surgery.
Effect of Prevalence and
Treatment Style on Surgical Rates
Radical procedures are performed for 
breast cancer, a disease whose incidence and 
death rate have not changed appreciably in 
the last 20 years.10 The rates in Canada 
for this surgical procedure have remained 
essentially the same over the 5-year study 
period with no change in disease rate. The 
rate variation between the provinces was 
small and remained essentially unchanged 
between 1968 and 1972.
The cesarian section rate per 100 000
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women aged 15 to 44 years is another exam­
ple of how surgical rates may be affected 
by prevalence and treatment styles. The 
cesarian section rate increased approxim­
ately 30% between 1968 and 1972 and 
interprovincial variation was greater than 
200% in both 1968 and 1972. Newfound­
land, which ranked lowest for most elective 
and nonelective surgery, ranked highest for 
cesarian section. However, when the ratio 
of cesarian sections to live births was cal­
culated, interprovincial variation was re­
duced and Newfoundland no longer had 
the highest rate. The increase of more than 
30% was due to closer fetal monitoring and 
more liberal indications for cesarian section,
since both the number of live births and the 
birth rate decreased slightly between 1968 
and 1972.11 If the prevalence of all condi­
tions for which a particular operation was 
done was known and if operative rates were 
related to prevalence rather than to popula­
tion, the presence of true differences could 
be more readily established.
E f f e c t  o f  N um bers of  Su r g eo n s  
and  H o spita l  Beds
The numbers of active surgeons* were 
positively correlated with combined elective
* Surgeons, surgical residents and general prac­
titioners who indicate a primary interest in sur­
gery.52
TABLE IV.—Seven Nonelective Procedures — P rovincial Rates* per 100 000 PopuLATioNf
Procedure
Province
Radical
mastec-
tomyX
Partial
thyroid­
ectomy
Heart
valve
surgery
Lobect­
omy-pneu­
monectomy
Nephrec­
tomy
Colectomy, 
partial and 
complete
Append­
ectomy
Newfoundland
1968 45 15 4 4 16 15 219
1970 56 24 4 7 16 29 194
1972 44 14 1 6 13 30 170
Nova Scotia
1968 69 20 7 7 16 25 258
1970 66 24 6 8 24 34 288
1972 71 20 6 9 20 33 256
New Brunswick
1968 66 22 — 5 10 17 230
1970 56 28 — 5 10 29 226
1972 55 23 7 4 11 26 226
Quebec
1968 52 15 11 9 11 20 196
1970 53 12 8 8 10 21 164
1972 54 13 8 9 11 27 161
Ontario
1968 57 22 6 7 12 22 242
1970 55 19 6 6 12 29 223
1972 57 18 7 9 13 31 207
Manitoba
1968 65 21 8 10 12 28 221
1970 66 23 7 10 14 30 229
1972 65 20 8 10 12 31 225
Saskatchewan
1968 64 29 4 8 9 19 278
1970 66 22 6 8 8 24 333
1972 63 26 8 9 10 29 298
Alberta
1968 58 30 8 9 13 22 297
1970 57 27 9 12 13 29 301
1972 59 24 8 11 14 30 256
British Columbia
1968 65 24 9 10 13 30 197
1970 60 23 8 13 14 35 207
1972 63 23 10 12 12 36 194
Canadian average
1968 58 21 8 8 12 22 229
1970 57 19 7 8 12 28 217
1972 58 18 8 9 12 30 202
*Source: tapes supplied by Statistics Canada.
fAge and sex standardized, Canada 1968 as reference standard.
{Age standardized for women only.
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TABLE V.--Statistically Significant (P <  0.05) Correlation Coefficients* 
Between Surgical P rocedures and Beds, Surgeons and H igh E conomic Status!
Year
Significant correlations 
between 8 elective 
operations combined, and
Coefficient of 
correlation
Significant correlations 
between 7 nonelective 
operations combined, and
Coefficient of 
correlation
1968 No. of surgeons 
High economic status
0.67
0.77
No. of beds 0.89
1969 No. of surgeons 
High economic status
0.69
0.70
No. of beds 0.87
1970 — No. of beds 0.90
1971 No. of surgeons 0.70 No. of beds 0.83
1972 — No. of beds 0.88
*Pearson product moment correlations.
(High economic status: percent of provincial population with incomes 'p $12 000/yr.
Other variables considered: low economic status, percent rural population, hospital pressure index.
surgical rates in 3 of the 5 years studied: 
1968, 1969 and 1971 (Table V). The num­
ber of hospital beds was not correlated with 
the combined elective surgery rates in any 
year, but the number of beds could be cor­
related with the combined nonelective sur­
gical rate in all 5 years. It appears therefore 
that the number of surgeons and not the 
number of hospital beds determines the 
number of elective procedures, and the num­
ber of acute-care hospital beds can influence 
the amount of nonelective surgery, regard­
less of the number of surgeons. The statistic­
al association between hospital beds and the 
seven non-elective operations studied may, 
however, be spurious because nonelective 
operations made up only 5% of all sur­
gery done and accounted for only about 
2.5% of all hospital admissions in the years 
studied.
Relations between surgeons, hospital beds 
and the elective surgery rate were best 
demonstrated at the extremes; Newfound­
land ranked low for all three and Alberta 
ranked high. If Newfoundland, which had 
substantially lower elective rates than Cana­
da or the other provinces, was removed from 
the analysis, correlations between numbers 
of surgical personnel and the combined 
elective surgical rate could no longer be 
demonstrated, although the correlation be­
tween hospital beds and the combined non­
elective rate persisted.
Elective surgery rates in Newfoundland 
in 1968 were closer to those in England and 
Wales in 1967 than to the 1968 Canadian 
rate (Table VI). Newfoundland, with a
widely dispersed, mainly nonurban popula­
tion of about 500 000, can hardly be likened 
to England and Wales with its more com­
pact urban population of 50 000 000. New­
foundland had more beds, fewer surgeons 
and slightly less medical insurance than 
England and Wales, and payment for sur­
gery was by fee-for-service rather than by 
salary. While elective surgery rates in New­
foundland were all substantially less than 
the corresponding Canadian rates, the 
province’s rate of prostatectomy (2x), hyste­
rectomy (1.6x) and cholecystectomy in 
women (3.8x) were none the less greater 
than those in England and Wales. For the 
other elective procedures studied, the rates 
for Newfoundland and England and Wales 
were similar. Although Newfoundland had 
fewer physicians doing surgery and slightly 
less insurance coverage than England and 
Wales, its combination of more beds and 
fee-for-service payment may have been 
responsible for higher rates for some elective 
operations.
Insurance Coverage
In 1968, Quebec, Nova Scotia and New 
Brunswick had less than 75% of their resi­
dents insured for surgical services.1 In the 
years immediately following adoption of uni­
versal medical care insurance, Nova Scotia’s 
combined elective surgery rate increased 
25%, New Brunswick’s, by 12% and 
Quebec’s, 7%. Of the two provinces with 
100% insurance coverage in 1968, the com­
bined elective surgical rate in Saskatchewan 
increased 1% between 1968 and 1972, and
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TABLE VI.—Comparison of Surgeons, I nsurance, H ospital Beds and Selected E lective 
Operations in Canada (1968), N ewfoundland (1968) and E ngland and Wales (1967)*
Canada
1968
Newfoundland
1968
England 
and Wales 
1967 England and Wales
Surgeons/100 000 population 27.3 13.2 19.0 0.7B eds/101)0 population 
Population with insurance for
5.9 5.6 3.7 1 .6
surgical services, % 
Surgical procedures/100 000
84 93 1 0 0 0.9
population!
Hysterectomy, F 472 339 213 1 .6
Cholecystectomy, M 135 43 27 1 .6F 487 268 70 3.8
All tonsillectomy and
adenoidectomy, M 964 469 489 1.0
F 1025 592 504 1 .2
Extraction of lens, M 75 40 38 1 .1
F 95 40 45 0.9
Prostatectomy, M 183 144 72 2 .0
Hemorrhoidectomy, M 104 6 8 54 1.3
F 94 46 31 1.5
Varicose-vein stripping, M 40 2 1 41 0.5
F 168 85 81 1.0
Nonrecurrent inguinal
herniorrhaphy, M 401 254 2 2 2 1.1
F 49 29 23 1.3
*Sources: Canada, Dominion Bureau of Statistics: Surgical Procedures and Treatments, 1968 (catalogue no 
82-529), Ottawa, Information Canada, March 1971; Great Britain, Ministry of Health: Report on Hospital 
In-Patient Enquiry for the Year 1967. Part I. Tables, London, Her M ajesty’s Stationery Office, 1970- pro­
vincial data by age and sex for individual surgical procedures supplied by Statistics Canada. 
fAge standardized, sex specific, population of Canada 1968 as reference standard.
decreased 13% in British Columbia. In 
the six provinces in which 80% or more of 
residents had medical insurance in 1968 the 
combined elective surgical rate decreased 
4% , while the combined rate in the three 
provinces with 75% or fewer residents in­
sured increased 13% (Table VII). If we 
consider the provinces where 75% or less
of the residents were previously covered, the 
incidence of elective surgery (based on our 
study of eight procedures) rose in most cases 
when universal medical insurance was in­
troduced. The fee-for-service method of re­
muneration for surgeons remained constant 
during the study period. In Nova Scotia only 
63% of the population had medical in-
TABLE VII.— Insurance Coverage and Combined E lective Surgical Rates*
Province and proportion of residents 
with insurance coverage for surgical 
series in 1968
Change in combined 
elective surgery 
rates from 1968 to 1972, %
Provinces
combined
< 75%
Nova Scotia 
New Brunswick 
Quebec
+25 
+ 1 2  
+  7
+13
> 80%
Saskatchewan -f l
British Columbia -1 3
Ontario — 7
Manitoba -  2 4
Alberta o
Newfoundland +  3
*Sources: Vayda and Anderson1 and tapes supplied by Statistics Canada.
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surance in 1968. That province had the 
greatest increase (2 5 % ) in its combined 
elective surgery rate after universal insurance 
was adopted, although surgical personnel 
increased by only 4%  and hospital beds 
by 3%  during the study period.
U ses a n d  L im it a t io n s  o f  L a r g e -Sc ale
U t il iz a t io n  D a t a
National and provincial comparisons iden­
tify differences and trends but cannot estab­
lish causes of observed differences. Compa­
risons are best done between small areas 
with differing surgical rates where disease 
incidence, treatment styles, availability of 
hospital beds, socioeconomic indicators, and 
provider and consumer expectations and 
characteristics can be more readily deter­
mined. On the other hand, cross-national 
or interprovincial differences do raise the 
question of too much or too little elective 
surgery. Answers to this question are ur­
gently required and can best be found by 
measuring outcomes using surgical and non- 
surgical treatments for specific conditions 
such as varicose veins,13 hemorrhoids or 
abnormal tonsils. Ideally, such studies should 
be done as controlled clinical trials with ap­
propriate randomization into surgical and 
nonsurgical treatment groups.
Review of trends over a period of time 
allows for detection of changes that are 
amenable to study and action. In Saskat­
chewan an increase of 75%  between 1964 
and 1971 in the rate of hysterectomy was 
brought to the attention of that province’s 
College of Physicians and Surgeons. The 
college then appointed a special committee 
made up of providers and consumers, which 
identified indications for abdominal hys­
terectomy and classified hysterectomies in 
1970 and 1973 at selected hospitals as “ jus­
tified” or “ unjustified” . Unjustified hysterec­
tomy rates ranged from 1.7 to 58 .6% . Hos­
pitals with low rates of unjustified hysterec­
tomies were commended and those with high 
rates were sent five recommendations, which 
included the statements that “ unnecessary 
surgery should cease” and “ Tissue Commit­
tees should take a renewed interest in their 
responsibility” . The committee reported a 
50%  reduction in the rate of hysterectomy 
in the one Saskatchewan city with the
highest “ unjustified”  hysterectomy rate, and 
an overall provincial reduction of 13% , 
which they attributed in part to the review.14
Perhaps the next step after criteria for 
“ justified”  and “ unjustified” elective sur­
gery are developed and agreed upon would 
be to allow hospital surgical utilization com ­
mittees to act prospectively to screen can­
didates for elective surgery and to pre­
authorize elective operations.
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MYOCARDIAL GLYCOGEN IN PREVENTION OF PERIOPERATIVE 
ISCHEMIC INJURY OF THE HEART: A PRELIMINARY REPORT*
S. R. K. IYENGAR, MD, FRCS[C], E. J. P. CHARRETTE, MD, FRCS[C],
C. K. S. IYENGAR, MD, FRCP[C] and S. WASAN, MD, FRCP[C]
The incidence of arrhythmias, low output and 
acute myocardial infarction in the perioperative 
period was analyzed for 119 patients who under’’ 
went aortocoronary bypass surgery. The inci­
dence for three groups of patients was as 
follows: 44%  for 72 patients who did not receive 
glucose-insulin-potassium (GIK) before operation 
(no-GIK group), 32%  for 25 patients who received 
preoperative GIK alone before operation (GIK 
group) and zero in 22 patients who received GIK 
before operation plus a bolus of 50%  glucose 
(0.5 ml/kg body weight) at the beginning of 
operation (GIK-G group) (the difference between 
the GIK-G group and the other two groups is 
significant; P <  0.001). Determination of myo­
cardial glycogen content of 63 ventricular biop­
sies revealed a 2 +  to 4 +  content in 48%  of the 
no-GIK group, 83%  of the GIK group and 100% 
of the GIK-G group (P <  0.05). The incidence of 
complications in patients with myocardial glyco­
gen content of 2 +  to 4 +  was significantly lower 
(P <  0.005) than in those with myocardial glyco­
gen content of 1+. Experimentally, myocar­
dial tolerance to ischemic injury parallels 
myocardial glycogen content. Our preliminary 
observation that prior administration of GIK-G 
increases myocardial glycogen content with a 
concomitant reduction in complications is con­
sistent with these experimental observations.
La frequence des arythmies, des etats de faible 
debit et des infarctus aigus du myocarde surve- 
nant pendant la periode perioperatoire a ete 
analysee chez 119 patients qui ont subi un pon­
tage aortocoronarien. La frequence pour trois 
groupes de patients etait la suivante: 44%  de 
72 patients qui n'ont pas regu de solution de 
glucose-insuline-potassium (GIK) avant ('opera­
tion (groupe sans GIK), 32%  de 25 patients qui 
ont regu une solution de GIK seule avant I'ope- 
ration (groupe GIK) et 0 de 22 patients qui ont 
regu la solution de GIK avant I'operation et une 
injection rapide de glucose a 50%  (0.5 ml/kg de
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University, Kingston, Ont.
Supported by Ontario Heart Foundation grant 
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poids) au debut de I’operation (groupe GIK-G) 
(la difference entre le groupe GIK-G et les deux 
autres groupes est significative a P <  0.001). 
Dans 63 biopsies ventricuiaires, la determination 
du giycogene myocardique a revele une teneur 
de 2 +  a 4 +  chez 48%  du groupe sans GIK, 
chez 83%  du groupe GIK et chez 100% du 
groupe GIK-G (P <  0.05). La frequence des com­
plications chez les patients ayant une teneur en 
giycogene myocardique de 2 +  a 4 +  a ete signi- 
ficativement plus faible (P <  0.005) que chez 
ceux ayant un giycogene myocardique de 1 +  . 
Experimentalement, la tolerance myocardique aux 
lesions ischemiques est proportionnelle a la 
teneur myocardique en giycogene. Nos observa­
tions preliminaires demontrent que I'adminis- 
tration pre-operatoire de GIK-G augmente la 
teneur en giycogene myocardique avec une 
diminution concomitante des complications, et 
s'accordent avec ces observations experimen- 
tales.
Perioperative ischemic injury of the heart 
is of major concern in myocardial revascu­
larization surgery. The reported incidence 
of myocardial infarction early after aorto­
coronary bypass graft procedures ranges 
from 5 to 40% .1-4 Data relating to the 
incidence of arrhythmias and low-output 
failure occurring either alone or in associa­
tion with myocardial infarction are lacking.
There are three distinct periods during 
surgical procedures when ischemic injury 
can occur: from induction of anesthesia to 
institution of cardiopulmonary bypass, dur­
ing cardiopulmonary bypass and in the post­
bypass period. We found that among 72 
patients ventricular fibrillation, other ar­
rhythmias or a low-output state developed 
during operation in 15%, even before by­
pass was instituted (Table I), which sug­
gested to us that certain metabolic altera­
tions in ischemic heart disease possibly con­
stitute an important predisposing factor 
rendering the myocardium vulnerable to pe­
rioperative ischemic injury.
Diminished myocardial perfusion in pa­
tients with coronary atherosclerosis and myo­
cardial ischemia in experimental models is 
associated with a shift from aerobic to an­
aerobic metabolism.5 13 The excess lactate
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TABLE I.-—N umbers (and %) of Complications
Group
No-GIK GIK GIK-G
Period and complication (n =  72) (n = 25) (n =  22)
Prebypass...............................................  11 (15) 1 (4) 0 (0)
Ventricular fibrillation.................  2(2.8) 1(4) 0 (0)
Arrhythmia..................................... 6 (8) 1 (4) 0 (0)
Low output..................................... 6 (8) 0 (0) 0 (0)
Postbypass.............................................  28 (39) 8 (32) 0 (0)
Ventricular fibrillation.................  6 (8) 0 (0) 0 (0)
Arrhythmia..................................... 16 (22) 4 (16) 0 (0)
Low output..................................... 8 (11) 1 (4) 0 (0)
Acute myocardial infarction.......  8 (11) 4 (l6) 0 (0)
Deaths............................................. 4 (5.5) 1 (4) 0 (0)
Overall....................................................  39 (54) 9 (36) 0 (0)
production is said to be derived from in­
creased breakdown of glycogen as an energy 
substrate. There is also preferential utiliza­
tion of glucose and loss of intracellular po­
tassium during ischemia. With the exhaustion 
of available glycogen there is rapid deple­
tion of high-energy phosphate compounds 
(adenosine triphosphate and creatine phos­
phate), which sets in motion the sequence 
of events leading to alterations in trans­
membrane potentials and electrophysiologic 
instability.16'18 There is a direct relation­
ship between myocardial glycogen content 
and tolerance to anoxia.14, 19 21 This com­
munication is a preliminary report on the 
effects of a therapeutic regimen before and 
during operation designed to increase myo­
cardial glycogen content and thus to prevent 
or decrease the extent of perioperative 
ischemic injury of the heart.
Patients and M ethods
The incidence of arrhythmias, low-output 
state and acute myocardial infarction was 
analyzed for 119 patients who underwent 
aortocoronary bypass procedures. There 
were 105 men and 14 women; among the 
former, ages ranged from 30 to 62 years and 
among the latter, 40 to 61 years (averages, 
38 and 42 yr, respectively). The patients 
were grouped according to three therapeutic 
regimens, as follows: 24 patients received a 
continuous intravenous infusion of 10% 
dextrose in water (D/W), 10 units of regu­
lar insulin and 40 meq of potassium chloride 
(G1K) starting at 9:00 pm the night before 
operation and continuing until the initiation 
of cardiopulmonary bypass; this group con­
stituted the GIK group. Another group of 
22 patients received, in addition to the GIK
infusion, a bolus of 50% D/W (0.5 ml/kg 
body weight) through the central venous 
pressure catheter at the beginning of opera­
tion (GIK-G group). A third group of 72 
patients (no-GIK group) received no pre­
operative treatment.
Glycogen content of myocardium was de­
termined as follows: a small piece of myo­
cardium (approximate dimensions, 2 x 2  
mm) was taken with Cushing’s forceps from 
the apex of the left ventricle of 63 patients, 
just before the left ventricular vent was in­
serted, and immediately fixed in Carnoy’s 
solution. Glycogen was quantitated in sec­
tions stained with periodic acid-Schiff on a 
scale of 0 to 4 +  (Fig. 1). The authors ex­
amining the slides were not informed as to 
the particular patient and group to which 
tissue was ascribed until the glycogen grad­
ing had been completed.
To monitor cardiac status 12-lead elec­
trocardiograms were taken preoperatively, 
soon after operation and daily thereafter. 
Perioperative ischemic injury was assessed 
as follows: The incidence of arrhythmias, 
low cardiac output and acute myocardial 
infarction during a 48-hour period from the 
time of induction of anesthesia was taken 
into account. Any disturbance of rhythm 
that required treatment by cardioversion or 
antiarrhythmic drugs was considered an 
arrhythmia. Hypotension that required treat­
ment with a vasopressor or with prolonged 
cardiopulmonary bypass support was in­
cluded under low output. And with respect 
to acute myocardial infarction, only those 
patients in whom the cardiologist reporting 
on the electrocardiograms had made a speci­
fic diagnosis of acute myocardial infarction 
were taken into account. Also determined
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were preoperative and postoperative serial 
concentrations of blood sugar and serum 
enzymes. The number of diseased vessels 
and bypass grafts in the three groups was 
also determined.
Excluded from the study were patients 
who had preoperative myocardial infarction 
of a few days’ duration, combined proce­
dures and emergency bypass grafts.
R esu lts
The average number of diseased vessels
TABLE II.—N umber (and %) of D iseased 
Vessels
Group
Vessel involvement
No-GIK
(n =  72)
GIK
(n = 25)
GIK-G
(n = 22)
Single (n = 15). . 12 (17) 3 (12) 0 (0)
Double (n = 41). 30 (41) 7 (28) 4 (18)
Triple (n = 63). . 30 (43) 15 (60) 18 (82)
Main left
(n = 15)..........
Average no./
7 (9) 2 (8) 6 (27)
patient.............. 2.25 2.48 2.81
per patient in the GIK (2.48) and GIK-G 
(2.81) groups was higher than in the no-GIK 
group (2.25) (Table II). A relatively high 
proportion of patients with left main coro­
nary artery disease (27%), an average of 
2.81 diseases vessels per patient and the 
absence of single-vessel disease (Table II) 
put the GIK-G group at a comparatively 
higher risk.
The numbers of bypass grafts are shown 
in Table III.
The proportion of patients with one or 
more perioperative ischemic complications 
in the prebypass and postbypass periods (Ta­
ble I) was 54% in the no-GIK group, 36% 
in the GIK group and zero in the GIK-G
Fig. lc
Fig. 1.—Ventricular biopsies stained for glyco­
gen content: (a) Less than 1+ , (b) 1+, (c) 4+  
(periodic acid-Schill stain, reduced by 15% from 
x 312).
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TABLE III.—Number (and %) of Aorto­
coronary Bypass Grafts
Group
Vessel graft
No-GIK
(n = 72)
GIK
(n =  25)
GIK-G
(n =  22)
Single (n = 19) .. 14 (19) 5 (20) 0 (0)
Double (n = 67). 42 (58) 13 (52) 12 (55)
Triple (n = 33). . 
Average no. of
16 (22) 7 (28) 10 (45)
grafts /patient. . 1.9 2.1 2.5
group; the difference in the incidence be­
tween the first two groups and that for the 
third is significant (P <  0.001). Of the 
patients in the no-GIK group, 15% had one 
or more of the complications compared with 
4% in the GIK group and zero in the GIK- 
G groups from the time of induction of an­
esthesia to the beginning of cardiopulmonary 
bypass (Table I). Of the patients in the no- 
GIK group who had complications in the 
prebypass period, two had ventricular fibril­
lation requiring defibrillation and quick in­
stitution of cardiopulmonary bypass. Rapid 
institution of cardiopulmonary bypass also 
became necessary in the remaining nine pa­
tients in whom arrhythmias or hypotension 
developed. In contrast there was only one 
patient in the GIK group in whom cardiac 
arrest occurred before cardiopulmonary by­
pass. The absence of ventricular irritability 
and hypotension was most impressive in the 
GIK-G group.
For the postbypass period the incidence 
of one or more complications was 39% in 
the no-GIK group, 32% in the GIK group 
and zero in the GIK-G group; the difference 
relating to the incidence in the GIK-G 
group is significant (P <  0.01) (Table 
I). The incidence of ventricular fibril­
lation was 8% in the no-GIK group and 
zero in the other two groups. The incidence 
of arrhythmia was lower by 6% and of low 
output by 7% in the GIK group compared 
with the no-GIK group. Although there was 
no decrease in the incidence of acute myo­
cardial infarction in the GIK group, none 
had serious hemodynamic problems and 
none died. In the no-GIK group 12.5% of 
the acute myocardial infarctions proved 
fatal and half of those who had postbypass 
myocardial infarction had associated major 
arrhythmias or a low-output state. The op­
erative mortality was 5.5%, 4% and zero, 
respectively, in the no-GIK, GIK and GIK-
TABLE IV.—M yocardial Glycogen Content in 
63 Ventricular B iopsies
Group
Grade of No GIK GIK GIK-G
glycogen content (n = 21) (n = 23) (» =  19)
+ ...................... 11 4 0
+  +  to +  +  +  + . 10 19 19
G groups.
The glycogen content of the myocardial 
tissue biopsied is shown in Table IV. Of 
the biopsies in the no-GIK group, 48 % had 
glycogen graded as 2 +  to 4 +  whereas 83 
and 100% in the GIK and GIK-G groups 
contained glycogen to this degree —  a 
difference that is significant (P <  0.05). 
The incidence of complications in relation 
to glycogen content is shown in Table V; 
19% of patients whose myocardium con­
tained 2 +  to 4 +  glycogen had one or more 
complications, compared with 60% in pa­
tients with 1 +  glycogen or less (P <  0.005). 
The mortality in patients with 1 +  glycogen 
was 20% and only 2% in those with 2 +  
to 4 +  glycogen.
Discussion
Many factors cause perioperative ischemic 
injury,1' 2’ 22 among which are the dura­
tion of cardiopulmonary bypass, the period 
of aortic cross-clamping, the extent of myo­
cardial ischemic disease, the adequacy of 
myocardial revascularization and the sur­
geon’s skill. The 15% incidence of com­
plications (Table I) before the institution 
of cardiopulmonary bypass and thus before 
any of the causative factors became oper­
ative suggested to us the possibility that cer­
tain metabolic alterations specific to ischemic 
heart disease may have an important role 
in rendering the myocardium vulnerable to 
ischemic injury in the perioperative period.
TABLE V.—Percentage Incidence of Compli­
cations in Relation to M yocardial Glycogen 
Content
Grade
+  + +  to
Complication
*"i
' II 3 II
Arrhythmia.. . . 47 12.5
Low output. . . . 33 2
Acute M I......... 27 6
Death................ 20 2
Complication 
rate, % ......... 60 19
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A review of the literature relating to myo­
cardial metabolism in clinical and experi­
mental myocardial ischemia shows that 
there is preferential utilization of glycogen 
and glucose during oxygen lack.21' 23 Myo­
cardial tolerance to anoxia is directly 
proportional to cardiac glycogen con­
tent.14- 19-21 a  higher incidence of peri­
operative ischemic complications (Table V) 
in our patients whose myocardial glycogen 
content was graded 1 +  is consistent with 
this observation.
It is common practice to operate on pa­
tients in a fasting state. That 52% of our 
patients’ myocardial tissue had only 1 +  
glycogen would suggest that in the majority 
of patients at fasting blood sugar concentra­
tions the myocardium does not store an 
optimum amount of glycogen and thus 
that the myocardium is more vulnerable 
to damage. Myocardial glycogen content is 
reported to be higher after the administra­
tion of glucose and insulin.24 Decrease in 
the area of experimental myocardial infarc­
tion and improved mechanical, and electro- 
physiologic performance after anoxic myo­
cardial injury has been reported with 
the administration of glucose, insulin, 
potassium and hypertonic glucose solu­
tions.14- 21- 24-32 Chiong, West and Par­
ker33 have observed that GIK infusion has 
a beneficial effect on pacing-induced angina, 
ST-segment depression and left ventricular 
end-diastolic pressure in patients with coro­
nary artery disease. In the present study 
with the preoperative administration of GIK 
83% of ventricular biopsies had a glycogen 
content of 2 +  to 4 +  ; with preoperative 
infusion of GIK plus a bolus of 50% glu­
cose at the beginning of the operation, 100% 
of the ventricular biopsies contained 2 +  
to 4 +  glycogen.
The incidence of perioperative complica­
tions showed a lower trend in the GIK group 
but it was significantly lower (P < 0.001) 
in the GIK-G group compared with the no- 
GIK group. Further, the incidence of com­
plications in the GIK-G group was signifi­
cantly lower (P < 0.01) than in the GIK 
group.
Available data concerning myocardial 
metabolism in experimental anoxia indicate 
that under such circumstances there is a
rapid decrease in myocardial oxygen ten­
sion, depletion of myocardial glycogen with­
in a matter of minutes and decrease in myo­
cardial pH due to lactate accumulation from 
anaerobic metabolism.14 In addition, the 
possibility of adverse effects of stasis of de- 
oxygenated blood in the coronary micro- 
circulation and platelet microemboli has to 
be considered. Therefore some form of myo­
cardial protection during intermittent anoxic 
arrest is advisable.14 Flushing of the coro­
nary artery bed with a physiologic solution 
(“Queen’s cocktail”) made up of 800 ml 
plain Ringer’s solution with 200 ml low- 
molecular-weight dextran, 2000 units of 
heparin, 20 meq of sodium bicarbonate, 2 
units of regular insulin, 20 mg hydrocorti­
sone sodium succinate (Solu-Cortef) and 8 
meq potassium chloride at 15 to 20°C has 
proved to be practical and effective.14 The 
solution is infused into the aortic root under 
gravity in a bolus of 100 to 200 ml during 
each period of aortic cross-clamping. Ex­
perimental work in dogs and isolated rabbit 
working heart models has shown that this 
technique preserves the myocardium and 
prevents myocardial glycogen depletion dur­
ing anoxia, and better recovery of function 
in the postanoxic period (Chiong and 
Iyengar, unpublished observations, 1975). 
Of the present series of patients 32 had 
asanguinous coronary artery perfusion dur­
ing intermittent aortic cross-clamping, and 
they were randomly distributed in the no- 
GIK, GIK and GIK-G groups.
Our preliminary observations suggest that 
it is possible to obtain optimal myocardial 
glycogen content before the onset of is­
chemic injury by first giving an infusion of 
glucose, insulin and potassium together with 
a bolus of dextrose, and a trend to a de­
creasing incidence of perioperative arrhyth­
mias, low output and myocardial infarction 
has been observed. Although our study sug­
gests that glycogen protects the myocardium 
from ischemic injury the exact mechanism 
of damage and the actions of glucose, insu­
lin and potassium are complex and mani­
fold. Our knowledge in these matters is still 
incomplete. Continued efforts to gain a bet­
ter insight into myocardial metabolism in 
coronary artery disease and to find methods 
that modify ischemic injury by preoperative
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and intraoperative metabolic intervention 
should help to reduce early morbidity and 
mortality and to achieve a better quality of 
life in the long term after myocardial re­
vascularization procedures.
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TECHNIQUE FOR CARDIOPULMONARY BYPASS IN THE GOAT*
W. G. WILLIAMS, MD, FRCS[C],t G. KENT, DVM, MSc,
A. J. GUNNING, MB, FRCS(Edin), R. SALT and E. H. SPRATT, MD, FRCS[C]
The goat is an ideal animal for intracardiac sur­
gical investigation. The animal is docile and 
easy to care for; it has an ideal heart size, a 
high cardiac output and a long life expectancy. 
The animal tolerates cardiopulmonary bypass 
well and does not require blood transfusion. 
Anoxic cardiac arrest is tolerated for up to 35 
minutes. Initial experience in 36 animals with 
operations on the right side of the heart resulted 
in a 72% long-term survival.
La chevre est I'animal ideal pour I’etude de la 
chirurgie intracardiaque. L'animal est docile et 
d'entretien facile; il possede un coeur de di­
mension ideale, un debit cardiaque eleve et une 
longue esperance de vie. L'animal tolere bien la 
derivation cardiopulmonaire et ne requiert pas 
de transfusion sanguine. L’arret cardiaque anoxi- 
que est tolere pour des periodes allant jusqu’a
35 minutes. Une experience initiale portant sur
36 animaux qui ont subit des interventions sur 
le cote droit du coeur, a resulte en une survie 
a long terme de 72%.
C ardiac surgery in the experimental labo­
ratory can be difficult and unpredictable. 
Because of the high mortality rate with 
cardiopulmonary bypass in dogs and calves1 
we decided to use the goat as an experi­
mental model. This paper describes our 
technique for cardiopulmonary bypass in 
36 goats and reports some baseline values, 
initial operative results and values for car­
diac output determined postoperatively.
Surgical M ethods
Preoperative Care
The goat may be housed either indoors 
or at a farm. Pen-space requirement is ap­
proximately 1.4 m'2 per animal. Feed con­
sists of alfalfa with 0.45 to 0.9 kg of mixed 
grain supplement daily. The animals pro­
cured from farmers tend to be malnourished 
and deficient in iron so we administer Im- 
feron, 2 ml, intramuscularly, every 2 weeks. 
A vermicide such as thiabendazole should
*From the cardiovascular division, Hospital for 
Sick Children, Toronto, Ont. and the Nuffield 
department of surgery, Radcliffe Infirmary, Ox­
ford, England.
fSupported by a grant from the Ontario Heart 
Foundation.
also be administered. The animal is fasted 
for 12 hours before operation; no premedi­
cation is given.
Intraoperative Procedures
General anesthesia is induced by inhala­
tion using a large rubber conical face mask. 
The animal breathes 4% halothane mixed 
with 5 l of oxygen and 5 / of nitrous oxide. 
No relaxants are given and the administra­
tion of atropine is avoided. When fully re­
laxed the animal is intubated with a 22.5- 
cm laryngoscope and an uncuffed 15-mm 
Cole endotracheal tube.* Anesthesia is 
maintained with a mixture of halothane, 1 
to 2% and oxygen (5 /), nitrous oxide (3 /) 
and carbon dioxide (800 ml/min).
A simple alternative to intubation is tra­
cheostomy. When the animal completely re­
laxes from inhalation of the general anes­
thetic, his neck is fully extended to bring 
the trachea to a subcutaneous position. A 
transverse, 2-cm incision is made over 
the midline, 3 cm below the cricoid 
cartilage. A transverse incision is made be­
tween the trachael rings and a no. 9 or 10 
cuffed endotracheal tube is passed. At the 
end of the operation, when the animal is 
fully awake, the endotracheal tube can be 
removed easily and the wound covered with 
gauze and allowed to close spontaneously.
Respiratory care during anesthesia is 
vitally important. For the average 40-kg 
goat, the tidal volumes should be maintained 
at 700 to 800 ml with a respiratory rate of 
10 to 12/min. Maximum airway pressure 
with these volumes is 35 cm H20 . Recently 
we have added a positive end-expiratory 
pressure of 5 cm FT20 . Adjustments may be 
necessary according to arterial blood-gas 
determinations.
Operative Technique
The procedures we have performed have 
been either complete or partial pulmonary 
valve replacement or vena caval valve im­
plantation with resection of the tricuspid
^Polyvinyl Cole equine tube, University of Colo­
rado Veterinary College, Fort Collins, CO.
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valve. Adequate exposure is obtained 
through either a right or left thoracotomy 
incision, without rib resection. (For a mid­
line approach the broad sternum could be 
divided longitudinally.) When a left thora­
cotomy is used, the descending aorta, beyond 
the origin of the left subclavian artery and 
posterior to the left phrenic nerve, is cannu­
lated for arterial inflow. With a right thora­
cotomy the ascending aorta is cannulated. 
Either technique gives adequate arterial re­
turn. The right atrium can be cannulated 
with a single cannula through the atrial ap­
pendage from the left side, or each vena 
cava can be cannulated separately when a 
right thoracotomy is used.
The electrocardiogram is monitored con­
tinuously during operation. An intravenous 
line is placed in one of the veins on the 
dorsum of the ear. The internal mammary 
artery (diameter, 2 to 3 mm) is cannulated 
during thoracotomy for monitoring of ar­
terial blood pressure and blood gases. We 
have not used a central venous pressure line 
or urinary catheter.
Cardiopulmonary Bypass
Each goat receives 200 units/kg of hepa­
rin before bypass; after bypass 300 units/kg 
of protamine is given to reverse hepariniza­
tion.
A medium-sized Bentley bubble oxygen­
ator (obtained after use in the clinical oper­
ating room) is flushed thoroughly with tap 
water, then irrigated with 1.5 / of distilled 
water on three separate occasions. The oxy­
genator may be gas autoclaved for reuse.
The oxygenator prime consists of Ringer’s 
lactate, 800 ml; dextran, 200 ml; sodium 
bicarbonate, 40 meq; calcium chloride, 5 ml; 
and heparin, 3000 units. When additional 
fluid is needed to maintain adequate flow 
we add 150 to 300 ml of dextran.
Bypass flow averages 2.085 //min and 
systemic pressure remains low at a mean 
of 30 to 40 mm Hg.
During bypass the heart is either perfused 
(in 24 of the animals in our series) or kept 
anoxic with topical hypothermia (Ringer’s 
lactate infusion into the pericardium at 4°C) 
, f (in 12 animals). The left heart is not vented 
unless it becomes distended.
To discontinue bypass, the venous pres­
sure is allowed to increase until the right
heart is full. If the arterial systolic pressure 
is less than 80 mm Hg, calcium chloride, 
2 ml, and adrenalin 1:100 000, 1 to 2 ml, 
is injected into the arterial line in single or 
repeated doses. An attempt is made to re­
transfuse all of the animal’s blood from the 
pump circuit.
Postoperative Care
The animal is kept in an upright position. 
When fully awake it is extubated and is 
usually returned to the pen within 1 hour 
after operation. Chest tubes are removed 
and the skin is closed. We have not moni­
tored pressures or the electrocardiogram 
after operation.
Cardiac Catheterization
Cardiac catheterization was performed 
in 21 goats in the late postoperative period. 
Under light general anesthesia, with or with­
out intubation, cardiac catheterization is 
simple; the goat has a large and easily 
accessible external jugular vein and a some­
what deeper carotid artery. Cardiac output 
was measured by means of the dye dilution 
method.
R esults
Long-term survival was achieved in 26 
(72%) of these 36 animals. Whether myo­
cardial perfusion or anoxic arrest was used 
did not affect operative mortality. The 
type of heart rhythm during bypass was an 
important factor in those animals who were 
continuously perfused: of 11 goats who 
maintained spontaneous sinus rhythm 
throughout bypass, 1 died; but of 3 who 
developed spontaneous ventricular fibrilla­
tion during bypass, 2 died. The total dura­
tion of bypass ranged from 22 to 60 min­
utes; it was greater in the anoxic arrest 
group (42.4 min) than in the perfused group 
(31.8 min). The mean duration of anoxic 
arrest was 26 minutes and mortality was 
not related to the duration of aortic cross­
clamping.
Thirty measurements of cardiac output 
were obtained in the late postoperative pe­
riod, each measurement averaging at least 
two samples. The mean cardiac output was 
4.4 //min (mean weight of the animals, 
39.6 kg).
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Course of illness
Group A (Trasylol) Group B (Placebo)
No. % No. %
Mild 30 56.6 22 42.3
Moderate 13 24.5 9 17.3
Severe 6 11.3 8 15.4
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Trapnell’s recent double-blind clinical trial 
involving 105 patients confirmed the 
effectiveness of Trasylol in acute 
pancreatitis. In addition to reducing 
mortality and altering the spectrum of the 
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effect of increasing age in this condition. 
Trasylol should be given concurrently with the 
usual measures for the treatment of 
pancreatitis, such as pain relief, 
fasting, gastric suction, etc. “ It 
(Trasylol) can therefore now be 
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effective and beneficial in the 
treatment of acute pancreatitis.”  *
*Trapnell, J.E. et al, British 
J. Surg., March 1974.
The Effect of
Trasylol
in
Hyperfibrinolytic
Hemorrhages
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tions due to hypersensitivity have been 
described infrequently, this possibility 
should always be kept in mind. In patients 
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observed prior to the administration of 
Trasylol.
Availability
Trasylol (aprotinin) is available in 10 ml 
am puls co n ta in ing  100,000 K.I.U . in 
boxes of 5 ampuls.
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D is c u s s io n
The goat is an ideal animal for cardiac 
research. Its heart size is equivalent 
to that of a teenager or small adult. The 
animal tolerates bypass for periods of up to 
60 minutes without blood transfusion and 
with satisfactory long-term survival. The 
goat heart is ideal for long-term follow-up 
of valve prostheses as it will not outgrow the 
prosthesis and the animal has a relatively 
long life expectancy (approximately 15 
years). The animal is docile and therefore 
is easy to handle and house. The cost of a 
goat is less than that of the purebred labo­
ratory dog.
The main problem we encountered was 
intrapulmonary shunting during the opera­
tion. This was manifested before bypass by 
a decrease in the arterial oxygen pressure 
(Po2). Subsequent hyperventilation to main­
tain an adequate Po2 resulted in respiratory 
alkalosis. To prevent this problem we intro­
duced carbon dioxide into the circuit and 
maintained continuous positive end-expira­
tory pressure. None the less, in some ani­
mals intrapulmonary shunting occurred 
early in spite of these measures, and survival, 
when this occurs, is much less likely.
Our experiments did not include proce­
dures using the goat’s coronary arteries but 
we believe they would be suitable for ex­
perimentation. Their anatomy appears to be 
similar to that of the human heart. We have 
not attempted intervention on the left side 
of the heart, but our favourable experience 
with anoxic arrest for periods of up to 35 
minutes suggests this also would be possible.
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EXPRESSION HEMODYNAMIQUE DU REJET CARDIAQUE*
CLAUDE CHARTRAND, MD, FRCS[C]+ et PAUL STANLEY, MDt
Ce travail avait pour but de prouver I'expression 
hemodynamique du rejet cadiaque en comparant 
1’evolution fonctionnelle postoperatoire d'un 
groupe homogene d’homotransplantes non mo­
difies a celle d’un groupe d'autogreffes etudies 
suivant un protocole identique. A partir du 4e 
jour postoperatoire, on observe initialement chez 
I'homotransplante une baisse significative du 
debit systolique maximum, de I'index de vitesse 
systolique maximum, de I'index du debit moyen 
d ejection systolique, de la puissance et du tra­
vail ventriculaires gauches, et surtout de ('acce­
leration. En phase terminale, on voit une accen­
tuation de I'atteinte deja existante des parame- 
tres, et de plus, une chute importante du debit 
cardiaque, du volume d'ejection systolique, du 
voltage electrocardiographique, et un allonge- 
ment du temps d'ejection. Dans les heures pre- 
cedant ie deces en defaillance cardiaque termi­
nale, la pression aortique s'affaisse et la tension 
veineuse centrale s'eleve rapidement. (.'evolution 
hemodynamique de I'autogreffe differe totale- 
ment a partir du 4e jour. La comparaison des re- 
sultats obtenus chez ces deux groupes experi- 
mentaux etablit la preuve que I’atteinte cardi­
aque fonctionnelle decrite chez I'homotransplante 
a partir de ce moment represente I'expression 
hemodynamique du rejet aigu.
The object of this investigation was to dem­
onstrate the hemodynamic features of cardiac 
rejection. The postoperative functional evolu­
tion of a homogeneous group of unmodified 
homografts was compared with that of a group 
of autografts studied by the same protocol.
^Section de chirurgie cardio-vasculaire, Hopital 
Ste-Justine, Montreal, PQ.
Presente a la reunion annuelle de la Societe cana- 
dienne de cardiologie, Montreal, PQ, le 23-25, 
octobre.
Travail subventionne par les octrois: Conseil de 
Recherches Medicales du Canada (MA-4391 et 
ME-4327); Conseil de Recherches Medicates du 
Quebec (710038); Fondation Canadienne des Ma­
ladies du Coeur; et Fondation Justine Lacoste- 
Beaubien.
fAdjoint de recherche, departement de chirurgie, 
Universite de Montreal. Assistant section de chi­
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Scholar du Conseil de Recherches Medicates du 
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JProfesseur agrege de chirurgie clinique, departe­
ment de chirurgie, Universite de Montreal. Chef, 
section de chirurgie cardio-vasculaire, Hopital Ste- 
Justine.
Les demandes de tires a part doivent etre adressees 
au Dr Claude Chartrand, Section de chirurgie 
cardio-vasculaire, Hopital Ste-Justine, 3175 che- 
min Ste-Catherine, Montreal, PQ H3T 1C5.
On the 4th postoperative day, a significant de­
crease was observed initially in the maximum 
systolic output, the maximum systolic rate in­
dex, the mean systolic ejection rate and also 
in the strength, work and, especially, accelera­
tion of the left ventricles of the homografts. 
In the terminal phase, the abnormalities already 
present in these parameters worsened; there 
was a large decrease in cardiac output, in the 
stroke volume, in the voltage of the electro­
cardiogram, and a slowdown in cardiac empty­
ing. During terminal heart failure, the aortic 
pressure became depressed and the central 
venous pressure increased rapidly. The he­
modynamic reaction following the homoplastic 
graft was totally different after the 4th day. The 
comparison of the results obtained from these 
two experimental groups established that the 
functional cardiac failure described for the homo­
plastic transplant represents the hemodynamic 
expression of acute rejection.
U ne  premiere ebauche descriptive de la 
fonction du coeur homotransplante a deja 
ete rapportee par Chartrand, Dong et Shum- 
way.1 Ces resultats indicateurs ont incite 
l’etude fonctionnelle de la phase postopera­
toire immediate ainsi qu’une premiere des­
cription de 1’evolution hemodynamique du 
sujet porteur d’une homogreffe cardiaque 
depuis le moment de l’intervention jusqu’au 
deces en rejet.2’ 3 Depuis, certaines de ces 
observations ont ete confirmees par Stinson 
et al.4’ 5 Toutefois, seulement certains pa- 
rametres de base ont ete analyses lors de ces 
etudes, le groupe d’animaux etudies etait 
heterogene et la preuve que les perturba­
tions cardio-vasculaires observees etaient 
secondaires au rejet aigu n’a pas ete pro­
duce. Le present travail a pour but d’exposer 
1’evolution hemodynamique postoperatoire 
d’un groupe homogene de sujets homotrans- 
plantes non modifies, d’inclure l’analyse de 
parametres valables de la fonction ventricu- 
laire, et de prouver I’expression hemodyna­
mique du rejet cardiaque en comparant les 
resultats obtenus chez I’homotransplante a 
ceux recueillis selon un protocole identique 
chez 1’autotransplante.
Materiel et Methode
Apres une periode de conditionnement 
approprie, des chiens batards (poids, 13 a
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21 kg) etaient selectionnes sur la base d’ex- 
amens cliniques normaux. Leur bon etat 
etait controle par des valeurs conformes a 
nos normogrammes hematologiques et bio- 
chimiques.0 Apres induction anesthesique 
au pentobarbital sodique (Nembutal), les 
animaux etaient intubes et ventiles a l’aide 
d’un respirateur a volume constant (Harvard, 
modele 607) relie a un distributeur d’halo- 
thane (Fluotec, Cyprane Ltd.)- Les animaux 
furent divises en trois groupes.
Groupe 1
Neuf chiens furent soumis a une homo­
transplantation cardiaque orthotopique. 
Apres thoracotomie et dissection vasculaire, 
l’animal etait relie au coeur-poumon artifi- 
ciel et place sous circulation extracorporelle 
selon la methode deja decrite.7 La pression 
partielle en oxygene etait intentionnellement 
maintenue en dega de 150 mm de Hg pour 
les raisons exposees anterieurement.8
La technique de transplantation orthoto­
pique fut essentiellement celle deja decrite 
par Lower, Stofer et Shumway.9 Toutefois, 
quelques modifications furent apportees et 
consisterent a sectionner la veine cave supe- 
rieure a 2 cm au-dessus de la jonction cavo- 
auriculaire droite afin de respecter l’inte- 
grite du noeud sinusal et a proteger le coeur 
durant la periode d’ischemie a l’aide d’un 
sac de refroidissement recemment mis au 
point dans notre laboratoire. Une fois les 
anastomoses completees, des fils conduc- 
teurs etaient respectivement sutures a la base 
de l’appendice auriculaire gauche et sur la 
paroi laterale du ventricule gauche. Ces fils 
metalliques devaient servir a l’enregistrement 
direct des potentiels ventriculaires et auricu- 
laires ainsi qu’a la verification du type de 
rythme cardiaque. L’aorte ascendante etait 
dissequee et entouree d’un manchon de ra­
tine de Teflon afin de prevenir les ruptures 
aortiques et une bague electromagnetique 
precalibree etait fixee a cet endroit. Un ca­
theter de polyvinyl (no 8 French) etait in- 
troduit dans la crosse de l’aorte par la sous- 
claviere gauche alors qu’un autre catheter 
de meme nature etait introduit dans l’oreil- 
lette droite par la veine jugulaire externe 
gauche. Les fils conducteurs, le cable de la 
bague magnetique ainsi que les catheters 
etaient tunnellises sous la peau et exteriori­
ses a la base du cou. Les plaies etaient re-
fermees, l’anesthesie et la ventilation artifi- 
cielle discontinues. En plus de prodiguer a 
l’animal les soins postoperatoires immediats 
conventionnels, 1’evaluation des apports et 
pertes sanguines etait verifiee par la deter­
mination du volume sanguin selon la me­
thode deja rapportee.10
Groupe 2
Chez six animaux, on proceda a une auto­
transplantation cardiaque selon la meme 
methode. Ces animaux furent traites et pre­
pares pour fins d’etudes physiologiques se- 
riees d’une fagon identique a celle des ani­
maux du groupe precedant.
Groupe 3
Enfin, un dernier groupe de cinq chiens 
servit de controle. Une thoracotomie gau­
che fut pratiquee et ils furent prepares pour 
fins d’etudes physiologiques de la meme 
fa?on que celle des deux premiers groupes.
Ces animaux furent examines tous les 
jours et leur bonne condition fut confirmee 
par la determination de l’hemoglobine, de 
I’hematocrite, de la formule blanche, des gaz 
sanguins et de l’equilibre acidobasique.0 
Chez l’homotransplante le rejet fut confirme 
par etude macroscopique et histologique 
et une attention particuliere fut apportee 
aux lesions vasculaires.11' 12
La preparation de ces modeles experimen- 
taux permit des etudes hemodynamiques se- 
riees chez 1’animal au repos, sans anesthesie 
et sans aucune forme de therapie. Les etu­
des debuterent 3 heures apres l’intervention 
et furent repetees quotidiennement jusqu’a 
ce que l’homotransplante decede a la suite 
d’un rejet aigu. Chez les deux autres groupes 
d’animaux, les etudes furent repetees quoti­
diennement sur une periode de 8 jours.
Durant chaque etude, l’electrocardiogram- 
me etait enregistre et incluait les derivations 
standards et corrigees ainsi que les potentiels 
auriculaires et ventriculaires directs; la deri­
vation D2 servait de point de reference et 
une attention particuliere etait apportee au 
voltage de l’onde “R ”; le trace auriculaire 
gauche servait a verifier si le rythme car­
diaque etait supraventriculaire. Un cardio- 
tachometre permettait l’enregistrement ins- 
tantane du rythme cardiaque. Les pressions 
aortique et auriculaire droite etaient mesu- 
rees a l’aide de traducteurs de pression de
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type “strain gauge” (Statham P23GB et 
P23BB). Un debitmetre electromagnetique 
servait a l’enregistrement des debits pha- 
sique et moyen (Statham SP 2200). Le debit 
cardiaque etait determine par trois courbes 
de dilution successives au Cardio-Green et 
les calculs du debit etaient bases sur la me- 
thode d’extrapolation semilogarythmique 
decrite par Hamilton-Stewart (Beckman, 
cardiodensitometer, modele 350127).13 
Simultanement, le volume d’ejection systo- 
lique etait obtenu par integration electroni- 
que du debit pulsatile et sa valeur etait 
etablie a partir d’un index de conversion 
(Statham cardioanalyzer SP1011). Le debit 
systolique instantane etait calcule par me- 
sure planimetrique de 1’onde phasique alors 
que la vitesse systolique l’etait en divisant 
le debit phasique par l’aire de section de 
l’aorte corrigee selon la formule de Mc­
Donald (H - 0.08:2R).14 L’acceleration 
etait obtenue par differenciation electroni- 
que du debit aortique instantane. La puis­
sance ventriculaire gauche etait calculee par 
multiplication electronique du debit aorti­
que et de la pression arterielle phasique alors 
que le travail ventriculaire l’etait par inte­
gration electronique de la puissance. Ces 
signaux analogiques etaient enregistres a 
l’aide d’un dynographe (Beckman, dyno- 
graph recorder RM-8) a huit canaux moni- 
torise continuellement sur ecran fluorosco- 
pique. Les parametres de base etaient 
transmis simultanement sur rubans magneti- 
ques (Philips Analog-7 tape recorder) pour 
fins de references, de verification et de traite- 
ment ulterieur (Fig. 1).
Ces signaux analogiques etaient ensuite 
traduits en donnees digitaliques, et les for- 
mules conventionnelles servaient aux cal­
culs de l’acceleration, de la puissance, du 
travail, du temps d’ejection systolique, du 
debit moyen d’ejection systolique, et de 
la resistance peripherique moyenne. La 
surface corporelle de l’animal etait deter- 
minee selon la formule
S =  6.67 P0-70 X- 0.34
T O l ’
ou S est la surface corporelle (cm2), P est le 
poids (g) et L est la longueur (cm), et tous les 
parametres etaient ramenes a un metre car- 
re de surface et exprimes en index. Apres 
verification par un programme de valida­
tion, les donnees etaient entrees en memoire 
et traitees a l’aide d ’un programme deja 
etabli (ordinateur CDC CYBER 74). Les 
resultats etaient ensuite compiles par groupe 
et par phase, et un ordinateur servait au 
calcul des statistiques de base (Olivetti 
Programma 101).
Les homotransplantes decederent de re­
jet aigu entre le 6e et le 7e jours postopera- 
toires. Ce groupe etant assez homogene 
quant a la survie moyenne, la compilation 
des resultats individuels fut facilitee et per­
mit d’etablir quatre phases postoperatoires 
bien identifiables aussi bien sur le plan tem- 
porel que fonctionnel. Les phases s’etablis- 
sent comme suit: a la phase I sont compiles 
les resultats obtenus 3 heures apres l’inter- 
vention. Durant la phase II, les homo­
transplantes avaient recupere sur le plan 
fonctionnel et avaient atteint un plateau de 
performance qui n’a pas ete depasse par la
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suite. Cet etat fonctionnel fut atteint entre 
le 2e et 3e jour apres l’intervention. La phase 
III correspond aux 4e et 5e jour apres l’in- 
tervention ou apparurent les signes fonction- 
nels d’atteinte de la performance cardiaque. 
A la phase IV, sont compiles les resultats 
des etudes pratiquees dans les 24 heures 
precedant la mort en rejet aigu qui survint 
entre le 6e et le 7e jour postoperatoires. De 
cinq a neuf determinations furent recueillies 
pour chacune des phases et pour chaque pa- 
rametre.
Afin de proceder a des comparaisons va- 
lables des resultats obtenus chez les trois 
groupes d’animaux, les etudes pratiquees 3 
heures, 2 a 3 jours, 4 a 5 jours, ainsi que 6 
a 7 jours apres l’intervention chez les auto­
transplantes et les animaux de controle 
furent analysees et reportees aux memes 
phases decrites plus haut chez les homotrans­
plantes. Quatre a six determinations chez 
les autotransplantes et cinq determinations 
chez les animaux de controle furent com- 
pilees pour chaque phase et pour chacun des 
parametres. La comparaison des resultats 
obtenus chez les animaux de controle avec 
ceux recueillies chez les autotransplantes 
devait d’abord permettre de discerner les 
effets de la denervation cardiaque, alors que 
l’etude comparee des autotransplantes et des 
homotransplantes avait pour but d’etablir les 
repercussions fonctionnelles rattachables au 
rejet.
R esultats
Groupe I—Homotransplantes
L’amplitude de l’onde “R” enregistree 3 
heures apres l’intervention fut prise comme 
point de reference et les changements ulte- 
rieurs de voltage furent exprimes en pour- 
centage. On remarquait d’abord une legere 
augmentation de voltage 2 a 3 jours apres 
l’intervention, suivie d’une diminution peu 
importante mais significative durant la phase 
III. Durant la derniere phase, on enregistrait 
une chute tres importante d’amplitude de 
l’ordre de 50% (Fig. 2).
Le rythme cardiaque etait sinusal et a 
155 battements par minute immediatement 
apres l’intervention. Le ralentissement de 
20% observe durant la phase II accompa- 
gnait vraisemblablement la recuperation 
fonctionnelle comme il sera demontre plus
Fig. 2 .—Variations postoperatoires du voltage 
de l’onde “R” en derivation D2 (RD,) (% change- 
ment). Figurent sur les graphiques les valeurs 
moyennes de chaque groupe ainsi que les erreurs 
standards de la moyenne. L’abscisse situe les pha­
ses postoperatoires comme suit: phase I, 3 h post­
operatoires; phase II, 2 a 3 jours postoperatoires; 
phase III, 4 a 5 jours postoperatoires; phase IV, 6 
a 7 jours postoperatoires.
loin. A la phase III, le rythme cardiaque 
moyen s’elevait legerement a cause d’une 
tachycardie sinusale survenue chez deux 
sujets. Par ailleurs, alors que la performance 
cardio-vasculaire de l’homotransplante etait 
tres atteinte durant la phase IV, le rythme 
cardiaque de ces sujets ne s’est pas accelere 
tel que prevu (Fig. 3).
Le debit cardiaque etait tres reduit 3 
heures apres l’intervention tel que demontre 
anterieurement.1 Apres 2 a 3 jours, il re- 
montait a 4.6 //min'm2. Durant la phase 
III, il n’y eut aucun changement statistique- 
ment significatif, alors que durant la phase 
terminale on observait une chute tres im­
portante de 1’index cardiaque jusqu’a une 
valeur moyenne de 2.15 //min*m2 (Fig. 4).
Fig. 3.—Variations postoperatoires du rythme 
cardiaque (RC) (battements/min). (La significa­
tion des valeurs et des phases est identique a celle 
de la Fig. 2.)
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Comme decrit anterieurement, l’index du 
volume d’ejection systolique etait tres reduit 
dans les heures suivant l’intervention.- 
Apres avoir atteint une valeur moyenne de 
36 ml 2 a 3 jours plus tard, on observait une 
diminution peu importante mais significa­
tive durant la phase III. Toutefois, l’accele- 
ration moyenne du rythme cardiaque durant 
la meme phase a pu etre en partie respon- 
sable de cette legere diminution du volume 
d’ejection, rendant Interpretation de ce 
changement fonctionnel douteuse. Durant la 
phase terminate, il y avait un abaissement 
tres important de l’index du volume d’ejec­
tion systolique chez tous les animaux en depit 
du ralentissement cardique observe durant 
cette phase (Fig. 5).
Apres avoir ete tres court 3 heures apres 
l’intervention, le temps d’ejection systolique 
s’allongeait a 157 ms durant phase II de 
pair avec l’augmentation du volume d’ejec­
tion systolique. Un leger raccourcissement 
fut observe en phase III, mais a pu s’expli- 
quer en partie par l’acceleration moyenne du 
rythme cardiaque. Toutefois, alors que le 
volume d’ejection systolique etait tres di- 
minue et que le rythme cardiaque etait in­
change en phase terminate, on remarquait 
un allongement significatif du temps d’ejec­
tion chez tous les animaux (Fig. 6).
L’index du debit moyen d’ejection systo­
lique etait reduit a 87 ml/s immediatement 
apres l’intervention. Apres 2 a 3 jours, il 
remontait a 230 ml/s pour ensuite accuser 
une baisse significative de 16% durant la 
phase III. Cette diminution progressait 
ulterieurement pour atteindre une valeur
Fig. 5. —Variations postoperatoires de l’index du volume d’ejection systolique (IVES) (ml). (La signification des valeurs et des phases est identique a celle de la Fig. 2.)
Fig. 6.—Variations postoperatoires du temps d’ejection systolique (TES) (ms). (La signification des valeurs et des phases est identique a celle de la Fig. 2.)
Fig. 7.—Variations postoperatoires de l’index du debit moyen d’ejection systolique (IDMES) (ml/s). (La signification des valeurs et des phases est identique a celle de la Fig. 2.)
moyenne de 125 ml/s durant la phase termi­
nate (Fig. 7).De 316 m l/s calcule durant la phase II, 
le debit systolique maximum de l’homo- 
transplante diminuait de 15% durant la 
phase III. Cette diminution statistiquement 
significative se continuait durant la phase
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Fig. 9.—Variations postoperatoires de l’index de 
la vitesse systolique maximum (IVSM) (cm/s). 
(La signification des valeurs et des phases est 
identique a celle de la Fig. 2.)
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Fig. 8 —Variations postoperatoires de l’index du 
debit systolique maximum (IDSM) (ml/s). (La 
signification des valeurs et des phases est identi­
que a celle de la Fig. 2.)
IV pour atteindre une valeur moyenne de 
208 ml/s (Fig. 8).
Les valeurs de l’index de vitesse systo­
lique maximum ont suivi la meme courbe 
devolution que celle du debit. Apres avoir 
atteint une valeur maximum 2 a 3 jours apres 
Fintervention, la vitesse systolique accusait 
un ralentissement peu marque mais signifi- 
catif durant la phase III en depit d’une acce­
leration du rythme cardiaque. Cette diminu­
tion se continuait dans la meme direction 
durant la phase IV chez tous les homotrans- 
plantes (Fig. 9).
L’acceleration du sang dans l’aorte aug- 
mentait substantiellement durant la phase 
de recuperation. De tous les parametres 
analyses, l’acceleration maximum protosys- 
tolique de l’homotransplante a presente les 
modifications les plus importantes durant
* i-J. li.JL iV
Fig. 10.—Variations postoperatoires de l’accele- 
ration protosystolique (ACCEL) (cm/s-s). (La 
signification des valeurs et des phases est identique 
a celle de la Fig. 2.)
la troisieme phase postoperatoire. En effet, 
on a pu observer durant cette phase une 
chute tres substantielle de l’ordre de 25% 
de la valeur de ce parametre. Cet abaisse- 
ment s’est accentue davantage durant la 
phase terminale chez tous les animaux (Fig. 
10) .
Apres que la puissance ventriculaire gau­
che eut triple de la phase I a la phase II, 
cet index accusait une baisse significative 
de 15% durant la phase III. Cette decrois- 
sance se continuait davantage durant la 
phase terminale pour atteindre une valeur 
moyenne de 3 x 104 ergs (Fig. 11).
Apres que le travail systolique ventricu­
laire gauche se soit eleve parallelement a la 
puissance durant la phase de recuperation, il 
s’abaissait de 20% 4 a 5 jours apres 1’inter- 
vention. Aussi, voit-on que sa valeur conti­
nuait a decroitre rapidement durant la phase 
IV (Fig. 12).
14 
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Fig. 11.—Variations postoperatoires de l’index 
de puissance systolique maximum (IPSM) ventri­
culaire gauche (ergs x 104). (La signification des 
valeurs et des phases est identique a celle de la 
Fig. 2.)
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Fig. 12. —Variations postoperatoires de l’index 
du travail systolique maximum (ITSM) ventricu- 
laire gauche (dynes x 103). (La signification des 
valeurs et des phases est identique a celle de la 
Fig. 2.)
Aucun changement significatif de la pres- 
sion aortique ne se produisit de la premiere 
a la troisieme phase postoperatoire. Toute- 
fois, durant la phase terminale, et plus 
particulierement dans les heures precedant 
le deces, on remarquait une chute substan- 
tielle des pressions arterielles systolique, dia- 
stolique et moyenne (Fig. 13).
__  __  ___ ContrSle
Fig. 13 .—Variations postoperatoires de la pres- 
sion de aortique systolique (PAS) (a), diastolique 
(PAD) (b), et moyenne (PAM) (c) (mm Hg). (La 
signification des valeurs et des phases est identique 
a celle de la Fig. 2.)
Comme demontre anterieurement, la re­
sistance peripherique etait tres elevee imme- 
diatement apres l’intervention. Elle diminu- 
ait a 36 unites durant la phase II pour 
demeurer stable jusqu’a 5 jours apres l’in- 
tervention. Durant la phase terminale, la 
resistance moyenne s’elevait, mais ce chan­
gement etait peu marque en depit d’une 
atteinte profonde de la performance cardia- 
que (Fig. 14).
En raison de la defaillance cardiaque 
postoperatoire immediate, la tension veineuse 
centrale etait elevee 3 heures apres l’inter- 
vention. Elle diminuait a des valeurs nor- 
males durant la phase de recuperation et ne 
se modifiait pas durant la phase III. Toute- 
fois, elle s’elevait d’une fagon substantielle 
et a des niveaux anormaux durant les 24 
heures precedant le deces (Fig. 15).
20 -
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Fig. 14 .—Variations postoperatoires de la re­
sistance peripherique moyenne (RPM) (unites). 
(La signification des valeurs et des phases est iden­
tique a celle de la Fig. 2.)
Fig. 15.—Variations postoperatoires de la ten­
sion veineuse centrale (TVC) (cm ILO). (La signi­
fication des valeurs et des phases est identique a 
celle de la Fig. 2.)
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Groupe 2— A utotransplantes
Les resultats des etudes hemodynamiques 
pratiquees chez les animaux autogreffes re- 
cueillis 3 heures ainsi que 2 a 3 jours apres 
l’intervention, etaient tout a fait superposa- 
bles a ceux obtenus chez le groupe d’homo- 
transplantes et ne necessitent aucun com- 
mentaire. Toutefois, durant la phase III, les 
resultats obtenus chez ce groupe se deta- 
chaient tres distinctement de ceux des homo­
greffes et Ton observait que la performance 
du coeur denerve s’ameliorait davantage 4 
a 5 jours apres l’intervention (Figs. 4, 
5 et 7 a 12). Au surplus, une legere ameliora­
tion subsequente de la performance cardiaque 
etait notee 6 a 7 jours apres l’intervention si 
l’on en juge par une elevation des valeurs de 
certains index tels le volume d’ejection systo- 
lique, le debit moyen d’ejection systolique, 
le debit et la vitesse systolique maximum 
ainsi que l’acceleration (Figs. 5 et 7 a 10).
Apres s’etre elevee durant la phase II 
Famplitude de Fonde “R” s'abaissait sub- 
stantiellement durant la phase III pour se 
stabiliser par la suite. Cette baisse de voltage 
fut analogue a celle observee chez le grou­
pe d’homotransplantes durant la meme pe- 
riode (Fig. 2). Enfin, on doit noter qu’en 
phase terminale, alors que la performance du 
coeur autogreffe etait encore inferieure a 
celle de l’animal de controle, la pression aor- 
tique systolique, diastolique et moyenne ainsi 
que la resistance peripherique etaient quand 
meme inferieures aux valeurs de controle 
(Figs. 13 et 14).
Groupe 3— Controles
La performance cardiaque du groupe 
controle etait remarquable en phase post- 
operatoire immediate. Deux a 3 jours apres 
Fintervention, la fonction cardiaque s’ame­
liorait substantiellement si Fon en juge par 
les resultats obtenus. II apparut que ces ani­
maux atteignaient leur plateau de perfor­
mance assez precocement puisqu’apres le 3e 
jour, on observait qu’une legere augmenta­
tion des valeurs moyennes de certains para- 
metres analyses (Figs. 4, 5 et 7 a 11). Enfin, 
on doit noter qu’il n’y eut aucun change- 
ment significatif d’amplitude de Fonde “R” 
durant les quatres phases postoperatoires 
(Fig. 2).
C O M M EN TA IR ES
La defaillance postoperatoire immediate 
a deja ete decrite par Fauteur, et l’impor- 
tance de l’acceleration du rythme cardiaque 
durant cette phase a ete soulignee.2 Aussi, 
une premiere ebauche descriptive de la fonc­
tion de l’homogreffe orthotopique a ete 
presentee.1 Ces resultats indicateurs ont in­
cite l’etude de l’evolution hemodynamique 
du sujet porteur d’une homogreffe cardiaque 
depuis le moment de Fintervention jusqu’au 
deces en rejet aigu.3' 3 Toutefois, seulement 
certains parametres de base ont ete analyses 
lors de ces etudes, le groupe d’allogreffes 
etait restreint et heterogene quant a la survie 
moyenne, et de ce fait, l’analyse statistique 
des resultats n’a pu etre produite. De plus, 
ces experiences n’incluaient pas d’animaux 
de controle, et les quelques autogreffes etu- 
dies n’etaient pas investigues suivant un pro­
tocole hemodynamique semblable a celui des 
homogreffes. Ainsi, l’importance relative de 
la denervation cardiaque et du rejet dans la 
genese de l’atteinte fonctionnelle observee 
chez l’homotransplante n’a pas ete etablie, 
et surtout la preuve que les perturbations 
cardio-vasculaires detectees plus tard chez 
Fhomotransplante etaient secondaires au re­
jet aigu n’a pas ete produite.
Dans le present travail, un nombre suf- 
fisant d’animaux de controle, d’autogreffes 
et d’homogreffes fut utilise. Ces animaux 
etaient conditionnes et exempts de toute 
morbidite selon les criteres mentionnes plus 
haut.6 Ils etaient prepares de la meme fagon 
pour fins d’etudes hemodynamiques seriees 
et le protocole d’investigation hemodyna­
mique adopte etait identique pour tous. En 
plus des parametres de base, ce protocole 
comprenait l’analyse d’indices additionnels 
valables de fonction ventriculaire tels les 
index de vitesse et de debit instantane, de 
puissance et de travail ventriculaire gauches, 
et d’acceleration. Enfin, le groupe d’homo­
transplantes choisis pour les fins de ce 
projet etait homogene quant a la survie 
moyenne. Ainsi, les resultats individuels 
recueillis chez les homogreffes ont ete com­
piles selon un ordre chronologique, quatre 
phases postoperatoires bien identifiables ont 
pu etre etablies, les donnees obtenues chez 
les deux autres groupes de sujets ont ete
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reportees a ces memes phases postopera- 
toires, et l’analyse statistique des resultats 
a pu etre produite.
Avant d’etablir le role du rejet dans revo­
lution fonctionnelle de l’homotransplante, les 
consequences de la denervation cardiaque 
devaient d’abord etre discernees. C’est pour- 
quoi les resultats obtenus chez les animaux 
de controle furent compares a ceux re- 
cueillis chez l’autotransplante uniquement 
pour situer et eliminer les variables induites 
par la denervation. Par la suite, Involution 
hemodynamique de l’homotransplante pou- 
vait etre comparee a celle de l’autogreffe et 
les repercussions fonctionnelles rattachables 
uniquement au rejet cardiaque aigu pou- 
vaient etre etablies.
La courbe de fonction cardiaque des auto- 
greffes est nettement inferieure a celle des 
animaux de controle durant toute la periode 
d’etude. Mis a part certains facteurs tels 
l’ischemie myocardique expliquant vraisem- 
blablement l’insuffisance cardiaque postope- 
ratoire immediate de l’autogreffe, on remar- 
que lors des phases ulterieures que sa 
recuperation fonctionnelle progressive est 
toutefois incomplete, ce qui signifie certaines 
repercussions de la denervation cardiaque. 
La physiopathologie de la denervation car­
diaque ne faisant pas l’objet de cet expose, 
aucun commentaire ulterieur ne sera fait a 
ce sujet. La courbe devolution fonctionnelle 
du coeur denerve etant maintenant etablie 
avec certitude, il nous est permis de proceder 
a l’analyse des resultats obtenus chez l’ho- 
motransplante orthotopique sujet au rejet 
cardiaque.
Comme rapporte anterieurement, la fonc­
tion cardiaque des homotransplantes est tres 
reduite immediatement apres l’intervention 
en raison des differents facteurs etiologiques 
deja mentionnes.2' 3 Deux a 3 jours plus 
tard, l’animal recupere et l’homogreffe at- 
teint un plateau de performance cardio- 
vasculaire qui n’est jamais depasse par la 
suite. Puisqu’a partir de ce moment la fonc­
tion de l’homogreffe cardiaque ne s’ameliore 
pas davantage comme celle de l’autogreffe, il 
est permis de conclure que le coeur homo- 
transplante rejete totalement entre 6 et 7 
jours, se voit altere dans sa fonction avant 
meme d’avoir atteint un niveau de perfor­
mance comparable a celui du coeur denerve.
Apres la 3e journee postoperatoire, Invo­
lution hemodynamique des homotransplantes 
differe totalement de celle des autogreffes. 
Durant la troisieme phase postoperatoire, on 
observe une deterioration progressive de la 
fonction contractile. Cette atteinte se ma- 
nifeste par une attenuation significative des 
valeurs de l’index du debit systolique maxi­
mum, de la vitesse systolique maximum, de 
l’index du debit moyen d’ejecdon systolique, 
de la puissance et du travail ventriculaires 
gauches, et surtout de Facceleration maxi­
mum protosystolique. La comparaison de 
ces resultats avec ceux recueillis chez l’auto- 
transplante durant la meme phase permet de 
conclure que cette atteinte fonctionnelle ini­
tiate observee chez Fhomotransplante est se- 
condaire au rejet cardiaque qui commence a 
se manifester.
Cette periode qualifiee de phase initiale 
de rejet n’indique pas que la crise de rejet 
debute a ce moment mais signifie plutot 
qu’elle n’est detectable hemodynamiquement 
et sur la base des parametres analyses qu’a 
partir de ce moment. Durant cette phase, 
aucun signe clinique de rejet n’a jamais ete 
detecte. De plus, aucune alteration electro- 
cardiographique n’a precede les indices he- 
modynamiques precoces du rejet dans cette 
etude. Enfin, la legere diminution d’ampli- 
tude de l’onde “R” observee durant cette 
troisieme phase fut aussi notee chez l’auto- 
greffe; cette similitude nous empeche de 
conclure que cette chute de voltage est se- 
condaire au rejet. Cette observation met en 
doute l’opinion maintes fois emise que la 
baisse de voltage electrocardiographique 
constituait un indice precoce de rejet car­
diaque. Quant a la baisse d’amplitude de 
l’onde “R” notee chez l’autotransplante, 
mise a part l’interruption des lymphatiques 
cardiaques comme facteur etiologique pro­
bable, aucune explication valable ne peut 
etre apportee.
Durant la phase terminale, l’atteinte car- 
dio-vasculaire du sujet porteur d’un coeur 
homotransplante est encore plus marquee. 
Cette perturbation se manifeste d’abord par 
une accentuation de l’atteinte des parametres 
deja existante durant la phase precedente. 
De plus, on voit une chute importante du 
debit cardiaque, de l’index du volume d’ejec- 
tion systolique, du voltage electrocardiogra-
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phique, et d’un allongement significatif du 
temps d’ejection systolique. Dans les heures 
precedant le deces en defaillance cardiaque 
terminate, les pressions aortiques systoli­
que, diastolique et moyenne s’affaissent, et 
la tension veineuse centrale s’eleve rapide- 
ment. Ces resultats different totalement de 
ceux obtenus chez les autotransplantes du- 
rant la meme periode, on peut conclure que 
cette atteinte fonctionnelle terminale ob- 
servee chez l’homotransplante est aussi se- 
condaire au rejet.
Durant cette phase terminale, la resistance 
peripherique s’eleve mais ce changement est 
peu marque en depit d’une atteinte pro- 
fonde de la fonction cardiaque; cette ob­
servation laisse suspecter un controle vas- 
culaire peripherique inadequat chez le 
transplant^. Enfin, alors que la performance 
cardio-vasculaire de l’homotransplante est 
tres atteinte durant cette phase, on remarque 
que le rythme cardiaque quoique sinusal ne 
s’est pas accelere. Cette absence de tachycar- 
die reflexe demontre qu’un mecanisme de 
defense normalement tres important est 
perdu par l’homogreffe en rejet cardiaque 
aigu. Durant cette phase terminale, les ma­
nifestations electrocardiographiques du re­
jet sont evidentes. Dans les 24 heures 
precedant le deces, les signes cliniques de 
defaillance cardiaque apparaissent, l’etat 
general du sujet se deteriore progressivement, 
et meme dans les heures precedant le deces, 
l’equilibre acidobasique est perturbe.
C o n c l u s io n
A partir du 4e jour postoperatoire, on ob­
serve initialement chez l’homotransplante 
une baisse significative du debit systolique 
maximum, de l’index de vitesse systolique 
maximum, de l’index du debit moyen d’ejec­
tion systolique, de la puissance et du travail 
ventriculaire gauches, et surtout de l’acce- 
leration maximum protosystolique. En 
phase terminale, on voit une accentuation de 
l’atteinte deja existante des parametres et 
de plus, une chute importante du debit car­
diaque, de l’index du volume d’ejection sys­
tolique, du voltage electrocardiographique, 
et un allongement du temps d’ejection. Dans 
les heures precedant le deces en defaillance 
cardiaque terminale, la pression aortique
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s’affaisse et la tension veineuse centrale 
s’eleve rapidement. L’evolution hemodyna- 
mique de l’autotransplante differe totalement 
a partir de la troisieme phase postoperatoire. 
La comparaison des resultats obtenus chez 
ces deux groupes experimentaux etablit la 
preuve que l’atteinte fonctionnelle graduelle 
decrite chez Fhomotransplante a partir de 
ce moment represente l’expression hemody- 
namique du rejet cardiaque aigu.
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SUDDEN HEMOLYSIS INDICATING PROSTHETIC 
VALVE DYSFUNCTION*
JEAN R. ALLARD, MD, FRCS[C], GEORGE FRASER, MD 
and ANTHONY R. C. DOBELL, MD, FRCS[C], FACS
Ten months after aortic valve replacement 
(Bjork-Shiley prosthesis) a 57-year-old man had 
thrombotic encapsulation of his prosthetic valve. 
The only clinical manifestation of this serious 
complication was gross hemoglobinuria. The 
management of the patient is described. The 
slightest change in the condition of a patient 
after prosthetic valve replacement should be 
viewed as a possible sign of thrombosis.
Dix mois apres le remplacement de la valvule 
aortique par une prothese de Bjork-Shiley, un 
homme de 57 ans a presente une encapsulation 
thrombotique de la valvule prosthetique. La 
seule manifestation clinique de cette serieuse 
complication a ete une hemoglobinurie severe. 
La traitement du patient est decrit. A la suite 
de la pose d'une valvule prosthetique, le moindre 
changement dans I'etat du patient devrait etre 
considere comme un signe possible de throm­
bose.
Thromboembolism is a serious complica­
tion of prosthetic valve replacement.1'3 The 
most common clinical manifestation is sys­
temic embolism, but occasionally interfer­
ence with valve function results in rapidly 
progressing and life-threatening heart failure.
We describe a patient with a large peri- 
valvular thrombus who had severe hemolysis 
producing hemoglobinuria without hemody­
namic symptoms.
Case R eport
A 57-year-old man with calcific aortic 
stenosis (NYHA class IV— confined to bed or 
chair) underwent aortic valve replacement with 
a no. 25 Bjork-Shiley prosthesis in March 
1974. Because of heavy calcification of the 
valve and annulus, sutures were placed with 
difficulty. His postoperative course was 
normal. At the time of discharge on the 12th 
postoperative day he was taking digoxin but 
no anticoagulants. His convalescence was pro­
longed, but by January 1975 he was able to 
return to his previous employment. At this 
time his physical activity was only slightly
*From the division of cardiovascular and thoracic 
surgery, and the department of cardiology, Royal 
Victoria Hospital, McGill University, Montreal, 
Que.
Reprint requests to: Dr. A. R. C. Dobell, Division 
of cardiovascular and thoracic surgery, Royal Vic­
toria Hospital, 687 Pine Ave. W, Montreal, PQ 
H3A 1A1.
limited (NYHA class II). On Jan. 11, 1975 
he noticed that his urine was dark brown. As 
the dark colour was still present after 2 days, 
he was admitted to hospital.
The patient gave no history of drug inges­
tion or of contact with noxious fumes. He 
denied any symptom other than dark brown 
urine. He was in no distress (pulse 80 beats/ 
min; blood pressure, 130/80 mm Hg; respira­
tion rate, 14/min; temperature, 37°C). There 
were no signs of congestive heart failure. Aus­
cultation of the heart revealed a harsh systolic 
ejection murmur (grade IV/VI) over the aortic 
area radiating to the base of the neck. There 
was a thrill over the area. A short (grade III/ 
VI) diastolic murmur could be heard over the 
aortic valve area. The characteristic prosthetic 
sounds were muffled. The rest of the physical 
findings were normal. Further investigation 
yielded the following pertinent findings: hemo­
globin, 14 g/dl; leukocyte count, 8.7 x 109//; 
urinalysis, dark brown urine strongly positive 
for blood and protein, but no red blood cells; 
chest radiograph, reduction in heart size since 
operation; electrocardiogram, residual left ven­
tricular hypertrophy with ischemic changes 
similar to the predischarge tracing.
The initial diagnostic possibilities were: (a) 
a sudden paravalvular leak producing hemoly­
sis without hemodynamic disturbance; (b) an 
obstruction at the valve site producing the 
harsh ejection murmur; (c) a combination of 
increased red cell fragility (from undetermined 
cause) and a mild hemodynamic lesion.
Further hematologic investigation showed 
evidence of intravascular hemolysis: the blood 
smear showed target cells, helmet cells, dis­
torted cells and many red blood cell frag­
ments; Coombs’ tests, direct and indirect, were 
negative; plasma hemoglobin concentration was 
64 mg/dl; the methemalbumin and the acid 
hemolysin tests were negative. The Ham test 
(red cell fragility) was negative. The urinary 
hemosiderin was negative, indicating recent 
onset of significant hemolysis. Blood chemis­
try findings were also compatible with hemoly­
sis: serum bilirubin concentration, 2.6 mg/dl; 
alkaline phosphatase value, 53 IU (normal, 
30 to 85); lactic acid dehydrogenase (LDH) 
value, 1485 IU (normal, 80 to 240); serum 
glutamic oxaloacetic transminase (SGOT) 
value, 103 IU (normal, 10 to 42); blood urea 
nitrogen concentration, 14 mg/dl; serum crea­
tinine concentration, 1.5 mg/dl.
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Cardiac fluoroscopy was normal and no ab­
normality of valve function was detected. All 
blood cultures were negative.
The patient remained afebrile and hemody- 
namically stable. His diastolic pressure re­
mained normal. The diastolic murmur was not 
always present, but the harsh systolic murmur 
and the thrill were constant. Three days after 
admission, the hemoglobin concentration had 
decreased to 12 g/dl and the platelet count 
was 365 x 109//. The next day the hemoglobin 
was 10.6 g/dl and the platelet count was 182 x 
10s//. The urine remained dark. The valve 
sounds were muffled.
We decided to perform an exploratory pro­
cedure. A large encapsulated thrombus was 
attached to the struts of the tilting-disc valve, 
filling much of the lesser orifice, thus pre­
venting complete opening (the harsh systolic 
murmur) or complete closure (the diastolic 
murmur). There was no valve dehiscence. The 
thrombus was removed and the valve was 
thoroughly cleaned and gently irrigated. Mo­
tion of the disc was adequate. Portions of the 
thrombus sent for culture were sterile.
The cardiac output (thermodilution tech­
nique) measured preoperatively with the pa­
tient under general anesthesia was 3.2 //m in. 
After the operative procedure, under similar 
conditions, it was 4.6 //min. The colour of the 
urine was normal immediately after operation.
The patient had an uneventful postoperative 
course. He received oral anticoagulants as soon 
as the mediastinal drainage tubes were re­
moved. On the 7th postoperative day, at time 
of discharge, his hemoglobin concentration was 
12 mg/dl; serum bilirubin concentration, 0.95 
mg/dl; LDH value, 397 IU; and SGOT, 22 
IU. He continued to take digoxin, 0.25 mg 
daily, and oral anticoagulants.
D iscussion
One of the prerequisites of the ideal 
prosthetic valve is lack of thrombogenicity, 
but, because we have not reached this uto­
pia, it is customary to prescribe long-term 
oral anticoagulation for all patients having 
valve replacement. Regrettably thromboem­
bolism still occurs.
Until recently, we, and others,4 used a 
cloth-covered valve in the aortic area and 
did not administer anticoagulants, since we 
had some tragic complications resulting 
from the use of anticoagulants. Our present 
recommendation is that all patients with 
prosthetic valves should receive well-super­
vised anticoagulant therapy.
Thrombosis has occurred both in un­
treated patients and those receiving antico­
agulants.3 The complication is usually mani­
fested by acute valvular dysfunction.3’ 5-7 
Recently, Byrd, Yahr and Greenberg8 re­
ported six cases of thrombotic encapsula­
tion seen in a 2-year period; all patients had 
either stenosis or incompetence of the pros­
thetic valve. Coagulation control in all pa­
tients was poor at the time. They proposed 
thrombectomy with or without valve replace­
ment as treatment. One patient with acute 
stenosis died of cardiac arrest before opera­
tion.
In our patient the presentation was dif­
ferent. Although there was a valvular throm­
bus he remained free of symptoms until 
hemolysis produced a clinical sign.
Conclusion
Thrombotic phenomena after prosthetic 
valve replacement are still a problem. This 
brief report and review show its protean 
manifestations. Whether or not patients are 
taking anticoagulants, any change in their 
condition, gross distress or a subtle ausculta­
tory change, should be looked upon as a 
possible manifestation of this complication.
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B O O K  R E V I E W S
THE ARTERIES AND VEINS OF THE HU­
MAN SPINAL CORD FROM BIRTH. G. 
F. Dommisse. 104 pp. Illust. Churchill Liv­
ingstone, Edinburgh; Longman Canada Lim­
ited, Toronto, 1975. $32.50.
This book is a detailed study of the vascular 
patterns of human spinal cord. The research 
was carried out over a 3-year period in the de­
partment of anatomy at the University of Pre­
toria. The researchers intended to clarify the 
variations of arterial supply and venous drain­
age by microdissection and injection tech­
niques. Neoprene latex, which fills all but the 
capillaries, and Micropaque, which enters the 
microvascular bed, were used in these studies.
The author summarizes his results from mi­
crodissection in 42 human specimens; radio- 
graphic studies and animal studies using ba­
boons supplemented the research. The 42 
outline drawings of the anterior and posterior 
longitudinal arterial trunks of the spinal 
cord, detail the size, number and disposi­
tion of the segmental vessels, and 30 colour 
pictures are included as examples of the vessel 
patterns. Information on the width of the spinal 
canal from examination of radiographs and 
specimens is included. Unfortunately some of 
the black and white reproductions are of poor 
quality.
The bibliography is useful and interesting. 
It includes reference to “Anatomy of the Brain 
and Nerves” by Thomas Willis, published 
in 1664. This was one of the first detailed de­
scriptions of the anatomy of spinal cord cir­
culation. Willis showed (Table 13) the radicular 
arteries coming off the vertebral arteries which 
“sends shoots into the spinal marrow that join 
from either sides”. The figures emphasized 
the longitudinal and side-to-side collaterals. 
We now know that the segmental pattern 
Willis described was far too regular. Dom­
misse has stressed the variability in size and 
arrangement of the spinal arteries. This in­
formation will be of great interest to neuro­
logists, neurosurgeons and neuroanatomists.
W. H. Feindel
Montreal Neurological Institute,
3801 University St.,
Montreal, Que.
AN ATLAS OF NORMAL ROENTGEN 
VARIANTS THAT MAY SIMULATE 
DISEASE. Theodore E. Keats. 351 pp. 
Illust. Year Book Medical Publishers, Inc., 
Chicago, 1973 (reprinted July 1974 and 
August 1975). $35.00.
The many normal radiographic variants can 
mislead the observer. It is a pleasure to see an 
atlas that illustrates the subtle normal ana­
tomical variants that may deceive the unwary. 
This atlas demonstrates that an apparent de­
parture from the norm is simply a variant and 
not an abnormality.
The atlas is made up of a series of excellent 
radiographic reproductions arranged anatomic­
ally to illustrate normal variants occurring in 
the skull, bones and soft tissues. The emphasis 
is properly placed on the illustrations, and the 
text is restricted to brief descriptive comments 
and suitable bibliographic references. The 
anatomical format allows ready reference de­
spite the absence of an index.
This book will be a considerable asset to 
the novice in radiology and to the more ex­
perienced observer; it will also be helpful to 
those who deal with problems in traumatic and 
orthopedic surgery. It is hoped that a com­
panion volume in neuroradiology and angio­
cardiography will soon be forthcoming.
M. P. Shannon
Department of diagnostic radiology,
Halifax Infirmary,
Halifax, NS.
ATLAS OF ORTHOTICS. Biomechanical 
Principles and Application. American Aca­
demy of Orthopaedic Surgeons. 507 pp. 
Illust. The C. V. Mosby Company, St. Louis, 
1975. $44.65.
This excellent and long-overdue text is the 
product of the committee of prosthetics and 
orthotics of the American Academy of Ortho­
paedic Surgeons. Unlike most enterprises de­
signed by committees, this book will become 
a classic in the field of applied orthotics. The 
great attribute of this volume is the lucid 
and understandable biomechanical approach in 
the discussion of the use of orthotics for hu­
man disability.
The division of the book into six parts— 
physical properties of materials, the upper 
limb, the lower limb, the foot, the spine and 
mobility aids—facilitates its use by both clini­
cian and engineer.
Previous orthotic texts have tended merely 
to list and describe orthosis; this book dis­
cusses the rationale behind the choice and use 
of orthosis from the Milwaukee brace to the 
simplest finger splint. The 29 chapters are by 
individual experts on orthotics. Several chap­
ters are unique—those on normal and abnor­
mal gait, shoes and shoe modifications, and
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the series of chapters on mobility aids. In the 
last group, architectural barriers and adaptive 
devices for automobiles are of special interest.
The epilogue on trends in research by 
Colin McLaurin is essential for anyone active 
in rehabilitation and orthotics. Though it is 
difficult to be critical of this book, the addi­
tion of a section on special devices and seating 
for spastic and dystrophic children would have 
been appreciated.
This is a text that can be read and under­
stood by orthotists, orthopedists, physiatrists, 
therapists, and biomedical engineers. I would 
highly recommend it to anyone concerned with 
rehabilitation of the physically handicapped.
R. M. Letts
Shriners Hospital for Crippled Children,
Winnipeg, Man.
CLINICAL NEUROSURGERY. Proceedings 
of the Congress of Neurological Surgeons, 
Vancouver, British Columbia, 1974. Edited 
by Robert H. Wilkins. 599 pp. Illust. The 
Williams & Wilkins Company, Baltimore; 
Burns & MacEachern Limited, Toronto, 
1975. $30.75.
This volume is an edited version of the pro­
ceedings of the 24th annual meeting of the 
Congress of Neurological Surgeons, held in 
Vancouver in September 1974. The initial 
chapters pay tribute to the neurosurgical con­
tributions of the honoured guest of the 
congress, Dr. Guy L. Odom. These initial 
chapters are followed by Dr. Odom’s excellent 
review of the state of knowledge concerning 
cerebral vasopasm. He demonstrates that the 
introductory chapters were not hollow plati­
tudes. The remaining 32 chapters cover broad­
ly the physiology of intracranial pressure and 
cerebral blood flow, medical and surgical as­
pects of cerebrovascular disease, monitoring 
in neurosurgical intensive care units, and 
economic and manpower reports relevant to 
neurosurgical practice. The contributions to 
these themes are well done, particularly the 
chapters on volume and pressure in the cranio­
spinal axis by J. Douglas Miller and clinical 
evaluation of the unconscious patient by Je­
rome B. Posner, and the twin chapters on the 
clinical aspects of cerebrovascular disease by 
C. Miller Fisher and James F. Toole.
Eleven chapters deal with the techniques 
and results of electronic monitoring of intra­
cranial pressure and other system functions 
in acutely ill neurologic patients. The final 
chapters dealing with economic and manpower
studies in neurosurgery are informative, al­
though the material discussed relates only to 
circumstances in the United States.
Like previous volumes in this series, this is 
an informative and up-to-date review of de­
velopments in neurosurgery and associated 
neurologic sciences. It is especially recom­
mended for trainees in these fields.
F . E . L e B la nc
Division of neurosurgery,
Foothills Hospital,
Calgary, Alta.
THE CURRENT STATUS OF CARDIAC
SURGERY. Edited by D. B. Longmore.
502 pp. Illust. University Park Press, Balti­
more, 1975. $39.50.
This book consists of an edited report of the 
proceedings of the fifth cardiac surgical course 
run by a group of venerable London hospitals. 
Participating in the course, which took place in 
1975, were 60 authors, mostly from Europe. It 
was moderated by Albert Starr of Oregon, who 
also contributed in a major way to the discus­
sion, which in the book is contained in a single 
section at the end.
The editing is excellent, and, despite the fact 
that the book is not intended to be compre­
hensive, it has an excellent balance and covers 
all areas of cardiac surgery.
An unexpected amount of space is devoted 
to cardiac transplantation and tetralogy, but 
both these sections are thoughtfully and clearly 
presented by many experts. There is no bias 
against heart replacement and the tone of this 
section indicates a sensible return to this treat­
ment in a few centres.
Prosthetic and tissue valves are described 
in detail, leaving the reader to make his own 
selection, but the glutaraldehyde-preserved 
xenograft emerges as a possible favourite. 
Congenital heart disease in infants and chil­
dren is thoroughly covered, as is postoperative 
care. One hears that much less coronary ar­
tery surgery is being done in Britain, but this 
section, too, is dealt with thoughtfully and 
extensively.
It is a very readable book of value to sur­
geons, cardiologists and their trainees. A few 
minor errors are evident— mislabelling of 
illustrations, mis-spelling of surnames—but 
these are few indeed.
A. R. C. D o b ell
Division of cardiovascular and thoracic surgery, 
Royal Victoria Hospital,
Montreal, Que.
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HYPOTHERMIA IN BIOLOGY AND IN 
MEDICINE. Vo jin Popovic and Pava 
Popovic. 305 pp. Illust. Grune & Stratton, 
Inc., New York; Longman Canada Limited, 
Toronto, 1974. $26.00.
This small book attempts to cover the entire 
field of mammalian hypothermia. It starts with 
basic principles of freezing and thawing, then 
deals with hypothermia in the several organ 
systems and the effect of drugs on the modifi­
cation of the hypothermic response, and closes 
with a discussion of organ preservation and 
hibernation.
Each chapter is crisp, succinct, and well 
documented, but in the attempt to introduce 
as much detailed information as possible with­
in the limits of the manuscript, the authors’ 
style has become crisp and succinct to the 
point where readability is occasionally sacri­
ficed on the altar of more information. As an 
initial reference source, the book should prove 
valuable: the total number of references ex­
ceeds 1700. The chapter headings are simple 
and straightforward and related to systems and 
organs such as the gastrointestinal tract, car­
diovascular and nervous systems. The greatest 
attention has been paid to the effects of hypo­
thermia on the circulatory system, perhaps be­
cause hypothermia has been most diligently 
used and explored in relation to circulatory 
arrest and the surgical efforts that once re­
quired its use.
In this book the authors give little of their 
own research, personal interest or bias, and it 
best serves as a reference work to lead into 
original manuscripts. It is a book for special­
ized interests. A few pages provide a multitude 
of facts upon any specific subject related to 
hypothermia, and the bibliography gives ade­
quate documentation as to where the basic 
information can be found.
C. B. Mueller
Department of surgery,
McMaster University,
Hamilton, Ont.
AN INTRODUCTION TO EXPERIMENTAL 
SURGERY. A Guide to Experimenting with 
Laboratory Animals. Edited by J. de Boer, 
.T. Archibald and H. G. Downie. 679 pp. 
Illust. Excerpta Medica, Amsterdam; Amer­
ican Elsevier Publishing Company, Inc., 
New York, 1975. $79.25.
Dedicated to the memory of a great Canadian 
experimental surgeon, J. Markowitz, this fine 
book appears when there is great need for a 
new approach to experimentation on labora­
tory animals. Of the 20 contributors, 8 are 
European and 12 are Canadian. The book is 
divided into five sections—planning, prepara­
tions, data aquisition, data processing and ap­
pendices—and gives important information 
such as normal values of biomedical parame­
ters and how to locate manufacturers of bio­
medical material.
As the titles of the sections indicate, the 
reader of this book is guided through all the 
major stages of the organization and methodo­
logy of an experiment. For example, the first 
section describes how to design an experiment, 
how to search the literature and how to con­
duct an experiment according to the law of 
experimentation. In the second section the 
care and health of laboratory animals are dis­
cussed, and the details of surgical procedures 
explained. The third section deals with tech­
niques of sampling, recording and measure­
ment and the fourth covers the principles of 
statistical analysis and computer utilization, 
terminating in a detailed discussion on the 
preparation of scientific reports. Finally, the 
appendices contain the information on normal 
values and biomedical parameters, information 
that is so difficult to collect from dispersed 
literature. Here an updated review of this 
topic becomes easily available to the experi­
menters using this valuable book.
I found the last two sections particularly 
interesting and important. Many medical scien­
tists and surgeons can perform technically fine 
experiments, but have no experience or ability 
in processing data according to modern scien­
tific requirements. This book clearly shows 
that, besides intelligent planning and technical 
perfection in the operating room, there re­
mains the most important problem of how to 
communicate the results. The instruction in 
this respect, included in the last section of the 
volume, is presented most satisfactorily.
The book is written clearly, well illustrated 
and rich in pertinent references. This volume 
should become an every-day companion for all 
scientists who work with laboratory animals.
K. Kowalewski
Surgical-Medical Research Institute,
University of Alberta,
Edmonton, Alta.
NEOPLASTIC DEVELOPMENT, Volume 2.
Leslie Foulds. 729 pp. Academic Press Inc.
(London) Ltd., London, 1975. $43.50.
This book is a worthy successor to, and con­
tinuation of, one that is a classic of its type. 
In the first volume, Leslie Foulds elaborated 
in considerable detail a concept of neoplastic
s
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progression that he developed through detailed 
study of the natural history and experimental 
aspects of cancer. In this volume he attempts 
to apply the general principles that cancer is 
not simply a change from a normal or prema- 
lignant cell to a cancer, but a series of intricate 
progressions during, in some instances, a 
lengthy period.
With reference to a series of neoplasms of 
different organs and systems, Fouids demon­
strates how both the natural history of the 
disease and experimental data can be linked 
with the theoretical and more experimental 
aspects of the study of tumours. His book is 
neither a compendium of tumours nor a text­
book of oncology but it does serve a unique 
function: one can refer to review articles, 
scientific papers and even monographs on de­
tailed aspects of cancer research or pathology, 
or to surgical textbooks that will give informa­
tion on particular tumours in both man and 
animals— but rarely can one find a treatise 
that brings together the detailed concepts of 
the development of tumours and the clinical 
manifestations. This book should not be con­
sidered as an alternative to standard textbooks, 
for it is in essence a means of seeing the prob­
lem of neoplasia in many of its perspectives; it 
will appeal to readers of varied backgrounds.
To obtain the maximum benefit from this 
second volume, readers should familiarize 
themselves with the first volume, because they 
certainly do not deal with separate subjects. 
Certain tumour systems are considered in more 
detail than others, and some of the sections 
are more up-to-date than others.
In a book that has developed over a period 
of years, it is not surprising that not all of the 
material represents immediate and up-to-date 
contributions. Nevertheless, there is a wealth 
of information that will be of value to re­
searchers, students, and practising oncologists 
of almost any discipline.
The book is not one to be read lightly and 
certainly it is not a superficial summary of 
tumours. Every section is joined together by 
the continuing thread of the concept of tu­
mour progression—the author’s unique con­
tribution to the study of cancer—in one of 
the best attempts to link many different facets 
of the study of cancer into a readable and ex- 
plorable presentation. Anyone with a serious 
interest in the field of neoplasia will find this 
and the previous volume a great asset and an 
essential addition. Both volumes are a worthy 
memorial to a man who saw the biology of 
cancer in a way that is rare in the history of 
the subject. No artificial distinctions are made
between the study of tumours in experimental 
animals and the equally important study of the 
natural history of the disease in man, and 
Fouids is one of few who have been able to 
bridge this often insurmountable gap. It 
is also refreshing to see that it is still possible 
to produce a scholarly description in a field 
that is so often filled with technical jargon 
and in which the principles of good literature 
appear to play a minor role.
Although this book contains perhaps few 
up-to-date references in several of the sections, 
it provides extensive coverage of the develop­
ment of this field over many of its critical 
years and still forms a firm foundation for 
anyone wishing to proceed further into the 
study of cancer.
M. G. Lewis
Cancer research unit,
McGill University,
Montreal, Que.
ORTHOPEDIC DISEASES. 4th ed. Edited 
by Ernest Aegerter and John A. Kirk­
patrick, Jr. 792 pp. Illust. W. B. Saunders 
Company, Philadelphia; W. B. Saunders 
Company Canada Limited, Toronto, 1975. 
$30.90.
Aegerter and Kirkpatrick have produced a 
fourth edition of a book that has been known 
to generations of graduate students simply by 
the authors’ names.
It is a readable book based on the authors’ 
own experience amplified by highly selected 
references to the literature. Candid comments 
about the varied usage of certain terms cor­
rect some common misunderstandings.
The first section contains a clear review of 
what we should all know but often forget con­
cerning connective tissues. An interpretation 
and systematization of disturbances in skeletal 
development follow. Few individual clinicians 
have enough experience of these rare condi­
tions to construct their own classification and 
most will prefer to use a framework such as 
this book provides and to fit their cases into it.
A large section deals with fractures, infec­
tions and circulatory disturbances of bone. A 
group of less common and often confusing 
subjects—the metabolic and endocrine dis­
turbances of bone—is explained simply and 
lucidly. Also included is a chapter on “the 
miscellaneous”, which is inescapable in at­
tempts to systematize bone pathology.
Problems in organizing the subject of bone 
tumours are also reviewed, and a good work­
able classification is offered. All the major 
bone tumours are described and illustrated.
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Where controversy rages supreme, the auth­
ors commit themselves to one viewpoint—an 
approach that is always more stimulating and 
helpful than one that is encyclopedic and in­
conclusive. In particular, they explain why 
there is no such entity as a giant cell tumour 
and then proceed to describe osteoclastoma 
very well.
Arthritis is covered concisely but compre­
hensively. A chapter on diseases of skeletal 
muscle draws attention to a rather neglected 
collection of disorders, and the book con­
cludes with a discussion of the soft-tissue tu­
mours that an orthopedic surgeon is likely to 
encounter.
The book is selective rather than compre­
hensive: it does not, for example, refer to 
pathology of congenital deformities or defi­
ciencies, or to scoliosis, but the large areas 
covered are simplified, classified and explained 
helpfully and authoritatively.
D. A. Gibson 
Division of orthopedics,
The Hospital for Sick Children,
Toronto, Ont.
PROBLEMS OF RECURRENT HERNIA. 
Robert C. Kimberly. 63 pp. Illust. Charles 
C Thomas, Publisher, Springfield, IL, 
1975. $6.50 paperbound.
This short book states clearly by means of 
texts and excellent drawings the author’s man­
agement of recurrent hernias. He makes a 
good case for the use of Marlex or Tantalum 
mesh in the repair of all recurrent hernias, 
though some would quarrel with this thesis.
The book will serve as a handy reference 
for medical students, residents and experienced 
surgeons just before operating on patients with 
these difficult problems. Because it illustrates 
only the author’s method it cannot be recom­
mended as a general discussion of the subject. 
A further defect is its lack of rating of the 
author’s results, so that his method cannot be 
compared with others. The book will have 
limited usefulness.
N. T. McPhedran 
Division of surgery,
University of Calgary,
Calgary, Alta.
SURGERY IN THE AGED. Lazar J. Green­
field. Volume XVII in Major Problems in 
Clinical Surgery. 151 pp. Illust. W. B. 
Saunders Company, Philadelphia; W. B. 
Saunders Company Canada Limited, To­
ronto, 1975. $12.90.
We are reminded at the beginning of this 
monograph that the US population over 65
years of age has increased from 1 in 25 per­
sons in 1900 to 1 in 10 today. The purpose 
of this text is to encourage interest in, and 
competent treatment of, the aged who require 
surgery. Malnutrition and infection (which 
may be causally related) are identified as the 
two factors most commonly responsible for 
deterioration and death in the elderly.
Special problems with anesthesia and wound 
healing, and cardiovascular, respiration, renal 
and genital problems are outlined for this age 
group and the use of preventive measures is 
emphasized. One concise chapter outlines the 
gastrointestinal problems unique to, or more 
common in, the elderly. Special efforts to sup­
port these patients psychologically are fre­
quently required.
The overall results of surgery in the aged 
are good, but the hazards of emergency oper­
ations are definitely increased especially in 
those over 80 years of age. Closure of wound 
dehiscence, cholecystostomy, aortic graft, su­
ture of perforated duodenal ulcer, resection 
and anastomosis of the small intestine in ob­
struction are all extremely hazardous in pa­
tients over 80. Earlier elective surgery would 
eliminate some of these problems.
This is an interesting text. It points out that 
though surgery is frequently required in the 
aged and the margin for error is extremely nar­
row, with our present knowledge the results 
are acceptable.
L. D. MacLean 
Department of surgery,
Royal Victoria Hospital,
Montreal, Que.
SURGICAL DISORDERS OF THE ADRE­
NAL GLAND: PHYSIOLOGIC BACK­
GROUND AND TREATMENT. Timothy 
S. Harrison, Donald S. Gann, Anthony 
John Edis and Richard H. Egdahl. 150 pp. 
Illust. Grune & Stratton, Inc., New York; 
Longman Canada Limited, Toronto, 1975. 
$16.75.
This monograph deals specifically, and in 
moderate depth, with the diseases of the 
adrenal glands and the operations required in 
their surgical treatment. Beginning with an in­
teresting chapter on the history of the dis­
covery of the adrenals, the authors immediate­
ly deal with the biochemistry of adrenal hor­
mone synthesis, discharge and systemic re­
sponse. Discussion of the categorical clinical 
disorders of tumours and hyperplasia is fol­
lowed by that of the clinical syndromes, the 
recognition of the patients, and then the weak­
nesses, fallacies and reliabilities of the many 
tests for the presence of adrenal tumours.
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This is an up-to-date discussion on clinical 
recognition of the disease and identification 
of the laterality, and a discussion of some 
elements of diagnosis, intraoperative and post­
operative management.
The section on the cortical abnormalities is 
followed by an excellent section on the adrenal 
medulla, and then by a most readable 
and educational account of the biosynthesis 
of medullary hormones and their release 
and effects. The discussion of medullary 
adrenal tumours, particularly pheochromocy- 
toma, is exhaustive, complete and instructive. 
The illustrations are well selected and suffi­
ciently clear for clinical interpretation. Refer­
ences to patients are scattered throughout the 
manuscript.
The authors of this book are recognized 
experts in this field and their contributions to 
the knowledge of the subject is considerable. 
Their synthesis of this material in their small 
book is another valuable contribution and 
makes a readable, informative handbook for 
easy reference with adequate documentation 
of source. This volume probably belongs 
in the reference library of every individual 
dealing with adrenal gland surgery.
C. B. Mueller 
Department of surgery,
McMaster University,
Hamilton, Ont.
THE YEAR BOOK OF ORTHOPEDICS AND
TRAUMATIC SURGERY. 1975. Edited
by H. Herman Young. 477 pp. Illust. Year
Book Medical Publishers, Inc., Chicago,
1975. $19.50.
The 1975 “Year Book of Orthopedics and 
Traumatic Surgery” provides an excellent op­
portunity for the busy orthopedic surgeon or 
senior resident to review his own personal 
filing system of important references from the 
orthopedic literature up to January 1975. I 
was surprised, though, to see that no articles 
were abstracted from Clinical Orthopaedics 
and Related Research, Orthopedic Clinics of 
North America or Injury.
One other small point needs comment. I 
question the need for or value of editorial 
comments such as “This article is excellent 
and should be studied in detail by every ortho­
paedic surgeon” (page 107) or “This technic 
is to be condemned” (page 193), when, in the 
foreword, the publisher states that only out­
standing abstracts are included in the book.
G. A. Hunter 
Department of surgery,
St. Michael’s Hospital,
Toronto, Ont.
Books Received
D’Abreau’s Practice of Cardiothoracic Surgery.
4th ed. J. Leigh Collis, D. B. Clarke and R. 
Abbey Smith. 710 pp. Illust. Edward Arnold 
(Publishers) Ltd., London; The Macmillan Com­
pany of Canada Limited, Toronto, 1976. $93.00.
The Adolescent Spine. Hugo A. Keim. 219 pp. 
Illust. Grune & Stratton, Inc., New York; Long­
man Canada Limited, Toronto, 1976. $21.25.
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Stratton Intercontinental Medical Book Cor­
poration, New York; Longman Canada Limited, 
Toronto, 1976. $28.50.
Cancer and Transplantation. (A Transplantation 
Proceedings Reprint, June 1975.) Edited by 
Gerald P. Murphy. 195 pp. Illust. Grune & 
Stratton, Inc., New York; Longman Canada 
Limited, Toronto, 1975. $16.75.
Clinical Tests of Oesophageal Function. Richard 
Earlam. 383 pp. Illust. Grune & Stratton, Inc., 
New York; Longman Canada Limited, Toronto, 
1975. $24.75.
Computed Tomography of the Brain and Orbit 
(EMI Scanning). Paul F. J. New and William 
R. Scott. 486 pp. Illust. The Williams & Wil­
kins Company, Baltimore; Burns & MacEachern 
Limited, Toronto, 1975. $43.45.
Human Neuroanatomy (Formerly Strong and 
Elwyn’s Human Neuroanatomy). 7th ed. Mal­
colm B. Carpenter. 741 pp. Illust. The Williams 
& Wilkins Company, Baltimore; Burns & Mac­
Eachern Limited, Toronto, 1976. $27.50.
Operative Anatomy of Abdomen and Pelvis. Ed­
ward A. Edwards, Paul D. Malone, John D. 
MacArthur. 418 pp. Illust. Lea & Webiger, 
Philadelphia; The Macmillan Company of Can­
ada Limited, Toronto, 1975. $41.75.
Principles of Thyroid Surgery. John M. Beaugie. 
225 pp. Illust. Grune & Stratton, Inc., New 
York; Longman Canada Limited, Toronto, 
1975. $19.00.
Progress in Cardiology 4. Edited by Paul N. Yu 
and John F. Goodwin, 224 pp. Illust. Lea & 
Febiger, Philadelphia; The Macmillan Com­
pany of Canada Limited, Toronto, 1975. 
$16.65.
Recent Advances in Plastic Surgery. 1. Edited by 
James Calnan. 210 pp. Illust. Churchill Living­
stone, Edinburgh; Longman Canada Limited, 
Toronto, 1976. $31.25.
Surgery of Peptic Ulcer. Vol. 18. Rene Menguy. 
297 pp. Illust. W. B. Saunders Company, Phila­
delphia; W. B. Saunders Company Canada 
Limited, Toronto, 1976. $15.45.
Surgical Management of Degenerative Arthritis 
of the Lower Limb. Edited by Richard L. 
Cruess and Nelson S. Mitchell. 236 pp. Illust. 
Lea & Febiger, Philadelphia; The Macmillan 
Company of Canada Limited, Toronto, 1975. 
24.50.
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CORRESPONDENCE
FACET FUSION
To the Editor: I have read with interest the 
recent paper by Dr. D. B. Forbes entitled 
“The Farfan Back Operation” (Can J Surg 
18: 546, 1975). In the opening paragraph 
the statement is made that “the operation 
differs from previously described facet oper­
ations advocated by Boucher and others”. 
My operation, however, does not include 
facet fusion, and a review of the technique 
described in “A Method of Spinal Fusion” 
(J Bone Joint Surg [Br] 41: 248, 1959) will 
verify this. The stability afforded by sound 
interbody fixation, using long, well-placed 
screws, is supplemented by leaving intact 
lateral articulations. My use of the long 
screw was to eliminate the reported multiple 
failures of facet fusions with the use of short 
screws and the associated lack of stability.
I trust you will appreciate that, as my 
operation was devised to avoid failure of 
fusion associated with facet fixation by short 
screws, and since the results have shown it 
did, it is necessary to correct the impression 
contained in Dr. Forbes’ paper.
Perhaps I should add that I have followed 
up my fusion operations by obtaining wide 
range bending films in two planes and I 
have been unable to detect a failure of fusion 
in the many I have done at the lumbosacral 
level. I believe these to be my most grateful 
patients.
H. H. Bo u ch er , MD, CM, MSc, FRCS[C]
925 West Georgia St.,
Vancouver, BC.
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